[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_7afcd79d-bb53-4ee4-9455-4e1539e045a2":865,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:7afcd79d-bb53-4ee4-9455-4e1539e045a2,\"}":919},{"meta":4,"data":6},{"total":5},"117",[7,56,246,295,379,474,535,646,710,744],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":25,"verifyStatus":26,"verifyTime":27,"verifyNote":28,"languages":29,"translateLanguages":28,"viewCount":32,"subjectFields":33,"manageAffiliations":34,"indexDatabases":35,"url":36,"thumbnailPath":28,"statistic":28,"gsStatistic":37,"type":55,"analyzePriority":28},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-08-27T01:57:29.562+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":14,"issn":16,"title":18,"introduce":21,"gsId":23},{"VOID":15},"VN",{"VOID":17},"08667535",{"EN":19,"VI":20},"Journal of Tropical Science and Engineering","Tạp chí Khoa học và Công nghệ nhiệt đới",{"EN":22},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":24},"MS2_GJQAAAAJ","PUBLISHER","VERIFIED","2025-10-27T06:27:25.058+00:00",null,[30,31],"VI","EN",0,[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":28,"impactFactorByYear":28,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":38,"totalPublicationByYear":39,"totalCitation":43,"totalCitationByYear":44,"totalCitationPerPublication":52,"totalCitationPerPublicationByYear":53,"hindexLast5Year":42,"hindex":42},483,{"0":40,"2020":40,"2021":40,"2022":40,"2024":40,"2025":41,"2026":42},1,475,3,117,{"2017":40,"2018":40,"2019":45,"2020":46,"2021":46,"2022":47,"2023":48,"2024":49,"2025":50,"2026":51},4,5,11,6,7,53,15,0.24,{"2020":46,"2021":46,"2022":47,"2024":49,"2025":54,"2026":46},0.11,"JOURNAL",{"id":57,"createTime":58,"updateTime":10,"relativeEntities":59,"slug":60,"properties":61,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":69,"subjectFields":70,"manageAffiliations":71,"indexDatabases":84,"url":101,"thumbnailPath":28,"statistic":102,"gsStatistic":195,"type":55,"analyzePriority":28},"cc3aedc1-bd17-441e-b403-4be82349b362","2023-05-29T12:05:16.902+00:00",[],"Vietnam-Journal-of-Mechanics",{"country":62,"issn":63,"title":65,"gsId":67},{"VOID":15},{"VOID":64},"08667136",{"EN":66},"Vietnam Journal of Mechanics",{"VOID":68},"B98qpzgAAAAJ",29,[],[72],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":74,"slug":28,"properties":75,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":83,"statistic":28},"5bf72910-eb8d-41eb-b358-ea294f24f765",[],{"title":76,"country":79,"abbreviation":80},{"EN":77,"VI":78},"Vietnam Academy of Science and Technology","Viện Hàn lâm Khoa học và Công nghệ Việt Nam",{"VOID":15},{"VOID":81},"VAST","https:\u002F\u002Fvast.gov.vn\u002F",[],[85],{"id":86,"indexDatabase":87,"url":97,"indexYears":98,"academicFieldIds":99,"indexDatabaseRanking":28},"61d05d3d-1119-4247-9062-3944e6a8afd5",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":89,"label":90,"description":92,"key":94,"publicationTags":95,"standard":28},"7c6668cf-5dbb-472f-ac65-0e3d0d95e1c2",[],{"EN":91,"VI":91},"ACI - Asean Citation Index",{"EN":93,"VI":93},"Cơ sở dữ liệu ACI","aci",[96],"ACI","https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=10758","2018-2022",[100],"007635a4-2624-49b8-a8f3-fec188e6a80e","http:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fvjmech\u002Findex",{"impactFactor":32,"impactFactorByYear":103,"i10Index":122,"i10IndexLast5Year":123,"totalPublication":124,"totalPublicationByYear":125,"totalCitation":143,"totalCitationByYear":144,"totalCitationPerPublication":163,"totalCitationPerPublicationByYear":164,"hindexLast5Year":146,"hindex":146},{"1994":104,"1995":105,"1997":54,"1998":106,"1999":105,"2000":107,"2001":108,"2002":107,"2003":107,"2004":109,"2005":110,"2006":111,"2007":105,"2008":110,"2010":112,"2011":113,"2012":114,"2013":115,"2014":105,"2015":116,"2016":111,"2017":116,"2018":117,"2019":109,"2020":118,"2021":119,"2022":115,"2023":120,"2024":121},0.12,0.08,0.05,0.02,0.1,0.15,0.14,0.09,0.07,0.21,0.73,0.52,0.13,0.26,0.36,0.61,0.64,0.27,23,2,1046,{"1979":126,"1980":127,"1981":128,"1982":129,"1983":51,"1984":129,"1985":130,"1986":128,"1987":51,"1988":51,"1989":122,"1990":128,"1991":129,"1992":128,"1993":131,"1994":132,"1995":133,"1996":133,"1997":132,"1998":131,"1999":128,"2000":122,"2001":134,"2002":130,"2003":135,"2004":122,"2005":136,"2006":133,"2007":137,"2008":138,"2009":131,"2010":134,"2011":47,"2012":139,"2013":131,"2014":134,"2015":131,"2016":135,"2017":140,"2018":132,"2019":131,"2020":141,"2021":122,"2022":142,"2023":130,"2024":123},12,17,18,19,20,25,28,27,22,21,24,38,35,37,26,39,36,1403,{"1980":40,"1982":40,"1983":40,"1991":132,"1992":45,"1993":48,"1994":49,"1995":145,"1996":146,"1997":134,"1998":140,"1999":47,"2000":136,"2001":127,"2002":128,"2003":147,"2004":148,"2005":131,"2006":149,"2007":150,"2008":151,"2009":152,"2010":153,"2011":154,"2012":155,"2013":156,"2014":152,"2015":157,"2016":158,"2017":138,"2018":159,"2019":160,"2020":159,"2021":161,"2022":162,"2023":45},9,13,31,30,46,40,65,43,119,105,89,72,63,66,70,59,68,58,1.34,{"1980":165,"1982":106,"1983":112,"1991":166,"1992":167,"1993":52,"1994":168,"1995":169,"1996":170,"1997":171,"1998":172,"1999":119,"2000":172,"2001":173,"2002":174,"2003":175,"2004":176,"2005":172,"2006":177,"2007":178,"2008":179,"2009":180,"2010":181,"2011":182,"2012":183,"2013":184,"2014":185,"2015":186,"2016":187,"2017":188,"2018":189,"2019":190,"2020":191,"2021":192,"2022":193,"2023":194},0.06,1.47,0.22,0.25,0.33,0.48,0.79,1.04,0.77,0.9,1.48,1.3,1.7,1.05,1.86,1.72,5.41,9.55,2.41,2.88,1.95,2.52,3.14,1.35,2.5,2.36,1.79,2.96,1.61,0.2,{"impactFactor":28,"impactFactorByYear":28,"i10Index":196,"i10IndexLast5Year":128,"totalPublication":197,"totalPublicationByYear":198,"totalCitation":203,"totalCitationByYear":204,"totalCitationPerPublication":219,"totalCitationPerPublicationByYear":220,"hindexLast5Year":126,"hindex":199},42,1244,{"0":147,"1979":146,"1980":127,"1981":127,"1982":199,"1983":199,"1984":129,"1985":129,"1986":128,"1987":129,"1988":51,"1989":140,"1990":127,"1991":129,"1992":129,"1993":133,"1994":147,"1995":132,"1996":69,"1997":132,"1998":131,"1999":134,"2000":140,"2001":131,"2002":134,"2003":131,"2004":133,"2005":132,"2006":131,"2007":200,"2008":138,"2009":140,"2010":132,"2011":122,"2012":201,"2013":132,"2014":140,"2015":148,"2016":122,"2017":202,"2018":69,"2019":140,"2020":69,"2021":132,"2022":139,"2023":130,"2024":133,"2025":131,"2026":138},16,47,41,32,2194,{"1997":126,"1998":205,"1999":126,"2000":145,"2001":145,"2002":126,"2003":205,"2004":127,"2005":129,"2006":146,"2007":132,"2008":136,"2009":47,"2010":131,"2011":138,"2012":206,"2013":207,"2014":208,"2015":162,"2016":209,"2017":209,"2018":210,"2019":211,"2020":212,"2021":213,"2022":214,"2023":215,"2024":216,"2025":217,"2026":218},10,54,64,62,93,123,118,122,168,159,177,205,255,154,1.76,{"1997":221,"1998":222,"1999":223,"2000":224,"2001":118,"2002":223,"2003":222,"2004":225,"2005":226,"2006":115,"2007":227,"2008":228,"2009":229,"2010":230,"2011":231,"2012":232,"2013":233,"2014":234,"2015":235,"2016":236,"2017":237,"2018":238,"2019":239,"2020":240,"2021":48,"2022":241,"2023":242,"2024":243,"2025":244,"2026":245},0.43,0.4,0.55,0.35,0.63,0.68,0.6,0.69,0.42,0.89,1.52,1.32,2.29,2.38,1.93,4.04,2.91,4.24,4.54,4.21,4.3,8.85,7.59,10.2,4.4,{"id":247,"createTime":248,"updateTime":10,"relativeEntities":249,"slug":250,"properties":251,"entityType":25,"verifyStatus":26,"verifyTime":261,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":147,"subjectFields":262,"manageAffiliations":263,"indexDatabases":264,"url":273,"thumbnailPath":28,"statistic":274,"gsStatistic":290,"type":55,"analyzePriority":28},"b5209d2b-2258-40ef-8732-874e80fe24a5","2023-08-01T04:13:30.887+00:00",[],"VNU-Journal-of-Science-Medical-and-Pharmaceutical-Sciences",{"country":252,"eissn":253,"issn":255,"title":257,"gsId":259},{"VOID":15},{"VOID":254},"25881132",{"VOID":256},"26159309",{"EN":258},"VNU Journal of Science: Medical and Pharmaceutical Sciences",{"VOID":260},"nxupvWQAAAAJ","2023-08-01T04:16:22.633+00:00",[],[],[265],{"id":266,"indexDatabase":267,"url":272,"indexYears":28,"academicFieldIds":28,"indexDatabaseRanking":28},"1c684ac3-c7bf-4466-8841-3c6146083c3c",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":268,"label":269,"description":270,"key":94,"publicationTags":271,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11969","https:\u002F\u002Fjs.vnu.edu.vn\u002FMPS",{"impactFactor":32,"impactFactorByYear":275,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":276,"totalPublicationByYear":277,"totalCitation":282,"totalCitationByYear":283,"totalCitationPerPublication":284,"totalCitationPerPublicationByYear":285,"hindexLast5Year":45,"hindex":45},{"2019":106,"2020":110,"2021":104,"2022":104,"2023":109,"2024":108},360,{"2016":140,"2017":278,"2018":69,"2019":148,"2020":279,"2021":200,"2022":280,"2023":281,"2024":200},34,48,49,50,163,{"2016":145,"2017":145,"2018":135,"2019":140,"2020":50,"2021":135,"2022":128,"2023":48},0.45,{"2016":224,"2017":117,"2018":286,"2019":287,"2020":288,"2021":284,"2022":289,"2023":104},0.72,0.87,1.1,0.37,{"impactFactor":28,"impactFactorByYear":28,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":136,"totalPublicationByYear":291,"totalCitation":127,"totalCitationByYear":292,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":294,"hindexLast5Year":123,"hindex":42},{"0":123,"2014":40,"2015":40,"2016":130},{"2016":40,"2019":123,"2021":123,"2023":45,"2024":42,"2025":40,"2026":40},0.71,{"2016":106},{"id":296,"createTime":297,"updateTime":10,"relativeEntities":298,"slug":299,"properties":300,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":51,"subjectFields":310,"manageAffiliations":311,"indexDatabases":312,"url":313,"thumbnailPath":28,"statistic":314,"gsStatistic":349,"type":55,"analyzePriority":28},"e7ce3904-ad2d-4341-b39e-98ebe8da5908","2023-06-13T10:30:04.853+00:00",[],"Communications-in-Physics",{"country":301,"eissn":302,"issn":304,"title":306,"gsId":308},{"VOID":15},{"VOID":303},"28155947",{"VOID":305},"08863166",{"EN":307},"Communications in Physics",{"VOID":309},"FStER9AAAAAJ",[],[],[],"https:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fcip",{"impactFactor":32,"impactFactorByYear":315,"i10Index":199,"i10IndexLast5Year":45,"totalPublication":321,"totalPublicationByYear":322,"totalCitation":326,"totalCitationByYear":327,"totalCitationPerPublication":335,"totalCitationPerPublicationByYear":336,"hindexLast5Year":126,"hindex":126},{"2008":110,"2009":316,"2010":165,"2011":317,"2012":317,"2013":112,"2014":318,"2015":105,"2016":108,"2017":116,"2018":318,"2019":52,"2020":319,"2021":284,"2022":320,"2023":116,"2024":222},0.3,0.03,0.16,0.34,0.28,738,{"2007":323,"2008":145,"2009":145,"2010":136,"2011":139,"2012":324,"2013":138,"2014":151,"2015":69,"2016":151,"2017":325,"2018":142,"2019":50,"2020":201,"2021":141,"2022":152,"2023":150,"2024":278,"2025":123},14,107,56,947,{"2007":148,"2008":49,"2009":49,"2010":127,"2011":328,"2012":155,"2013":278,"2014":329,"2015":206,"2016":330,"2017":331,"2018":332,"2019":333,"2020":334,"2021":127,"2022":132,"2023":148},52,94,86,129,76,91,106,1.28,{"2007":337,"2008":338,"2009":338,"2010":293,"2011":339,"2012":340,"2013":341,"2014":342,"2015":179,"2016":232,"2017":343,"2018":344,"2019":180,"2020":345,"2021":346,"2022":347,"2023":348},2.14,0.78,1.41,0.83,0.97,1.45,2.3,2.11,2.59,0.44,0.65,0.75,{"impactFactor":28,"impactFactorByYear":28,"i10Index":133,"i10IndexLast5Year":145,"totalPublication":350,"totalPublicationByYear":351,"totalCitation":355,"totalCitationByYear":356,"totalCitationPerPublication":363,"totalCitationPerPublicationByYear":364,"hindexLast5Year":145,"hindex":323},1117,{"0":48,"1972":40,"1991":127,"1992":51,"1993":49,"1994":47,"1995":323,"1996":42,"1997":40,"1998":146,"1999":146,"2000":205,"2001":47,"2002":128,"2003":136,"2004":132,"2005":136,"2006":148,"2007":141,"2008":149,"2009":352,"2010":353,"2011":196,"2012":208,"2013":280,"2014":354,"2015":150,"2016":328,"2017":137,"2018":142,"2019":325,"2020":152,"2021":139,"2022":139,"2023":142,"2024":148,"2025":147,"2026":132},33,44,92,1611,{"2004":46,"2005":357,"2006":47,"2007":47,"2008":126,"2009":140,"2010":69,"2011":147,"2012":147,"2013":147,"2014":208,"2015":353,"2016":201,"2017":280,"2018":161,"2019":358,"2020":212,"2021":331,"2022":212,"2023":359,"2024":360,"2025":361,"2026":362},8,85,153,178,188,132,1.44,{"2004":365,"2005":169,"2006":289,"2007":320,"2008":117,"2009":171,"2010":366,"2011":367,"2012":368,"2013":225,"2014":369,"2015":288,"2016":171,"2017":370,"2018":371,"2019":231,"2020":372,"2021":373,"2022":374,"2023":375,"2024":376,"2025":377,"2026":378},0.18,0.66,0.74,0.5,0.67,1.29,1.89,2.84,3.49,3.3,4.25,5.93,6.06,4.71,{"id":380,"createTime":381,"updateTime":382,"relativeEntities":383,"slug":384,"properties":385,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":394,"translateLanguages":28,"viewCount":127,"subjectFields":395,"manageAffiliations":396,"indexDatabases":404,"url":418,"thumbnailPath":28,"statistic":419,"gsStatistic":446,"type":55,"analyzePriority":28},"2300fd63-13a8-4ee9-92b0-d24d9e616c6b","2023-05-29T12:05:31.684+00:00","2026-08-27T01:57:29.561+00:00",[],"Journal-of-Computer-Science-and-Cybernetics",{"country":386,"issn":387,"title":389,"gsId":392},{"VOID":15},{"VOID":388},"18139663",{"EN":390,"VI":391},"Journal of Computer Science and Cybernetics","Tạp chí tin học và điều khiển học",{"VOID":393},"hVh9fuMAAAAJ",[30,31],[],[397],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":398,"slug":28,"properties":399,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":403,"statistic":28},[],{"title":400,"country":401,"abbreviation":402},{"EN":77,"VI":78},{"VOID":15},{"VOID":81},[],[405],{"id":406,"indexDatabase":407,"url":412,"indexYears":413,"academicFieldIds":414,"indexDatabaseRanking":28},"0c897c2c-8ca4-4a7a-91b9-14955abc3043",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":408,"label":409,"description":410,"key":94,"publicationTags":411,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11305","2019-2021",[100,415,416,417],"a24a4497-b6ac-43f3-ae94-c044be819e49","b2d37900-0c9f-4074-a519-9ee0b570caa7","37da756c-1c5e-4925-87f2-a9bd3ce5859c","http:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fjcc",{"impactFactor":32,"impactFactorByYear":420,"i10Index":129,"i10IndexLast5Year":42,"totalPublication":425,"totalPublicationByYear":426,"totalCitation":431,"totalCitationByYear":432,"totalCitationPerPublication":438,"totalCitationPerPublicationByYear":439,"hindexLast5Year":323,"hindex":323},{"2013":107,"2014":107,"2015":111,"2016":365,"2017":107,"2018":421,"2019":117,"2020":422,"2021":227,"2022":423,"2023":368,"2024":424},0.04,0.32,0.39,0.57,1184,{"2012":427,"2013":358,"2014":278,"2015":428,"2016":429,"2017":51,"2018":430,"2019":148,"2020":130,"2021":136,"2022":199,"2023":132,"2024":42},473,71,251,134,995,{"2012":433,"2013":434,"2014":434,"2015":333,"2016":435,"2017":436,"2018":437,"2019":211,"2020":281,"2021":434,"2022":126,"2023":152},149,45,114,51,232,0.84,{"2012":422,"2013":440,"2014":232,"2015":335,"2016":284,"2017":441,"2018":442,"2019":443,"2020":189,"2021":444,"2022":348,"2023":445},0.53,3.4,1.73,3.93,1.88,1.54,{"impactFactor":28,"impactFactorByYear":28,"i10Index":150,"i10IndexLast5Year":132,"totalPublication":447,"totalPublicationByYear":448,"totalCitation":449,"totalCitationByYear":450,"totalCitationPerPublication":192,"totalCitationPerPublicationByYear":460,"hindexLast5Year":51,"hindex":199},1105,{"0":47,"1981":40,"1985":199,"1986":135,"1987":136,"1988":323,"1989":126,"1990":199,"1991":127,"1992":126,"1993":47,"1994":129,"1995":130,"1996":132,"1997":142,"1998":148,"1999":201,"2000":196,"2001":353,"2002":353,"2003":352,"2004":132,"2005":131,"2006":148,"2007":147,"2008":133,"2009":131,"2010":139,"2011":201,"2012":281,"2013":142,"2014":202,"2015":69,"2016":140,"2017":136,"2018":140,"2019":134,"2020":134,"2021":133,"2022":134,"2023":134,"2024":136,"2025":49},3272,{"2007":145,"2008":323,"2009":46,"2010":48,"2011":129,"2012":148,"2013":140,"2014":69,"2015":152,"2016":160,"2017":162,"2018":451,"2019":452,"2020":453,"2021":454,"2022":455,"2023":456,"2024":457,"2025":458,"2026":459},109,173,236,318,398,469,442,440,297,{"2007":461,"2008":115,"2009":194,"2010":318,"2011":462,"2012":227,"2013":286,"2014":463,"2015":175,"2016":464,"2017":465,"2018":466,"2019":467,"2020":468,"2021":469,"2022":470,"2023":471,"2024":472,"2025":473},0.29,0.46,0.91,2.27,2.42,4.19,7.86,10.73,11.78,18.09,21.32,18.42,62.86,{"id":475,"createTime":476,"updateTime":382,"relativeEntities":477,"slug":478,"properties":479,"entityType":25,"verifyStatus":26,"verifyTime":491,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":202,"subjectFields":492,"manageAffiliations":493,"indexDatabases":509,"url":510,"thumbnailPath":28,"statistic":511,"gsStatistic":525,"type":55,"analyzePriority":28},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":480,"issn":481,"title":483,"introduce":486,"gsId":489},{"VOID":15},{"VOID":482},"23541210",{"EN":484,"VI":485},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"EN":487,"VI":488},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"VOID":490},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",[],[494],{"id":495,"createTime":28,"updateTime":28,"relativeEntities":496,"slug":28,"properties":497,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":507,"parentIds":508,"statistic":28},"6413896b-eca9-442b-a73f-182a58a0ce40",[],{"title":498,"address":501,"country":504,"abbreviation":505},{"EN":499,"VI":500},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"EN":502,"VI":503},"No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam","Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam",{"VOID":15},{"VOID":506},"ctump","http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":32,"impactFactorByYear":512,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":520,"totalCitationByYear":521,"totalCitationPerPublication":108,"totalCitationPerPublicationByYear":523,"hindexLast5Year":45,"hindex":45},{"2022":513,"2023":111,"2024":106},0.01,1556,{"2020":47,"2021":516,"2022":517,"2023":518,"2024":519,"2025":122},57,306,801,358,161,{"2021":146,"2022":280,"2023":522},99,{"2021":524,"2022":318,"2023":104},0.23,{"impactFactor":28,"impactFactorByYear":28,"i10Index":123,"i10IndexLast5Year":123,"totalPublication":526,"totalPublicationByYear":527,"totalCitation":526,"totalCitationByYear":528,"totalCitationPerPublication":40,"totalCitationPerPublicationByYear":531,"hindexLast5Year":49,"hindex":49},476,{"0":205,"2019":123,"2021":139,"2022":459,"2023":451,"2024":357,"2025":49,"2026":48},{"2021":42,"2022":123,"2023":161,"2024":529,"2025":360,"2026":530},136,83,{"2021":105,"2022":513,"2023":532,"2024":127,"2025":533,"2026":534},0.62,25.43,13.83,{"id":536,"createTime":537,"updateTime":382,"relativeEntities":538,"slug":539,"properties":540,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":552,"translateLanguages":28,"viewCount":133,"subjectFields":553,"manageAffiliations":554,"indexDatabases":555,"url":556,"thumbnailPath":557,"statistic":558,"gsStatistic":594,"type":55,"analyzePriority":28},"6984a56a-db70-403b-9cc4-4013e1ceaffa","2023-05-09T06:47:40.346+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Nghi%C3%AAn%20c%E1%BB%A9u%20n%C6%B0%E1%BB%9Bc%20ngo%C3%A0i",{"country":541,"issn":542,"title":544,"introduce":547,"gsId":550},{"VOID":15},{"VOID":543},"25252445",{"EN":545,"VI":546},"VNU Journal of Foreign Studies","Tạp chí Nghiên cứu nước ngoài",{"EN":548,"VI":549},"{\"ops\":[{\"insert\":\"\\n\\nThe \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\"\\n was established in 1985 for the publication of national and international research papers in all fields of natural sciences and technology, social sciences and humanities. Since then, the journal has grown in quality, size and scope and now comprises a dozen of serials spanning academic research. In 2002, with the rapid expansion of the field of Foreign Languages and International Studies, the \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\"\\n was delighted to announce the launch of the \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Foreign Studies\"},{\"insert\":\"\\n.\\n\\n\\nSince 2017, as a natural development from its predecessor \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Foreign Studies\"},{\"insert\":\"\\n, the\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\" \"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"VNU Journal of Foreign Studies \"},{\"insert\":\"\\ncontinues to be an official, independent publication of the University of Languages and International Studies (ULIS) under Vietnam National University (VNU).\\nThe\\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\" VNU Journal of Foreign Studies\"},{\"attributes\":{\"italic\":true},\"insert\":\" \"},{\"insert\":\"\\npublishes \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"blind\"},{\"insert\":\"\\n \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"peer-reviewed\"},{\"insert\":\"\\n research papers, discussions and reviews concerning:\\nLinguisticsForeign language educationInternational studiesRelated social sciences and humanities\\nBimonthly in 4 English editions and 2 Vietnamese editions in the current year in both print and electronic forms, the journal provides maximum exposure for published articles, making research available to all to read and share.\\n\\n\\n\"}]}","{\"ops\":[{\"attributes\":{\"italic\":true},\"insert\":\"Tạp chí Khoa học, Đại học Quốc gia Hà Nội\"},{\"insert\":\"\\n được thành lập năm 1985 với mục đích xuất bản các bài báo nghiên cứu trong nước và quốc tế về tất cả các lĩnh vực khoa học tự nhiên và công nghệ, khoa học xã hội và nhân văn. Kể từ đó, tạp chí đã phát triển về chất lượng, quy mô và phạm vi với hàng chục số báo liên quan đến nghiên cứu học thuật. Năm 2002, với sự phát triển nhanh chóng của lĩnh vực Ngoại ngữ và Quốc tế học, \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Tạp chí Khoa học Đại học Quốc gia Hà Nội\"},{\"insert\":\"\\n đã vui mừng thông báo ra mắt Chuyên san \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Nghiên cứu Nước ngoài.\"},{\"insert\":\"\\n\\n\\nKể từ năm 2017, như một sự kế thừa và phát triển từ tiền thân Chuyên san \\n\"},{\"attributes\":{\"italic\":true},\"insert\":\"Nghiên cứu Nước ngoài\"},{\"insert\":\"\\n của Tạp chí Khoa học, Đại học Quốc gia Hà Nội, \\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tạp chí\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\" \"},{\"insert\":\"\\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"Nghiên cứu nước ngoài \"},{\"insert\":\"\\ntiếp tục là ấn phẩm khoa học chính thức và độc lập của Trường Đại học Ngoại ngữ, Đại học Quốc gia Hà Nội.\\nTạp chí \\n\"},{\"attributes\":{\"italic\":true,\"bold\":true},\"insert\":\"Nghiên cứu nước ngoài\"},{\"insert\":\"\\n xuất bản các bài báo nghiên cứu, trao đổi và đánh giá đã được phản biện kín về:\\nNgôn ngữ họcGiảng dạy ngoại ngữ\u002Fngôn ngữQuốc tế họcCác ngành khoa học xã hội và nhân văn có liên quan\\nTạp chí xuất bản định kì 06 số\u002Fnăm (gồm 04 số tiếng Anh\u002Fnăm và 2 số tiếng Việt\u002Fnăm) dưới dạng bản in và bản điện tử. Tạp chí cung cấp khả năng tiếp cận tối đa tới các bài báo đã xuất bản nhằm giúp độc giả dễ dàng đọc và chia sẻ.\\n\"}]}",{"VOID":551},"jyihv3YAAAAJ",[30,31],[],[],[],"https:\u002F\u002Fjfs.ulis.vnu.edu.vn\u002Findex.php\u002Ffs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6984a56a-db70-403b-9cc4-4013e1ceaffa\u002F92693604f5caf63c64520c5c2cd756b5.jpg",{"impactFactor":32,"impactFactorByYear":559,"i10Index":560,"i10IndexLast5Year":205,"totalPublication":561,"totalPublicationByYear":562,"totalCitation":568,"totalCitationByYear":569,"totalCitationPerPublication":579,"totalCitationPerPublicationByYear":580,"hindexLast5Year":140,"hindex":140},{"2007":317,"2010":112,"2011":109,"2012":421,"2013":165,"2014":421,"2015":421,"2016":111,"2017":116,"2018":104,"2019":109,"2020":320,"2021":284,"2022":168,"2023":116,"2024":108},67,1200,{"2002":51,"2003":51,"2004":47,"2005":352,"2006":142,"2007":131,"2008":147,"2009":139,"2010":278,"2011":138,"2012":69,"2013":206,"2014":137,"2015":69,"2016":196,"2017":563,"2018":209,"2019":564,"2020":565,"2021":566,"2022":530,"2023":567,"2024":428,"2025":281},130,78,90,80,61,3204,{"2002":42,"2003":123,"2004":123,"2005":570,"2006":47,"2007":127,"2008":571,"2009":572,"2010":196,"2011":573,"2012":130,"2013":560,"2014":574,"2015":149,"2016":325,"2017":575,"2018":576,"2019":577,"2020":578,"2021":453,"2022":206,"2023":205,"2025":51},189,223,765,246,98,171,377,355,199,2.67,{"2002":194,"2003":116,"2004":365,"2005":581,"2006":582,"2007":226,"2008":583,"2009":584,"2010":585,"2011":586,"2012":228,"2013":585,"2014":587,"2015":588,"2016":589,"2017":232,"2018":590,"2019":591,"2020":592,"2021":593,"2022":347,"2023":318,"2025":316},5.73,0.31,7.19,20.68,1.24,7.03,2.58,1.59,1.33,4.05,4.55,2.21,2.95,{"impactFactor":28,"impactFactorByYear":28,"i10Index":595,"i10IndexLast5Year":596,"totalPublication":597,"totalPublicationByYear":598,"totalCitation":609,"totalCitationByYear":610,"totalCitationPerPublication":625,"totalCitationPerPublicationByYear":626,"hindexLast5Year":142,"hindex":152},379,311,2120,{"0":361,"1960":40,"1971":40,"1975":40,"1987":40,"1988":40,"1989":40,"1990":45,"1992":40,"1993":40,"1994":46,"1995":46,"1996":45,"1997":42,"1998":49,"1999":42,"2000":123,"2001":42,"2002":48,"2003":46,"2004":145,"2005":131,"2006":51,"2007":131,"2008":135,"2009":146,"2010":127,"2011":122,"2012":148,"2013":352,"2014":201,"2015":149,"2016":599,"2017":600,"2018":601,"2019":209,"2020":602,"2021":603,"2022":604,"2023":605,"2024":606,"2025":607,"2026":608},77,75,97,143,167,156,182,231,230,128,13225,{"2003":149,"2004":150,"2005":201,"2006":196,"2007":157,"2008":436,"2009":328,"2010":611,"2011":612,"2012":333,"2013":522,"2014":613,"2015":520,"2016":614,"2017":615,"2018":616,"2019":617,"2020":618,"2021":619,"2022":620,"2023":621,"2024":622,"2025":623,"2026":624},74,88,146,228,310,347,413,636,944,1261,1400,1846,2511,1882,6.24,{"2003":627,"2004":628,"2005":629,"2006":630,"2007":186,"2008":631,"2009":45,"2010":632,"2011":633,"2012":634,"2013":42,"2014":635,"2015":636,"2016":192,"2017":637,"2018":638,"2019":628,"2020":639,"2021":640,"2022":641,"2023":642,"2024":643,"2025":644,"2026":645},9.2,4.44,1.64,2.8,2.43,4.35,3.83,3.03,3.56,3.5,4.13,3.58,4.45,5.65,8.08,7.69,7.99,10.92,14.7,{"id":647,"createTime":648,"updateTime":382,"relativeEntities":649,"slug":650,"properties":651,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":664,"languages":665,"translateLanguages":28,"viewCount":142,"subjectFields":666,"manageAffiliations":667,"indexDatabases":668,"url":677,"thumbnailPath":678,"statistic":679,"gsStatistic":699,"type":55,"analyzePriority":28},"21d239d8-ac9d-48c7-a176-9d8aadc5eba5","2023-08-21T02:43:48.721+00:00",[],"Khoa-h%E1%BB%8Dc-%C4%90HQGHN-Khoa-h%E1%BB%8Dc-T%E1%BB%B1-nhi%C3%AAn-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87",{"country":652,"eissn":653,"issn":655,"title":657,"introduce":660,"gsId":662},{"VOID":15},{"VOID":654},"25881140",{"VOID":656},"26159317",{"EN":658,"VI":659},"VNU Journal of Science: Natural Science and Technology","Khoa học ĐHQGHN: Khoa học Tự nhiên và Công nghệ",{"EN":661},"{\"ops\":[{\"insert\":\"The \"},{\"attributes\":{\"italic\":true},\"insert\":\"Journal\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"of\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"Science\"},{\"insert\":\" was established in 1985 for the publication of national and international research papers in all fields of natural sciences and technology, social sciences and humanities. Since then, the journal has grown in quality, size and scope and now comprises a dozen of serials spanning academic research.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"With the rapid expansion of the field of Economics, the VNU \"},{\"attributes\":{\"italic\":true},\"insert\":\"Journal\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"of\"},{\"insert\":\" \"},{\"attributes\":{\"italic\":true},\"insert\":\"Science\"},{\"insert\":\" is delighted to announce the launch of the \"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science: Natural Sciences and Technology (JS: NST) \"},{\"insert\":\"since 1985. This serial publication provides researchers with the opportunity to publish research covering aspects in these areas in the popular \"},{\"attributes\":{\"italic\":true},\"insert\":\"VNU Journal of Science\"},{\"insert\":\" series.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"As a fully open access publication, the journal will provide maximum exposure for published articles, making the research available to all to read and share. The journal will be published quarterly in March, June, September and December.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"JS: NST is an open access journal publishing double-blinded peer-reviewed research papers, communications and reviews dealing with Biology, Bio-technology, Chemistry, Chemical engineering, Energy, Environmental technology and Materials engineering.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Publication Ethics\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"VNUJS is committed to maintaining the highest standards of publication ethics and takes all possible measures against any publication malpractices. The journal follows the guidelines and recommendations of the Committee on Publication Ethics (C.O.P.E) to ensure ethical publishing practices.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Plagiarism is strictly prohibited and will not be tolerated. Any form of plagiarism, including but not limited to copying, paraphrasing, or reusing previously published work without proper attribution, will result in rejection of the manuscript and potential sanctions against the author. VNUJS utilizes DoIt as plagiarism detection software to verify the originality of submitted manuscripts.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The publication ethics statement with full detail of the responsibilities of authors, reviewers and editors can be found \"},{\"attributes\":{\"bold\":true,\"color\":\"#464d50\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fjs.vnu.edu.vn\u002FNST\u002Fethics\"},\"insert\":\"here\"},{\"attributes\":{\"bold\":true},\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Peer Review Process\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Any manuscript followed the journal’s scope and author guideline will be assigned to the managing editors. All manuscripts have undergone editorial screening and anonymous double-blind peer-review by the at least one independent expert in the field. The managing editor makes an editorial decision, which is subject to endorsement by the Editor – in - Chief.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The journal publishing process can be found in detail \"},{\"attributes\":{\"bold\":true,\"color\":\"#464d50\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fdrive.google.com\u002Ffile\u002Fd\u002F136BOGahfq9_5BB3TzSBsLBkQKfCUe5yN\u002Fview?usp=share_link\"},\"insert\":\"here\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"VOID":663},"ZfBridMAAAAJ","Admin update database",[30,31],[],[],[669],{"id":670,"indexDatabase":671,"url":676,"indexYears":28,"academicFieldIds":28,"indexDatabaseRanking":28},"6684da33-2cb9-49f9-8332-28f0bcd72e39",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":672,"label":673,"description":674,"key":94,"publicationTags":675,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=11968","https:\u002F\u002Fjs.vnu.edu.vn\u002FNST","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F21d239d8-ac9d-48c7-a176-9d8aadc5eba5\u002Fb081d4211e382646c2cdc054ead551b3.jpg",{"impactFactor":32,"impactFactorByYear":680,"i10Index":130,"i10IndexLast5Year":40,"totalPublication":682,"totalPublicationByYear":683,"totalCitation":685,"totalCitationByYear":686,"totalCitationPerPublication":691,"totalCitationPerPublicationByYear":692,"hindexLast5Year":47,"hindex":47},{"2000":317,"2005":513,"2007":107,"2010":513,"2011":317,"2012":106,"2013":107,"2014":317,"2015":107,"2016":107,"2017":421,"2018":317,"2019":421,"2020":113,"2021":582,"2022":681,"2023":194,"2024":104},0.19,1700,{"1985":131,"1986":353,"1987":130,"1988":69,"1989":69,"1990":200,"1991":196,"1992":146,"1993":279,"1994":148,"1995":200,"1996":201,"1999":278,"2000":140,"2001":128,"2002":202,"2003":353,"2004":138,"2005":202,"2006":136,"2007":278,"2008":139,"2009":137,"2010":141,"2011":278,"2012":132,"2013":202,"2014":202,"2015":278,"2016":684,"2017":359,"2018":160,"2019":162,"2020":281,"2021":157,"2022":436,"2023":358,"2024":136,"2025":135},165,870,{"1995":123,"1999":123,"2001":45,"2002":130,"2003":40,"2004":123,"2005":42,"2007":69,"2008":687,"2009":352,"2010":688,"2011":137,"2012":127,"2013":47,"2014":46,"2015":146,"2016":331,"2017":689,"2018":331,"2019":690,"2020":353,"2021":567,"2022":130,"2023":357},82,60,55,102,0.51,{"1995":421,"1999":165,"2001":167,"2002":532,"2003":107,"2004":165,"2005":111,"2007":693,"2008":694,"2009":287,"2010":445,"2011":695,"2012":119,"2013":319,"2014":318,"2015":696,"2016":338,"2017":118,"2018":697,"2019":219,"2020":698,"2021":341,"2022":423,"2023":111},0.85,2.22,1.12,0.38,2.19,0.88,{"impactFactor":28,"impactFactorByYear":28,"i10Index":126,"i10IndexLast5Year":123,"totalPublication":570,"totalPublicationByYear":700,"totalCitation":701,"totalCitationByYear":702,"totalCitationPerPublication":703,"totalCitationPerPublicationByYear":704,"hindexLast5Year":46,"hindex":205},{"0":48,"1999":146,"2000":47,"2001":45,"2002":40,"2003":199,"2004":123,"2005":42,"2006":123,"2007":145,"2008":145,"2009":46,"2010":49,"2011":47,"2012":47,"2013":49,"2014":45,"2015":45,"2016":157,"2017":40},425,{"2008":42,"2009":357,"2010":47,"2011":51,"2012":199,"2013":135,"2014":323,"2015":51,"2016":278,"2017":69,"2018":69,"2019":137,"2020":142,"2021":140,"2022":148,"2023":122,"2024":202,"2025":135,"2026":126},2.25,{"2008":169,"2009":705,"2010":706,"2011":707,"2012":342,"2013":42,"2014":636,"2015":708,"2016":709,"2017":69},1.6,1.57,1.36,3.75,0.54,{"id":711,"createTime":712,"updateTime":382,"relativeEntities":713,"slug":714,"properties":715,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":664,"languages":28,"translateLanguages":28,"viewCount":150,"subjectFields":727,"manageAffiliations":728,"indexDatabases":729,"url":730,"thumbnailPath":731,"statistic":732,"gsStatistic":738,"type":55,"analyzePriority":28},"954132b5-ca74-461c-b819-45ad6e49a404","2023-08-17T03:30:52.301+00:00",[],"HPU2-Journal-of-Science-Natural-Sciences-and-Technology",{"country":716,"issn":717,"title":719,"introduce":722,"gsId":725},{"VOID":15},{"VOID":718},"28155637",{"EN":720,"VI":721},"HPU2 Journal of Science: Natural Sciences and Technology","TẠP CHÍ KHOA HỌC TRƯỜNG ĐHSP HÀ NỘI 2: CHUYÊN SAN KHOA HỌC TỰ NHIÊN VÀ CÔNG NGHỆ",{"EN":723,"VI":724},"{\"ops\":[{\"insert\":\"HPU2 journal of Science aims to provide an interdisciplinary platform for the dissemination of advances in sciences and technology. The journal publishes original papers of scientific or technological value in all areas of natural, social or educational sciences.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Natural sciences and technology is in papers that describe valuable findings in physics, mathematics, chemistry, biology; solving engineering or technological problems.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Social Sciences and Humanity is to facilitate the publication of high-quality papers in various areas of social sciences and studies for human development.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"The main interest of HPU2 Journal of Science: Educational Sciences is to publish papers in the field of educational sciences and applications of advances to education for improving and enhancing science education at all levels.\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Papers that are published by HPU2 Journal of Science are doubled-blind, peer-reviewed by at least two experts, are evaluated by the section editor and editor in chief.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Types of Articles\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Research articles\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Academic reports of original research that have never been published elsewhere in any languages. Manuscripts, where appropriate, should contain the following sections in the order: Title, Authors, Author affiliations, Email address of corresponding authors, Abstract, Keywords, Nomenclature (if any), Introduction, Experiment, Theory, Results and Discussion, Conclusions, Conflict of Interest, Acknowledgments (if any), References, Appendix (if any). Pre-published are to be formatted according to Templates (MS-Word version). \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Review articles\"},{\"attributes\":{\"align\":\"justify\",\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"In addition to invited reviews, literature reviews, systematic reviews, and critical reviews will be accepted for consideration. The manuscript should be composed and organized according to the required sequence: Titles, Author names, Affiliations, Email addresses, Abstract, Keywords, Main text, Conclusion, Conflict of Interest, Acknowledgments (if any), References. Although, the main text structure may vary based on the review subtopics, the articles should be formatted according to suitable Templates as research articles.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Khoa học Trường ĐHSP Hà Nội 2 nhằm mục đích cung cấp một nền tảng liên ngành của sự phổ biến những tiến bộ của khoa học và công nghệ. Tạp chí xuất bản các bài báo gốc có giá trị khoa học hoặc công nghệ trong tất cả các lĩnh vực khoa học tự nhiên, xã hội hoặc giáo dục.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học tự nhiên và công nghệ:\"},{\"insert\":\" Là các bài báo mô tả những phát hiện có giá trị trong vật lý, toán học, hóa học, sinh học; giải quyết các vấn đề kỹ thuật hoặc công nghệ.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học Xã hội và Nhân văn:\"},{\"insert\":\" là các bài báo xuất bản chất lượng cao trong các lĩnh vực khác nhau của khoa học xã hội và nghiên cứu phát triển con người.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Chuyên san Khoa học giáo dục:\"},{\"insert\":\" là các bài báo xuất bản trong lĩnh vực khoa học giáo dục và các ứng dụng của tiến bộ vào giáo dục để cải thiện và nâng cao giáo dục khoa học ở tất cả các cấp.\"},{\"attributes\":{\"list\":\"bullet\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí trường ĐHSP Hà Nội 2 xuất bản được phản biện kín, xét duyệt bởi ít nhất 02 chuyên gia, và được đánh giá, chọn lựa từ ban biên tập và Tổng biên tập.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Các loại bài báo\"},{\"insert\":\":\\nBài báo nghiên cứu:\"},{\"attributes\":{\"list\":\"ordered\"},\"insert\":\"\\n\"},{\"insert\":\"Báo cáo học thuật về nghiên cứu ban đầu chưa từng được xuất bản ở bất kỳ nơi nào, hay bằng bất kỳ ngôn ngữ nào khác. Bản thảo thích hợp, nên chứa các phần sau theo thứ tự: Tiêu đề, Tác giả, Liên kết tác giả, Địa chỉ email của tác giả tương ứng, Tóm tắt, Từ khóa, Danh pháp (nếu có), Giới thiệu, Thử nghiệm, Lý thuyết, Kết quả và thảo luận, Kết luận, Xung đột quan tâm, Lời cảm ơn (nếu có), Tài liệu tham khảo, Phụ lục (nếu có). Bản xuất bản trước phải được định dạng theo Mẫu (phiên bản MS-Word).\\n2. Bài báo tổng quan:\\nNgoài các bài phê bình được mời, các bài phê bình tài liệu, bài phê bình có hệ thống và bài phê bình sẽ được chấp nhận để xem xét. Bản thảo cần được soạn thảo và sắp xếp theo trình tự yêu cầu: Tên sách, Tên tác giả, Liên kết, Địa chỉ email, Tóm tắt, Từ khóa, Nội dung chính, Kết luận, Xung đột lợi ích, Lời cảm ơn (nếu có), Tài liệu tham khảo. Mặc dù, cấu trúc văn bản chính có thể thay đổi dựa trên các chủ đề phụ của bài đánh giá, các bài báo nên được định dạng theo các Mẫu phù hợp như các bài báo nghiên cứu.\\n\"}]}",{"VOID":726},"YPoBvsIAAAAJ",[],[],[],"https:\u002F\u002Fsj.hpu2.edu.vn\u002Findex.php\u002Fjournal","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F954132b5-ca74-461c-b819-45ad6e49a404\u002F2790ef1d0a7d7a40a504c2fc1647f670.jpg",{"impactFactor":32,"impactFactorByYear":733,"i10Index":32,"i10IndexLast5Year":32,"totalPublication":329,"totalPublicationByYear":735,"totalCitation":134,"totalCitationByYear":736,"totalCitationPerPublication":524,"totalCitationPerPublicationByYear":737,"hindexLast5Year":123,"hindex":123},{"2024":734},0.17,{"2022":136,"2023":278,"2024":142},{"2022":357,"2023":126,"2024":123},{"2022":169,"2023":224,"2024":165},{"impactFactor":28,"impactFactorByYear":28,"i10Index":45,"i10IndexLast5Year":45,"totalPublication":330,"totalPublicationByYear":739,"totalCitation":154,"totalCitationByYear":740,"totalCitationPerPublication":741,"totalCitationPerPublicationByYear":742,"hindexLast5Year":46,"hindex":46},{"0":123,"2022":134,"2023":136,"2024":69,"2025":145},{"2023":46,"2024":136,"2025":201,"2026":278},1.22,{"2023":113,"2024":340,"2025":743},4.56,{"id":745,"createTime":746,"updateTime":747,"relativeEntities":748,"slug":749,"properties":750,"entityType":25,"verifyStatus":26,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":69,"subjectFields":762,"manageAffiliations":763,"indexDatabases":771,"url":817,"thumbnailPath":28,"statistic":818,"gsStatistic":850,"type":55,"analyzePriority":28},"21ccdb34-414d-420f-8a60-a592a2fa848e","2023-05-29T10:42:53.358+00:00","2026-08-27T01:57:29.560+00:00",[],"Vietnam-Journal-of-Earth-Sciences",{"country":751,"eissn":752,"issn":754,"title":756,"introduce":758,"gsId":760},{"VOID":15},{"VOID":753},"26159783",{"VOID":755},"08667187",{"EN":757},"Vietnam Journal of Earth Sciences",{"EN":759},"Science of the Earth, formerly Vietnam Journal of Earth Sciences, is a peer-reviewed journal to publish high-quality articles on the entire range of earth sciences and the environment, focused on the Asia Pacific region and their correlations and connections to the globe. The journal publishes fundamental and applied research in earth sciences and the environment, including geology, geophysics, geography, soil science, hydrology, meteorology, oceanography, petroleum, geohazards, environmental sciences, environmental engineering, sustainable development, geoinformatics, geodesy, GIS, and remote sensing.",{"VOID":761},"5htfr3YAAAAJ",[],[764],{"id":73,"createTime":28,"updateTime":28,"relativeEntities":765,"slug":28,"properties":766,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":82,"parentIds":770,"statistic":28},[],{"title":767,"country":768,"abbreviation":769},{"EN":77,"VI":78},{"VOID":15},{"VOID":81},[],[772,789,800],{"id":773,"indexDatabase":774,"url":784,"indexYears":785,"academicFieldIds":786,"indexDatabaseRanking":788},"6ace2085-a177-4a27-b309-8813b832111e",{"id":775,"createTime":28,"updateTime":28,"relativeEntities":776,"label":777,"description":779,"key":781,"publicationTags":782,"standard":28},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":778,"VI":778},"Scopus - Elsevier",{"EN":778,"VI":780},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[783],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F21101039869","2018-2024",[787],"1689391c-5702-4349-aaa7-d720ee4321fc","NONE",{"id":790,"indexDatabase":791,"url":796,"indexYears":797,"academicFieldIds":798,"indexDatabaseRanking":28},"dadb15a8-ee22-41c2-a287-49e969d9a998",{"id":88,"createTime":28,"updateTime":28,"relativeEntities":792,"label":793,"description":794,"key":94,"publicationTags":795,"standard":28},[],{"EN":91,"VI":91},{"EN":93,"VI":93},[96],"https:\u002F\u002Fasean-cites.org\u002Fjournal_info?jid=10629","2016-2022",[799],"e04f14cf-280b-4aa8-b711-b77ddd79cbaf",{"id":801,"indexDatabase":802,"url":814,"indexYears":28,"academicFieldIds":815,"indexDatabaseRanking":28},"06f278ee-37b9-41eb-a9b0-3d2d77fa502b",{"id":803,"createTime":28,"updateTime":28,"relativeEntities":804,"label":805,"description":807,"key":810,"publicationTags":811,"standard":28},"88bab0f7-443b-476c-a72a-7fa5222da393",[],{"EN":806,"VI":806},"ISI\u002FESCI  - Emerging Sources Citation Index",{"EN":808,"VI":809},"ESCI database","Cơ sở dữ liệu ESCI","esci",[812,813],"ESCI","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0866-7187",[816],"0db73426-2364-455f-81a4-efe0f91d712e","https:\u002F\u002Fvjs.ac.vn\u002Findex.php\u002Fjse\u002F",{"impactFactor":32,"impactFactorByYear":819,"i10Index":151,"i10IndexLast5Year":132,"totalPublication":824,"totalPublicationByYear":825,"totalCitation":827,"totalCitationByYear":828,"totalCitationPerPublication":838,"totalCitationPerPublicationByYear":839,"hindexLast5Year":129,"hindex":129},{"2007":513,"2008":513,"2010":513,"2011":107,"2012":513,"2013":513,"2014":317,"2015":107,"2016":54,"2017":168,"2018":222,"2019":820,"2020":821,"2021":371,"2022":445,"2023":822,"2024":823},1.03,1.08,1.49,1.43,1180,{"2000":689,"2001":688,"2002":281,"2003":160,"2004":279,"2005":325,"2006":516,"2007":137,"2008":200,"2009":162,"2010":436,"2011":826,"2012":434,"2013":689,"2014":280,"2015":152,"2016":150,"2017":148,"2018":352,"2019":147,"2020":152,"2021":69,"2022":148,"2023":280,"2024":139,"2025":45},79,2421,{"2000":205,"2001":51,"2002":145,"2003":146,"2004":126,"2005":51,"2006":130,"2007":128,"2008":127,"2009":152,"2010":122,"2011":137,"2012":567,"2013":200,"2014":829,"2015":687,"2016":830,"2017":831,"2018":832,"2019":833,"2020":834,"2021":835,"2022":836,"2023":837,"2024":145,"2025":40},73,197,219,380,281,328,148,183,160,2.05,{"2000":365,"2001":168,"2002":365,"2003":167,"2004":168,"2005":121,"2006":224,"2007":840,"2008":118,"2009":367,"2010":284,"2011":170,"2012":707,"2013":693,"2014":822,"2015":841,"2016":842,"2017":843,"2018":844,"2019":845,"2020":846,"2021":847,"2022":848,"2023":849,"2024":52,"2025":168},0.47,1.91,4.93,7.3,11.52,9.06,7.63,5.1,6.1,3.27,{"impactFactor":28,"impactFactorByYear":28,"i10Index":435,"i10IndexLast5Year":155,"totalPublication":130,"totalPublicationByYear":851,"totalCitation":852,"totalCitationByYear":853,"totalCitationPerPublication":860,"totalCitationPerPublicationByYear":861,"hindexLast5Year":136,"hindex":133},{"1017":40,"2015":40,"2016":123,"2017":42,"2018":42,"2019":40,"2020":45,"2022":123,"2023":123,"2024":40},3528,{"2014":323,"2015":140,"2016":201,"2017":158,"2018":522,"2019":613,"2020":854,"2021":855,"2022":701,"2023":856,"2024":857,"2025":858,"2026":859},280,403,436,525,589,366,176.4,{"2015":140,"2016":862,"2017":134,"2018":352,"2019":613,"2020":159,"2022":863,"2023":864,"2024":857},20.5,212.5,218,{"code":866,"data":867,"meta":28},"SUCCESS",{"id":868,"createTime":869,"updateTime":870,"relativeEntities":871,"slug":872,"properties":873,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":883,"manageAffiliations":896,"indexDatabases":904,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},"7afcd79d-bb53-4ee4-9455-4e1539e045a2","2023-05-29T10:28:51.527+00:00","2025-11-21T09:51:41.057+00:00",[],"Surgical-Neurology-International",{"country":874,"issn":876,"title":878,"introduce":880},{"VOID":875},"IN",{"VOID":877},"21527806",{"EN":879},"Surgical Neurology International",{"EN":881},"Surgical Neurology International® (SNI) is an open access, Internet-only journal that publishes the latest developments in the field of neurosurgery and related clinical and basic neurosciences. SNI® will also discuss timely and controversial clinical, social, ethical, and political subjects related to the neurosciences of its readers worldwide. SNI® is an independent publication that is not affiliated with any society or organization. The journal welcomes papers and opinions from neurosurgeons and clinical and basic neuroscientists everywhere. Articles submitted to SNI must undergo a double-blind peer review process. SNI publishes on a continuous basis, currently averaging 25 articles per month. Its papers can be downloaded for free by anyone.","PENDING",[884,890],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":886,"label":887,"description":889,"parentId":28,"standard":28,"scholarHubFieldId":28},"f3c7480d-9f85-464a-ad0d-807993a45c26",[],{"EN":888},"Surgery",{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":892,"label":893,"description":895,"parentId":28,"standard":28,"scholarHubFieldId":28},"228d6ea6-4b2a-4153-bf22-36784b0cd31c",[],{"EN":894},"Neurology (clinical)",{},[897],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":899,"slug":28,"properties":900,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":903,"statistic":28},"dc0662fa-29b5-474d-a7dc-bf20dce6a5bc",[],{"title":901},{"EN":902},"Scientific Scholar LLC",[],[905],{"id":906,"indexDatabase":907,"url":912,"indexYears":913,"academicFieldIds":914,"indexDatabaseRanking":917},"87a05238-1043-4f16-ab38-3123c560330c",{"id":775,"createTime":28,"updateTime":28,"relativeEntities":908,"label":909,"description":910,"key":781,"publicationTags":911,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],"https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F19700201171","2011-2025",[915,916],"d729cb0b-d468-4829-9bfc-9e3b992eeefe","c75f06a2-b70a-4b9b-8c02-99f3ab012851","SCOPUS__Q3","https:\u002F\u002Fsurgicalneurologyint.com\u002F",{"meta":920,"data":922},{"total":921},"20",[923,1083,2051,2432,2646,2791,3048,3293,3711,3880],{"id":924,"createTime":925,"updateTime":925,"relativeEntities":926,"slug":927,"properties":928,"entityType":941,"verifyStatus":26,"verifyTime":925,"verifyNote":942,"languages":943,"translateLanguages":28,"viewCount":32,"primaryUrl":944,"fullTextUrl":28,"authors":945,"publicationType":963,"publisherRelationship":964,"citationCount":1001,"citationInfo":1002,"publishDate":1005,"publishYear":1003,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":1006,"openAccess":28,"references":1007,"isForceReanalyzing":1082},"157f221b-74b7-4975-9116-67359e7382ca","2025-01-30T16:41:21.762+00:00",[],"Multidisciplinary-in-hospital-teams-improve-patient-outcomes-A-review",{"openalex":929,"mag":931,"title":933,"pm":935,"doi":937,"pmc":939},{"VOID":930},"W2019031219",{"VOID":932},"2019031219",{"EN":934},"Multidisciplinary in-hospital teams improve patient outcomes: A review",{"VOID":936},"25289149",{"VOID":938},"10.4103\u002F2152-7806.139612",{"VOID":940},"4173201","PUBLICATION","Auto Verify",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fmultidisciplinary-in-hospital-teams-improve-patient-outcomes-a-review\u002F",[946],{"id":947,"sortIndex":32,"researcher":28,"roles":948,"affiliations":949,"properties":958,"displayName":960,"givenName":28,"familyName":28},"22863ca3-8aa4-49ef-87de-fd3fb187cfbd",[],[950],{"id":951,"sortIndex":32,"affiliation":952,"properties":28},"614ede8d-3d0e-4ca5-a804-48759cc5cdc3",{"id":951,"createTime":28,"updateTime":28,"relativeEntities":953,"slug":28,"properties":954,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":957,"statistic":28},[],{"title":955},{"EN":956},"Winthrop University Hospital, Chief of Neurosurgical Spine, Education, and Research, Mineola, NY 11501, USA.",[],{"title":959,"openalex":961},{"EN":960},"NancyE Epstein",{"VOID":962},"A5110510226","ARTICLE",{"url":28,"publisher":965,"properties":994},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":966,"slug":872,"properties":967,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":971,"manageAffiliations":980,"indexDatabases":986,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":968,"title":969,"country":970},{"VOID":877},{"EN":879},{"VOID":875},[972,976],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":973,"label":974,"description":975,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":977,"label":978,"description":979,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[981],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":982,"slug":28,"properties":983,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":985,"statistic":28},[],{"title":984},{"EN":902},[],[987],{"id":906,"indexDatabase":988,"url":912,"indexYears":913,"academicFieldIds":993,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":989,"label":990,"description":991,"key":781,"publicationTags":992,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":995,"pages":997,"volume":999},{"VOID":996},"8",{"VOID":998},"295",{"VOID":1000},"5",325,{"total":1001,"publishYear":1003,"statisticByYear":1004},2014,{"2015":40,"2016":357,"2017":140,"2018":147,"2019":148,"2020":689,"2021":279,"2022":138,"2023":201,"2024":353},"2014-01-01",[917],[1008,1011,1014,1017,1020,1023,1026,1029,1032,1035,1038,1041,1044,1047,1051,1054,1057,1060,1063,1066,1069,1072,1076,1079],{"id":28,"text":1009,"url":28,"identifiers":1010},"Adobamen, 2014, Indian J Otolaryngol Head Neck Surg, Ear, nose, throat, head and neck surgery department functioning as a team in Nigeria: Any benefit?, 299",{},{"id":28,"text":1012,"url":28,"identifiers":1013},"Anderson, 2011, Nurs Res, Characterizing the structure of operating room staffing using social network analysis, 378",{},{"id":28,"text":1015,"url":28,"identifiers":1016},"Antoniadis, 2014, J Surg Res, Identification and interference of intraoperative distractions and interruptions in operating rooms, 21",{},{"id":28,"text":1018,"url":28,"identifiers":1019},"Arriaga, 2014, Ann Surg, ; Harvard Surgical Safety Collaborative.Pilot testing of a model for insurer-driven, large-scale multicenter simulation training for operating room teams, 403",{},{"id":28,"text":1021,"url":28,"identifiers":1022},"Ausman, 1999, Surg Neurol, Editorial; The business of surgery: Business principles applied to preoperative planning, operating room management, and surgical strategy, 113",{},{"id":28,"text":1024,"url":28,"identifiers":1025},"Bloos, 2009, Br J Anaesth, Effects of staff training on the care of mechanically ventilated patients: A prospective cohort study, 232",{},{"id":28,"text":1027,"url":28,"identifiers":1028},"D′Amours, 2013, Curr Opin Crit Care, Utility of simultaneous interventional radiology and operative surgery in a dedicated suite for seriously injured patients, 587",{},{"id":28,"text":1030,"url":28,"identifiers":1031},"Estryn-Behar, 2014, J Patient Saf, Shift change handovers and subsequent interruptions: Potential impacts on quality of care, 29",{},{"id":28,"text":1033,"url":28,"identifiers":1034},"Garbee, 2013, Nurs Educ Perspect, Interprofessional teamwork among students in simulated codes: A quasi-experimental study, 339",{},{"id":28,"text":1036,"url":28,"identifiers":1037},"Haugen, 2013, BMC Surg, A survey of surgical team members′ perceptions of near misses and attitudes towards Time Out protocols, 46",{},{"id":28,"text":1039,"url":28,"identifiers":1040},"Hwang, 2014, J Neurosci Nurs, Assessment of satisfaction with care among family members of survivors in a neuroscience intensive care unit, 106",{},{"id":28,"text":1042,"url":28,"identifiers":1043},"Jacobs, 2012, Surg Neurol Int, Consequences and potential problems of operating room outbursts and temper tantrums by surgeons, S167",{},{"id":28,"text":1045,"url":28,"identifiers":1046},"Justic, 2000, Crit Care Nurse, Does \"ICU psychosis\" really exist?, 28",{},{"id":28,"text":1048,"url":28,"identifiers":1049},"Koivunen M, Anttila M, Kuosmanen L, Katajisto J, Välimäki M. Team climate and attitudes toward information and communication technology among nurses on acute psychiatric wards. Inform Health Soc Care 2014 Jan 6. [Epub ahead of print]",{"doi":1050},"10.3109\u002F17538157.2013.872112",{"id":28,"text":1052,"url":28,"identifiers":1053},"Mangum, 2002, AORN J, Increased efficiency through OR redesign and process simplification, 1041",{},{"id":28,"text":1055,"url":28,"identifiers":1056},"McGuinness, 2012, Surg Neurol Int, How to reduce hospital-acquired pressure ulcers on a neuroscience unit with a skin and wound assessment team, 138",{},{"id":28,"text":1058,"url":28,"identifiers":1059},"Overdyk, 1998, Anesth Analg, Successful strategies for improving operating room efficiency at academic institutions, 896",{},{"id":28,"text":1061,"url":28,"identifiers":1062},"Paige, 2014, J Am Coll Surg, Getting a head start: High-fidelity, simulation-based operating room team training of interprofessional students, 140",{},{"id":28,"text":1064,"url":28,"identifiers":1065},"Papaconstantinou, 2013, Ochsner J, Implementation of a surgical safety checklist: Impact on surgical team perspectives, 299",{},{"id":28,"text":1067,"url":28,"identifiers":1068},"Porter, 2014, Jt Comm J Qual Patient Saf, Sustainable, effective implementation of a surgical preprocedural checklist: An \"attestation\" format for all operating team members, 3",{},{"id":28,"text":1070,"url":28,"identifiers":1071},"Pucher, 2014, Surgery, Nontechnical skills performance and care processes in the management of the acute trauma patient, 902",{},{"id":28,"text":1073,"url":28,"identifiers":1074},"Scott JK, Leary SD, Ness AR, Sandy JR, Persson M, Kilpatrick N, et al. Centralization of services for children born with orofacial clefts in the United Kingdom: A cross-sectional survey. Cleft Palate Craniofac J 2014 Feb 7. [Epub ahead of print]",{"doi":1075},"10.1597\u002F13-110",{"id":28,"text":1077,"url":28,"identifiers":1078},"Tsai, 2013, Kaohsiung J Med Sci, Outcomes of the patients in the respiratory care center are not associated with the seniority of the caring resident, 43",{},{"id":28,"text":1080,"url":28,"identifiers":1081},"Williams, 2014, J Crit Care, In-hospital fellow coverage reduces communication errors in the surgical intensive care unit, 445",{},false,{"id":1084,"createTime":1085,"updateTime":1085,"relativeEntities":1086,"slug":1087,"properties":1088,"entityType":941,"verifyStatus":26,"verifyTime":1085,"verifyNote":942,"languages":1101,"translateLanguages":28,"viewCount":32,"primaryUrl":1102,"fullTextUrl":28,"authors":1103,"publicationType":963,"publisherRelationship":1155,"citationCount":1191,"citationInfo":1192,"publishDate":1005,"publishYear":1003,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":1194,"openAccess":28,"references":1195,"isForceReanalyzing":1082},"e3fad7aa-20c4-4aa5-85a0-848da8e73870","2025-02-11T07:13:05.805+00:00",[],"Glioblastoma-multiforme-State-of-the-art-and-future-therapeutics",{"openalex":1089,"mag":1091,"title":1093,"pm":1095,"doi":1097,"pmc":1099},{"VOID":1090},"W2003438982",{"VOID":1092},"2003438982",{"EN":1094},"Glioblastoma multiforme: State of the art and future therapeutics",{"VOID":1096},"24991467",{"VOID":1098},"10.4103\u002F2152-7806.132138",{"VOID":1100},"4078454",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fglioblastoma-multiforme-state-of-the-art-and-future-therapeutics\u002F",[1104,1121,1136],{"id":1105,"sortIndex":32,"researcher":28,"roles":1106,"affiliations":1107,"properties":1116,"displayName":1118,"givenName":28,"familyName":28},"a46b65b0-9cc3-4a71-bf1e-01d3467b0e98",[],[1108],{"id":1109,"sortIndex":32,"affiliation":1110,"properties":28},"590536a8-21f1-4563-ad41-91330819698a",{"id":1109,"createTime":28,"updateTime":28,"relativeEntities":1111,"slug":28,"properties":1112,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1115,"statistic":28},[],{"title":1113},{"EN":1114},"Department of Neurosurgery, Division of Oncology, New York University School of Medicine, NY, USA.",[],{"title":1117,"openalex":1119},{"EN":1118},"DavidH. Harter",{"VOID":1120},"A5111625474",{"id":1122,"sortIndex":40,"researcher":28,"roles":1123,"affiliations":1124,"properties":1131,"displayName":1133,"givenName":28,"familyName":28},"fdcb7a52-03cc-48a2-bc45-762759e8c1e6",[],[1125],{"id":1109,"sortIndex":32,"affiliation":1126,"properties":28},{"id":1109,"createTime":28,"updateTime":28,"relativeEntities":1127,"slug":28,"properties":1128,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1130,"statistic":28},[],{"title":1129},{"EN":1114},[],{"title":1132,"openalex":1134},{"EN":1133},"TaylorA Wilson",{"VOID":1135},"A5111625475",{"id":1137,"sortIndex":123,"researcher":28,"roles":1138,"affiliations":1139,"properties":1148,"displayName":1152,"givenName":28,"familyName":28},"4c2d34a5-c16e-4a15-89fb-25c9e6916949",[],[1140],{"id":1141,"sortIndex":32,"affiliation":1142,"properties":28},"02d5be43-888e-432d-ba96-a01500a8523d",{"id":1141,"createTime":28,"updateTime":28,"relativeEntities":1143,"slug":28,"properties":1144,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1147,"statistic":28},[],{"title":1145},{"EN":1146},"Department of Pediatrics, Division of Oncology, New York University School of Medicine, NY, USA.",[],{"orcid":1149,"title":1151,"openalex":1153},{"VOID":1150},"https:\u002F\u002Forcid.org\u002F0000-0002-7151-6528",{"EN":1152},"Matthias A. Karajannis",{"VOID":1154},"A5007528270",{"url":28,"publisher":1156,"properties":1185},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":1157,"slug":872,"properties":1158,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":1162,"manageAffiliations":1171,"indexDatabases":1177,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":1159,"title":1160,"country":1161},{"VOID":877},{"EN":879},{"VOID":875},[1163,1167],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":1164,"label":1165,"description":1166,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":1168,"label":1169,"description":1170,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[1172],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":1173,"slug":28,"properties":1174,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":1176,"statistic":28},[],{"title":1175},{"EN":902},[],[1178],{"id":906,"indexDatabase":1179,"url":912,"indexYears":913,"academicFieldIds":1184,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":1180,"label":1181,"description":1182,"key":781,"publicationTags":1183,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":1186,"pages":1188,"volume":1190},{"VOID":1187},"1",{"VOID":1189},"64",{"VOID":1000},289,{"total":1191,"publishYear":1003,"statisticByYear":1193},{"2014":49,"2015":148,"2016":69,"2017":128,"2018":134,"2019":147,"2020":122,"2021":148,"2022":152,"2023":202,"2024":136},[917],[1196,1199,1202,1205,1208,1211,1214,1217,1220,1223,1226,1229,1232,1235,1238,1241,1244,1247,1250,1253,1256,1259,1262,1265,1268,1271,1274,1277,1280,1283,1286,1289,1292,1295,1298,1301,1304,1307,1310,1313,1316,1319,1322,1325,1328,1331,1334,1337,1340,1343,1346,1349,1352,1355,1358,1361,1364,1367,1370,1373,1376,1379,1382,1385,1388,1391,1394,1397,1400,1403,1406,1409,1412,1415,1418,1421,1424,1427,1430,1433,1436,1439,1443,1446,1449,1452,1455,1458,1461,1464,1467,1470,1473,1476,1479,1482,1485,1488,1491,1494,1497,1500,1503,1506,1509,1512,1515,1518,1521,1524,1527,1530,1533,1536,1539,1542,1545,1548,1551,1554,1557,1560,1563,1566,1569,1572,1575,1578,1581,1584,1587,1590,1593,1596,1599,1602,1605,1608,1611,1614,1617,1620,1623,1626,1629,1632,1635,1638,1641,1644,1647,1650,1653,1656,1659,1662,1665,1668,1671,1674,1677,1680,1683,1686,1689,1692,1695,1698,1701,1704,1707,1710,1713,1716,1719,1722,1725,1728,1731,1734,1737,1740,1743,1746,1749,1752,1755,1758,1761,1764,1767,1770,1773,1776,1779,1782,1785,1788,1791,1794,1797,1800,1803,1806,1809,1812,1815,1818,1821,1824,1827,1830,1833,1836,1839,1842,1845,1848,1851,1854,1857,1860,1863,1866,1869,1872,1875,1878,1881,1884,1887,1890,1893,1897,1900,1903,1906,1909,1912,1915,1918,1921,1924,1927,1930,1933,1936,1939,1942,1945,1948,1951,1954,1957,1960,1963,1967,1970,1973,1976,1979,1982,1985,1988,1991,1994,1997,2000,2003,2006,2009,2012,2015,2018,2021,2024,2027,2030,2033,2036,2039,2042,2045,2048],{"id":28,"text":1197,"url":28,"identifiers":1198},"Aguilar, 2012, Curr Treat Options Oncol, The spectrum of vaccine therapies for patients with glioblastoma multiforme, 437",{},{"id":28,"text":1200,"url":28,"identifiers":1201},"Ahmed, 2011, Mol Ther, Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma, 1714",{},{"id":28,"text":1203,"url":28,"identifiers":1204},"Ahmed, 2011, Mol Pharm, A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma, 1559",{},{"id":28,"text":1206,"url":28,"identifiers":1207},"Anton, 2012, Hematol Oncol Clin North Am, Glioblastoma multiforme: Overview of current treatment and future perspectives, 825",{},{"id":28,"text":1209,"url":28,"identifiers":1210},"Ardon, 2010, Pediatr Blood Cancer, Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours, 519",{},{"id":28,"text":1212,"url":28,"identifiers":1213},"Ardon, 2010, J Neurooncol, Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: A pilot study, 261",{},{"id":28,"text":1215,"url":28,"identifiers":1216},"Arjona, 2006, Curr Mol Med, Early genetic changes involved in low-grade astrocytic tumor development, 645",{},{"id":28,"text":1218,"url":28,"identifiers":1219},"Bai, 2011, Trends Mol Med, Molecular targeting of glioblastoma: Drug discovery and therapies, 301",{},{"id":28,"text":1221,"url":28,"identifiers":1222},"Balss, 2008, Acta Neuropathol, Analysis of the IDH1 codon 132 mutation in brain tumors, 597",{},{"id":28,"text":1224,"url":28,"identifiers":1225},"Bao, 2006, Nature, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, 756",{},{"id":28,"text":1227,"url":28,"identifiers":1228},"Barba, 1989, J Neurosurg, Intratumoral LAK cell and interleukin-2 therapy of human gliomas, 175",{},{"id":28,"text":1230,"url":28,"identifiers":1231},"Batchelor, 2010, J Clin Oncol, Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma, 2817",{},{"id":28,"text":1233,"url":28,"identifiers":1234},"Bello, 2001, Neurosurgery, Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery, 380",{},{"id":28,"text":1236,"url":28,"identifiers":1237},"Beltinger, 1999, Proc Natl Acad Sci U S A, Herpes simplex virus thymidine kinase\u002Fganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases, 8699",{},{"id":28,"text":1239,"url":28,"identifiers":1240},"Beroukhim, 2007, Proc Natl Acad Sci U S A, Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma, 20007",{},{"id":28,"text":1242,"url":28,"identifiers":1243},"Bigner, 1995, J Neurooncol, Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′) 2--a preliminary report, 109",{},{"id":28,"text":1245,"url":28,"identifiers":1246},"Blancher, 1993, Eur Cytokine Netw, Local immunotherapy of recurrent glioblastoma multiforme by intracerebral perfusion of interleukin-2 and LAK cells, 331",{},{"id":28,"text":1248,"url":28,"identifiers":1249},"Boiardi, 1994, Cancer Immunol Immunother, Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients, 193",{},{"id":28,"text":1251,"url":28,"identifiers":1252},"Brady, 1992, Int J Radiat Oncol Biol Phys, Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial, 225",{},{"id":28,"text":1254,"url":28,"identifiers":1255},"Brennan, 2009, PloS One, Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations, e7752",{},{"id":28,"text":1257,"url":28,"identifiers":1258},"Brown, 2008, J Clin Oncol, Phase I\u002FII trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177, 5603",{},{"id":28,"text":1260,"url":28,"identifiers":1261},"Buchschacher, 2000, Blood, Development of lentiviral vectors for gene therapy for human diseases, 2499",{},{"id":28,"text":1263,"url":28,"identifiers":1264},"Cahoy, 2008, J Neurosci, A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function, 264",{},{"id":28,"text":1266,"url":28,"identifiers":1267},"Calabrese, 2007, Cancer Cell, A perivascular niche for brain tumor stem cells, 69",{},{"id":28,"text":1269,"url":28,"identifiers":1270},"Cancer, 2008, Nature, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, 1061",{},{"id":28,"text":1272,"url":28,"identifiers":1273},"Candolfi, 2009, Clin Cancer Res, Release of HMGB1 in response to proapoptotic glioma killing strategies: Efficacy and neurotoxicity, 4401",{},{"id":28,"text":1275,"url":28,"identifiers":1276},"Caruso, 2004, Neuro Oncol, Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer, 236",{},{"id":28,"text":1278,"url":28,"identifiers":1279},"Castro, 2011, Curr Gene Ther, Gene therapy and targeted toxins for glioma, 155",{},{"id":28,"text":1281,"url":28,"identifiers":1282},"Chambers, 1995, Proc Natl Acad Sci U S A, Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma, 1411",{},{"id":28,"text":1284,"url":28,"identifiers":1285},"Chang, 2011, J Clin Neurosci, A phase I\u002FII clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma, 1048",{},{"id":28,"text":1287,"url":28,"identifiers":1288},"Chaudhry, 2001, Histopathology, Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas, 409",{},{"id":28,"text":1290,"url":28,"identifiers":1291},"Chen, 2012, Nature, A restricted cell population propagates glioblastoma growth after chemotherapy, 522",{},{"id":28,"text":1293,"url":28,"identifiers":1294},"Chen, 2012, Cell, Malignant glioma: Lessons from genomics, mouse models, and stem cells, 36",{},{"id":28,"text":1296,"url":28,"identifiers":1297},"Chinot, 2007, J Clin Oncol, Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide, 1470",{},{"id":28,"text":1299,"url":28,"identifiers":1300},"Chinot, 2011, Adv Ther, AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme, 334",{},{"id":28,"text":1302,"url":28,"identifiers":1303},"Chiocca, 2004, Mol Ther, A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting, 958",{},{"id":28,"text":1305,"url":28,"identifiers":1306},"Choi, 2009, Brain Pathol, EGFRvIII-targeted vaccination therapy of malignant glioma, 713",{},{"id":28,"text":1308,"url":28,"identifiers":1309},"Chow, 2011, Immunotherapy, Cellular immunotherapy for high-grade glioma, 423",{},{"id":28,"text":1311,"url":28,"identifiers":1312},"Clarke, 2010, Arch Neurol, Recent advances in therapy for glioblastoma, 279",{},{"id":28,"text":1314,"url":28,"identifiers":1315},"Cloughesy, 2006, J Clin Oncol, Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium Study, 3651",{},{"id":28,"text":1317,"url":28,"identifiers":1318},"Cloughesy, 2008, PLoS Med, Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma, e8",{},{"id":28,"text":1320,"url":28,"identifiers":1321},"Combs, 2006, BMC Cancer, Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I\u002FII trial: Study protocol, 133",{},{"id":28,"text":1323,"url":28,"identifiers":1324},"Corey, 1986, Diagn Microbiol Infect Dis, Laboratory diagnosis of herpes simplex virus infections.Principles guiding the development of rapid diagnostic tests, 111",{},{"id":28,"text":1326,"url":28,"identifiers":1327},"Curtin, 2009, PLoS Med, HMGB1 mediates endogenous TLR2 activation and brain tumor regression, e10",{},{"id":28,"text":1329,"url":28,"identifiers":1330},"Cutter, 2006, Expert Rev Anticancer Ther, Gene therapeutics: The future of brain tumor therapy?, 1053",{},{"id":28,"text":1332,"url":28,"identifiers":1333},"Day ED, Lassiter S, Woodhall B, Mahaley JL, Mahaley MS Jr. The localization of radioantibodies in human brain tumors. I. Preliminary exploration. Cancer Res 1965;25:773-8.",{},{"id":28,"text":1335,"url":28,"identifiers":1336},"Day, 2012, Neurosurg Clin N Am, Clinical trials of small molecule inhibitors in high-grade glioma, 407",{},{"id":28,"text":1338,"url":28,"identifiers":1339},"De, 2008, Clin Cancer Res, Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme, 3098",{},{"id":28,"text":1341,"url":28,"identifiers":1342},"Debinski, 2000, Mol Med, Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer\u002Ftestis antigen, 440",{},{"id":28,"text":1344,"url":28,"identifiers":1345},"Debinski, 1999, Int J Oncol, Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme, 481",{},{"id":28,"text":1347,"url":28,"identifiers":1348},"Debinski, 1996, J Biol Chem, Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells, 22428",{},{"id":28,"text":1350,"url":28,"identifiers":1351},"Debinski, 1995, Clin Cancer Res, Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin, 1253",{},{"id":28,"text":1353,"url":28,"identifiers":1354},"Debinski, 2000, J Neurooncol, Expression of a restrictive receptor for interleukin 13 is associated with glial transformation, 103",{},{"id":28,"text":1356,"url":28,"identifiers":1357},"Del, 2010, Curr Opin Mol Ther, Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme, 741",{},{"id":28,"text":1359,"url":28,"identifiers":1360},"Dembinski, 2010, Cancer Gene Ther, Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells, 289",{},{"id":28,"text":1362,"url":28,"identifiers":1363},"Dillman, 2011, Cancer Biother Radiopharm, Cancer immunotherapy, 1",{},{"id":28,"text":1365,"url":28,"identifiers":1366},"Dillman, 2009, J Immunother, Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma, 914",{},{"id":28,"text":1368,"url":28,"identifiers":1369},"Dillman, 2004, J Immunother, Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma, 398",{},{"id":28,"text":1371,"url":28,"identifiers":1372},"Dirks, 2008, J Clin Oncol, Brain tumor stem cells: Bringing order to the chaos of brain cancer, 2916",{},{"id":28,"text":1374,"url":28,"identifiers":1375},"Drablos, 2004, DNA Repair (Amst), Alkylation damage in DNA and RNA--repair mechanisms and medical significance, 1389",{},{"id":28,"text":1377,"url":28,"identifiers":1378},"Dresemann, 2005, Ann Oncol, Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: A patient series, 1702",{},{"id":28,"text":1380,"url":28,"identifiers":1381},"Dvorak, 2002, J Clin Oncol, Vascular permeability factor\u002Fvascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy, 4368",{},{"id":28,"text":1383,"url":28,"identifiers":1384},"Ehtesham, 2004, Cancer Control, Recent progress in immunotherapy for malignant glioma: Treatment strategies and results from clinical trials, 192",{},{"id":28,"text":1386,"url":28,"identifiers":1387},"El-Aneed, 2004, J Control Release, An overview of current delivery systems in cancer gene therapy, 1",{},{"id":28,"text":1389,"url":28,"identifiers":1390},"Eller, 2005, Neurosurgery, Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo, 155",{},{"id":28,"text":1392,"url":28,"identifiers":1393},"Ferguson, 2010, Discov Med, Crossing the boundaries: Stem cells and gene therapy, 192",{},{"id":28,"text":1395,"url":28,"identifiers":1396},"Ferrara, 2005, Oncology, VEGF as a therapeutic target in cancer, 11",{},{"id":28,"text":1398,"url":28,"identifiers":1399},"Ferrara, 2009, Eur Cytokine Netw, VEGF-A: A critical regulator of blood vessel growth, 158",{},{"id":28,"text":1401,"url":28,"identifiers":1402},"Ferrara, 2003, Nat Med, The biology of VEGF and its receptors, 669",{},{"id":28,"text":1404,"url":28,"identifiers":1405},"Floeth, 2001, Cancer Gene Ther, Local inflammation and devascularization--in vivo mechanisms of the \"bystander effect\" in VPC-mediated HSV-Tk\u002FGCV gene therapy for human malignant glioma, 843",{},{"id":28,"text":1407,"url":28,"identifiers":1408},"Forsyth, 2008, Mol Ther, A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas, 627",{},{"id":28,"text":1410,"url":28,"identifiers":1411},"Friedman, 2009, J Clin Oncol, Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma, 4733",{},{"id":28,"text":1413,"url":28,"identifiers":1414},"Fueyo, 2003, J Natl Cancer Inst, Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway, 652",{},{"id":28,"text":1416,"url":28,"identifiers":1417},"Fueyo, 2000, Oncogene, A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo, 2",{},{"id":28,"text":1419,"url":28,"identifiers":1420},"Fujisawa, 2000, Lab Invest, Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas, 65",{},{"id":28,"text":1422,"url":28,"identifiers":1423},"Fukai, 2008, Cancer Sci, Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III, 2062",{},{"id":28,"text":1425,"url":28,"identifiers":1426},"Furnari, 2007, Genes Dev, Malignant astrocytic glioma: Genetics, biology, and paths to treatment, 2683",{},{"id":28,"text":1428,"url":28,"identifiers":1429},"Galanis, 2005, J Clin Oncol, Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study, 5294",{},{"id":28,"text":1431,"url":28,"identifiers":1432},"Geoerger, 2002, Cancer Res, Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts, 764",{},{"id":28,"text":1434,"url":28,"identifiers":1435},"Germano, 2003, J Neurooncol, Adenovirus\u002Fherpes simplex-thymidine kinase\u002Fganciclovir complex: Preliminary results of a phase I trial in patients with recurrent malignant gliomas, 279",{},{"id":28,"text":1437,"url":28,"identifiers":1438},"Gerson, 2004, Nat Rev Cancer, MGMT: Its role in cancer aetiology and cancer therapeutics, 296",{},{"id":28,"text":1440,"url":28,"identifiers":1441},"Gilbert M, editor RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). 2013 ASCO Annual Meeting; 2013; Chicago.",{"doi":1442},"10.1200\u002Fjco.2013.31.18_suppl.1",{"id":28,"text":1444,"url":28,"identifiers":1445},"Gomez-Manzano, 2012, Handb Clin Neurol, Gene therapy, 331",{},{"id":28,"text":1447,"url":28,"identifiers":1448},"Grandi, 2009, Expert Rev Neurother, Design and application of oncolytic HSV vectors for glioblastoma therapy, 505",{},{"id":28,"text":1450,"url":28,"identifiers":1451},"Haas-Kogan, 2005, J Natl Cancer Inst, Epidermal growth factor receptor, protein kinase B\u002FAkt, and glioma response to erlotinib, 880",{},{"id":28,"text":1453,"url":28,"identifiers":1454},"Han, 2007, J Gene Med, Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy, 99",{},{"id":28,"text":1456,"url":28,"identifiers":1457},"Harsh, 2000, J Neurosurg, Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: A gene-marking and neuropathological study, 804",{},{"id":28,"text":1459,"url":28,"identifiers":1460},"Hart, 2008, Cochrane Database Syst Rev, Chemotherapeutic wafers for High Grade Glioma, CD007294",{},{"id":28,"text":1462,"url":28,"identifiers":1463},"Hasselbalch, 2010, Neuro Oncol, Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: A phase II trial, 508",{},{"id":28,"text":1465,"url":28,"identifiers":1466},"Hasselbalch, 2010, Cancer Invest, Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling, 775",{},{"id":28,"text":1468,"url":28,"identifiers":1469},"Hawasli, 2013, Neurosurgery, Magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions: Single-institution series, 1007",{},{"id":28,"text":1471,"url":28,"identifiers":1472},"Hayes, 2001, Crit Rev Oncol Hematol, Adoptive cellular immunotherapy for the treatment of malignant gliomas, 31",{},{"id":28,"text":1474,"url":28,"identifiers":1475},"Hayes, 1995, Cancer, Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma, 840",{},{"id":28,"text":1477,"url":28,"identifiers":1478},"Hegi, 2005, N Engl J Med, MGMT gene silencing and benefit from temozolomide in glioblastoma, 997",{},{"id":28,"text":1480,"url":28,"identifiers":1481},"Heimberger, 2009, Expert Opin Biol Ther, The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients, 1087",{},{"id":28,"text":1483,"url":28,"identifiers":1484},"Holladay, 1996, J Neurooncol, Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III\u002FIV astrocytoma, 179",{},{"id":28,"text":1486,"url":28,"identifiers":1487},"Hoover, 2010, Neuroimaging Clin N Am, Clinical trials in brain tumor surgery, 409",{},{"id":28,"text":1489,"url":28,"identifiers":1490},"Immonen, 2004, Mol Ther, AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: A randomised, controlled study, 967",{},{"id":28,"text":1492,"url":28,"identifiers":1493},"Iwami, 2010, Neurol Med Chir, Gene therapy for high-grade glioma, 727",{},{"id":28,"text":1495,"url":28,"identifiers":1496},"Izquierdo, 1997, Acta Neurochir Suppl, Gene therapy in brain tumours: Implications of the size of glioblastoma on its curability, 111",{},{"id":28,"text":1498,"url":28,"identifiers":1499},"Izquierdo, 1996, Gene Ther, Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)\u002Fganciclovir gene therapy, 491",{},{"id":28,"text":1501,"url":28,"identifiers":1502},"Jacobs, 1999, Neoplasia, HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: Part I.HSV-1 structure, replication and pathogenesis, 387",{},{"id":28,"text":1504,"url":28,"identifiers":1505},"Jacobs, 1999, Neoplasia, HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: Part II.Vector systems and applications, 402",{},{"id":28,"text":1507,"url":28,"identifiers":1508},"Jacobs, 1986, Cancer Res, Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: Phase I trial, 2101",{},{"id":28,"text":1510,"url":28,"identifiers":1511},"Jain, 2007, Nat Rev Neurosci, Angiogenesis in brain tumours, 610",{},{"id":28,"text":1513,"url":28,"identifiers":1514},"Joshi, 2001, Cancer Res, In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures, 8058",{},{"id":28,"text":1516,"url":28,"identifiers":1517},"Kahn, 1998, J Mag Reson Imaging, In vivo MRI thermometry using a phase-sensitive sequence: Preliminary experience during MRI-guided laser-induced interstitial thermotherapy of brain tumors, 160",{},{"id":28,"text":1519,"url":28,"identifiers":1520},"Kaina, 2007, DNA Repair (Amst), MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents, 1079",{},{"id":28,"text":1522,"url":28,"identifiers":1523},"Kalofonos, 1989, J Nucl Med, Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase, 1636",{},{"id":28,"text":1525,"url":28,"identifiers":1526},"Kamoun, 2009, J Clin Oncol, Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice, 2542",{},{"id":28,"text":1528,"url":28,"identifiers":1529},"Kanaly, 2010, Neurosurg Clin N Am, Clinical applications of a peptide-based vaccine for glioblastoma, 95",{},{"id":28,"text":1531,"url":28,"identifiers":1532},"Kang, 2008, J Neurooncol, Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety, 113",{},{"id":28,"text":1534,"url":28,"identifiers":1535},"Kangasniemi, 2004, Lasers Surg Med, Thermal therapy of canine cerebral tumors using a 980 nm diode laser with MR temperature-sensitive imaging feedback, 41",{},{"id":28,"text":1537,"url":28,"identifiers":1538},"Kendall, 2008, Stem Cells, Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling, 1575",{},{"id":28,"text":1540,"url":28,"identifiers":1541},"Kikuchi, 2004, J Immunother, Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12, 452",{},{"id":28,"text":1543,"url":28,"identifiers":1544},"Kirson, 2007, Proc Natl Acad Sci U S A, Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors, 10152",{},{"id":28,"text":1546,"url":28,"identifiers":1547},"Kitahara, 1987, J Neurooncol, Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor, 329",{},{"id":28,"text":1549,"url":28,"identifiers":1550},"Kleihues, 1999, Neuro Oncol, Primary and secondary glioblastomas: From concept to clinical diagnosis, 44",{},{"id":28,"text":1552,"url":28,"identifiers":1553},"Kootstra, 2003, Annu Rev Pharmacol Toxicol, Gene therapy with viral vectors, 413",{},{"id":28,"text":1555,"url":28,"identifiers":1556},"Kranzler, 2009, Curr Gene Ther, Stem cells as delivery vehicles for oncolytic adenoviral virotherapy, 389",{},{"id":28,"text":1558,"url":28,"identifiers":1559},"Kreisl, 2009, J Clin Oncol, Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma, 740",{},{"id":28,"text":1561,"url":28,"identifiers":1562},"Kroeger, 2010, Discov Med, Gene therapy and virotherapy: Novel therapeutic approaches for brain tumors, 293",{},{"id":28,"text":1564,"url":28,"identifiers":1565},"Kruse, 1997, Cancer Immunol Immunother, Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2, 77",{},{"id":28,"text":1567,"url":28,"identifiers":1568},"Kunwar, 2010, Neuro Oncol, Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma, 871",{},{"id":28,"text":1570,"url":28,"identifiers":1571},"Kunwar, 2007, J Clin Oncol, Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group, 837",{},{"id":28,"text":1573,"url":28,"identifiers":1574},"Latchman, 2001, Gene, Gene delivery and gene therapy with herpes simplex virus-based vectors, 1",{},{"id":28,"text":1576,"url":28,"identifiers":1577},"Lee, 2006, Cancer Cell, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, 391",{},{"id":28,"text":1579,"url":28,"identifiers":1580},"Leibel, 1987, J Neurosurg, Radiation therapy for neoplasms of the brain, 1",{},{"id":28,"text":1582,"url":28,"identifiers":1583},"Lewis, 1994, J Virol, Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus, 510",{},{"id":28,"text":1585,"url":28,"identifiers":1586},"Li, 2010, J Neurosurg, A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme, 192",{},{"id":28,"text":1588,"url":28,"identifiers":1589},"Li, 2010, Toxins, Targeted toxins in brain tumor therapy, 2645",{},{"id":28,"text":1591,"url":28,"identifiers":1592},"Liau, 2005, Clin Cancer Res, Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment, 5515",{},{"id":28,"text":1594,"url":28,"identifiers":1595},"Lillehei, 1991, Neurosurgery, Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy, 16",{},{"id":28,"text":1597,"url":28,"identifiers":1598},"Long, 1998, Hum Gene Ther, Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells, 1165",{},{"id":28,"text":1600,"url":28,"identifiers":1601},"Long, 1999, Hum Gene Ther, Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy, 733",{},{"id":28,"text":1603,"url":28,"identifiers":1604},"Luptrawan, 2008, Rev Recent Clin Trials, Dendritic cell immunotherapy for malignant gliomas, 10",{},{"id":28,"text":1606,"url":28,"identifiers":1607},"Mahaley MS Jr, Mahaley JL, Day ED. The localization of radioantibodies in human brain tumors. II. Radioautography. Cancer Res 1965;25:779-93.",{},{"id":28,"text":1609,"url":28,"identifiers":1610},"Markert, 2009, Mol Ther, Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM, 199",{},{"id":28,"text":1612,"url":28,"identifiers":1613},"Markert, 2000, Gene Ther, Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial, 867",{},{"id":28,"text":1615,"url":28,"identifiers":1616},"Martinez, 2009, Epigenetics, A microarray-based DNA methylation study of glioblastoma multiforme, 255",{},{"id":28,"text":1618,"url":28,"identifiers":1619},"McGirt, 2009, J Neurosurg, Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme, 583",{},{"id":28,"text":1621,"url":28,"identifiers":1622},"Mellinghoff, 2007, Clin Cancer Res, PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors, 378",{},{"id":28,"text":1624,"url":28,"identifiers":1625},"Merchant, 1988, Cancer, Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2, 665",{},{"id":28,"text":1627,"url":28,"identifiers":1628},"Mesnil, 2000, Cancer Res, Bystander effect in herpes simplex virus-thymidine kinase\u002Fganciclovir cancer gene therapy: Role of gap-junctional intercellular communication, 3989",{},{"id":28,"text":1630,"url":28,"identifiers":1631},"Mintz, 2003, J Neurooncol, Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma, 117",{},{"id":28,"text":1633,"url":28,"identifiers":1634},"Mintz, 2002, Neoplasia, IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13, 388",{},{"id":28,"text":1636,"url":28,"identifiers":1637},"Mischel, 2003, Oncogene, Identification of molecular subtypes of glioblastoma by gene expression profiling, 2361",{},{"id":28,"text":1639,"url":28,"identifiers":1640},"Mitchell, 2008, Immunol Rev, Immunotherapy of malignant brain tumors, 70",{},{"id":28,"text":1642,"url":28,"identifiers":1643},"Mitchell, 2009, Neurotherapeutics, Toward effective immunotherapy for the treatment of malignant brain tumors, 527",{},{"id":28,"text":1645,"url":28,"identifiers":1646},"Mohanam, 1994, J Neurooncol, Proteolysis and invasiveness of brain tumors: Role of urokinase-type plasminogen activator receptor, 153",{},{"id":28,"text":1648,"url":28,"identifiers":1649},"Mohyeldin, 2012, Cancer J, Gene and viral therapy for glioblastoma: A review of clinical trials and future directions, 82",{},{"id":28,"text":1651,"url":28,"identifiers":1652},"Msaouel, 2009, Curr Opin Mol Ther, Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: An overview, 43",{},{"id":28,"text":1654,"url":28,"identifiers":1655},"Mueller, 2011, J Neurooncol, Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study, 267",{},{"id":28,"text":1657,"url":28,"identifiers":1658},"Murat, 2008, J Clin Oncol, Stem cell-related \"self-renewal\" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma, 3015",{},{"id":28,"text":1660,"url":28,"identifiers":1661},"Nakamura, 2000, J Neuropathol Exp Neurol, Loss of heterozygosity on chromosome 19 in secondary glioblastomas, 539",{},{"id":28,"text":1663,"url":28,"identifiers":1664},"Neyns, 2011, J Neurooncol, Phase II study of sunitinib malate in patients with recurrent high-grade glioma, 491",{},{"id":28,"text":1666,"url":28,"identifiers":1667},"Neyns, 2009, Ann Oncol, Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma, 1596",{},{"id":28,"text":1669,"url":28,"identifiers":1670},"Nobusawa, 2009, Clin Cancer Res, IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas, 6002",{},{"id":28,"text":1672,"url":28,"identifiers":1673},"Ohgaki, 2004, Cancer Res, Genetic pathways to glioblastoma: A population-based study, 6892",{},{"id":28,"text":1675,"url":28,"identifiers":1676},"Ohgaki, 2013, Clin Cancer Res, The definition of primary and secondary glioblastoma, 764",{},{"id":28,"text":1678,"url":28,"identifiers":1679},"Ohgaki, 2007, Am J Pathol, Genetic pathways to primary and secondary glioblastoma, 1445",{},{"id":28,"text":1681,"url":28,"identifiers":1682},"Ostman, 2004, Cytokine Growth Factor Rev, PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma, 275",{},{"id":28,"text":1684,"url":28,"identifiers":1685},"Parker, 2000, Proc Natl Acad Sci U S A, Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors, 2208",{},{"id":28,"text":1687,"url":28,"identifiers":1688},"Parsons, 2008, Science, An integrated genomic analysis of human glioblastoma multiforme, 1807",{},{"id":28,"text":1690,"url":28,"identifiers":1691},"Patel, 2012, Expert Opin Investig Drugs, Molecular targeted therapy in recurrent glioblastoma: Current challenges and future directions, 1247",{},{"id":28,"text":1693,"url":28,"identifiers":1694},"Peereboom, 2010, J Neurooncol, Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme, 93",{},{"id":28,"text":1696,"url":28,"identifiers":1697},"Pelloski, 2006, Clin Cancer Res, Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma, 3935",{},{"id":28,"text":1699,"url":28,"identifiers":1700},"Perry, 2012, Neurol Res Int, Novel therapies in glioblastoma, 428565",{},{"id":28,"text":1702,"url":28,"identifiers":1703},"Phillips, 2006, Cancer Cell, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, 157",{},{"id":28,"text":1705,"url":28,"identifiers":1706},"Piccirillo, 2006, Nature, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, 761",{},{"id":28,"text":1708,"url":28,"identifiers":1709},"Pichlmeier, 2008, Neuro Oncol, Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients, 1025",{},{"id":28,"text":1711,"url":28,"identifiers":1712},"Pitter, 2011, PloS One, Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma, e14545",{},{"id":28,"text":1714,"url":28,"identifiers":1715},"Plautz, 1998, J Neurosurg, Systemic T cell adoptive immunotherapy of malignant gliomas, 42",{},{"id":28,"text":1717,"url":28,"identifiers":1718},"Plautz, 2000, Clin Cancer Res, T cell adoptive immunotherapy of newly diagnosed gliomas, 2209",{},{"id":28,"text":1720,"url":28,"identifiers":1721},"Pollard, 2009, Cell Stem Cell, Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens, 568",{},{"id":28,"text":1723,"url":28,"identifiers":1724},"Prados, 2009, J Clin Oncol, Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma, 579",{},{"id":28,"text":1726,"url":28,"identifiers":1727},"Prados, 2006, Neuro Oncol, Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma, 67",{},{"id":28,"text":1729,"url":28,"identifiers":1730},"Prados, 2003, J Neurooncol, Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: A phase I\u002FII multi-institutional trial, 269",{},{"id":28,"text":1732,"url":28,"identifiers":1733},"Prasad, 2011, Neuro Oncol, Inhibition of PI3K\u002FmTOR pathways in glioblastoma and implications for combination therapy with temozolomide, 384",{},{"id":28,"text":1735,"url":28,"identifiers":1736},"Presta, 1997, Cancer Res, Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders, 4593",{},{"id":28,"text":1738,"url":28,"identifiers":1739},"Prins, 2011, Clin Cancer Res, Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy, 1603",{},{"id":28,"text":1741,"url":28,"identifiers":1742},"Puri, 1999, Toxicol Pathol, Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma, 53",{},{"id":28,"text":1744,"url":28,"identifiers":1745},"Quattrocchi, 1999, J Neurooncol, Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas, 141",{},{"id":28,"text":1747,"url":28,"identifiers":1748},"Rahmathulla, 2013, OncoTargets Ther, Bevacizumab in high-grade gliomas: A review of its uses, toxicity assessment, and future treatment challenges, 371",{},{"id":28,"text":1750,"url":28,"identifiers":1751},"Rainov, 2000, Hum Gene Ther, A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme, 2389",{},{"id":28,"text":1753,"url":28,"identifiers":1754},"Rainov, 2000, Gene Ther, Immune response induced by retrovirus-mediated HSV-tk\u002FGCV pharmacogene therapy in patients with glioblastoma multiforme, 1853",{},{"id":28,"text":1756,"url":28,"identifiers":1757},"Rainov, 2003, J Neurooncol, Clinical trials with retrovirus mediated gene therapy--what have we learned?, 227",{},{"id":28,"text":1759,"url":28,"identifiers":1760},"Raizer, 2010, Neuro Oncol, A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy, 95",{},{"id":28,"text":1762,"url":28,"identifiers":1763},"Raizer, 2010, Neuro Oncol, A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas, 87",{},{"id":28,"text":1765,"url":28,"identifiers":1766},"Ram, 1997, Nat Med, Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells, 1354",{},{"id":28,"text":1768,"url":28,"identifiers":1769},"Rand, 2000, Clin Cancer Res, Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma, 2157",{},{"id":28,"text":1771,"url":28,"identifiers":1772},"Raymond, 2008, J Clin Oncol, Phase II study of imatinib in patients with recurrent gliomas of various histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study, 4659",{},{"id":28,"text":1774,"url":28,"identifiers":1775},"Reardon, 2009, Br J Cancer, Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma, 1995",{},{"id":28,"text":1777,"url":28,"identifiers":1778},"Reardon, 2009, Cancer, Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma, 2188",{},{"id":28,"text":1780,"url":28,"identifiers":1781},"Reardon, 2005, J Clin Oncol, Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme, 9359",{},{"id":28,"text":1783,"url":28,"identifiers":1784},"Reardon, 2008, J Clin Oncol, Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme, 5610",{},{"id":28,"text":1786,"url":28,"identifiers":1787},"Reardon, 2008, Expert Opin Investig Drugs, Cilengitide: An integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme, 1225",{},{"id":28,"text":1789,"url":28,"identifiers":1790},"Reardon, 2011, J Neurooncol, Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma, 621",{},{"id":28,"text":1792,"url":28,"identifiers":1793},"Reijneveld, 2000, J Neurol, Angiogenesis in malignant primary and metastatic brain tumors, 597",{},{"id":28,"text":1795,"url":28,"identifiers":1796},"Ricci-Vitiani, 2010, Nature, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, 824",{},{"id":28,"text":1798,"url":28,"identifiers":1799},"Rich, 2004, J Clin Oncol, Phase II trial of gefitinib in recurrent glioblastoma, 133",{},{"id":28,"text":1801,"url":28,"identifiers":1802},"Riva, 1995, Cancer Res, Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: Comparison of the results obtained in recurrent and newly diagnosed tumors, 5952",{},{"id":28,"text":1804,"url":28,"identifiers":1805},"Rustamzadeh, 2006, Int J Cancer, Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice, 2594",{},{"id":28,"text":1807,"url":28,"identifiers":1808},"Rustamzadeh, 2007, Int J Cancer, Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice, 411",{},{"id":28,"text":1810,"url":28,"identifiers":1811},"Rustamzadeh, 2003, J Neurooncol, Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme, 63",{},{"id":28,"text":1813,"url":28,"identifiers":1814},"Rustamzadeh, 2006, J Neurooncol, Immunotoxin pharmacokinetics: A comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13, 257",{},{"id":28,"text":1816,"url":28,"identifiers":1817},"Sampson, 2003, J Neurooncol, Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors, 27",{},{"id":28,"text":1819,"url":28,"identifiers":1820},"Sampson, 2008, Semin Immunol, Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma, 267",{},{"id":28,"text":1822,"url":28,"identifiers":1823},"Sampson, 2009, Mol Cancer Ther, An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme, 2773",{},{"id":28,"text":1825,"url":28,"identifiers":1826},"Sampson, 2010, J Clin Oncol, Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma, 4722",{},{"id":28,"text":1828,"url":28,"identifiers":1829},"Sandmair, 2000, Hum Gene Ther, Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses, 2197",{},{"id":28,"text":1831,"url":28,"identifiers":1832},"Sathornsumetee, 2007, Cancer, Molecularly targeted therapy for malignant glioma, 13",{},{"id":28,"text":1834,"url":28,"identifiers":1835},"Scaringi, 2012, Anticancer Res, Integrin inhibitor cilengitide for the treatment of glioblastoma: A brief overview of current clinical results, 4213",{},{"id":28,"text":1837,"url":28,"identifiers":1838},"Schmidt, 1999, Int J Cancer, Levels of vascular endothelial growth factor, hepatocyte growth factor\u002Fscatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis, 10",{},{"id":28,"text":1840,"url":28,"identifiers":1841},"Schwarzmaier, 2005, J Magn Reson Imaging, MR-guided laser irradiation of recurrent glioblastomas, 799",{},{"id":28,"text":1843,"url":28,"identifiers":1844},"Schwarzmaier, 2006, Eur J Radiol, MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: Preliminary results in 16 patients, 208",{},{"id":28,"text":1846,"url":28,"identifiers":1847},"Schwarzmaier, 1998, J Magn Reson Imaging, Treatment planning for MRI-guided laser-induced interstitial thermotherapy of brain tumors--the role of blood perfusion, 121",{},{"id":28,"text":1849,"url":28,"identifiers":1850},"Sebolt-Leopold, 2004, Nat Rev Cancer, Targeting the mitogen-activated protein kinase cascade to treat cancer, 937",{},{"id":28,"text":1852,"url":28,"identifiers":1853},"Shah, 2003, J Neurooncol, Oncolytic viruses: Clinical applications as vectors for the treatment of malignant gliomas, 203",{},{"id":28,"text":1855,"url":28,"identifiers":1856},"Shai, 2003, Oncogene, Gene expression profiling identifies molecular subtypes of gliomas, 4918",{},{"id":28,"text":1858,"url":28,"identifiers":1859},"Shand, 1999, Hum Gene Ther, A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.GLI328 European-Canadian Study Group, 2325",{},{"id":28,"text":1861,"url":28,"identifiers":1862},"Shapiro, 1989, J Neurosurg, Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma.Brain Tumor Cooperative Group Trial 8001, 1",{},{"id":28,"text":1864,"url":28,"identifiers":1865},"Shaw, 2006, Nature, Ras, PI(3) K and mTOR signalling controls tumour cell growth, 424",{},{"id":28,"text":1867,"url":28,"identifiers":1868},"Silva, 2008, Arterioscler Thromb Vasc Biol, Integrins: The keys to unlocking angiogenesis, 1703",{},{"id":28,"text":1870,"url":28,"identifiers":1871},"Singh, 2003, Cancer Res, Identification of a cancer stem cell in human brain tumors, 5821",{},{"id":28,"text":1873,"url":28,"identifiers":1874},"Singh, 2004, Nature, Identification of human brain tumour initiating cells, 396",{},{"id":28,"text":1876,"url":28,"identifiers":1877},"Sloan, 2013, J Neurosurg, Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: Clinical article, 1202",{},{"id":28,"text":1879,"url":28,"identifiers":1880},"Sloan, 2000, Neurosurg Focus, Adoptive immunotherapy in patients with recurrent malignant glioma: Preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes, e9",{},{"id":28,"text":1882,"url":28,"identifiers":1883},"Smitt, 2003, Mol Ther, Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir, 851",{},{"id":28,"text":1885,"url":28,"identifiers":1886},"Son, 2009, Cell Stem Cell, SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma, 440",{},{"id":28,"text":1888,"url":28,"identifiers":1889},"Stiles, 2008, Neuron, Glioma stem cells: A midterm exam, 832",{},{"id":28,"text":1891,"url":28,"identifiers":1892},"Stummer, 2006, Lancet Oncol, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial, 392",{},{"id":28,"text":1894,"url":28,"identifiers":1895},"Stupp R, editor. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. 2013 ASCO; 2013; Chicago.",{"doi":1896},"10.1200\u002Fjco.2013.31.18_suppl.lba2009",{"id":28,"text":1898,"url":28,"identifiers":1899},"Stupp, 2009, Lancet Oncol, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, 459",{},{"id":28,"text":1901,"url":28,"identifiers":1902},"Stupp, 2010, J Clin Oncol, Phase I\u002FIIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma, 2712",{},{"id":28,"text":1904,"url":28,"identifiers":1905},"Stupp, 2006, Oncologist, Changing paradigms--an update on the multidisciplinary management of malignant glioma, 165",{},{"id":28,"text":1907,"url":28,"identifiers":1908},"Stupp, 2005, N Engl J Med, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, 987",{},{"id":28,"text":1910,"url":28,"identifiers":1911},"Sun, 2006, Cancer Cell, Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain, 287",{},{"id":28,"text":1913,"url":28,"identifiers":1914},"Teicher, 2011, Clin Cancer Res, Antibody conjugate therapeutics: Challenges and potential, 6389",{},{"id":28,"text":1916,"url":28,"identifiers":1917},"Terada, 2006, Gene Ther, Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models, 705",{},{"id":28,"text":1919,"url":28,"identifiers":1920},"Thomas, 2012, Cancer J, Immunotherapy for the treatment of glioblastoma, 59",{},{"id":28,"text":1922,"url":28,"identifiers":1923},"Tobias, 2013, J Neurol Neurosurg Psychiatry, The art of gene therapy for glioma: A review of the challenging road to the bedside, 213",{},{"id":28,"text":1925,"url":28,"identifiers":1926},"Todhunter, 2004, Protein Eng Des Sel, A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model, 157",{},{"id":28,"text":1928,"url":28,"identifiers":1929},"Todo, 2001, Proc Natl Acad Sci U S A, Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing, 6396",{},{"id":28,"text":1931,"url":28,"identifiers":1932},"Trask, 2000, Mol Ther, Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors, 195",{},{"id":28,"text":1934,"url":28,"identifiers":1935},"Tsuboi, 2003, Clin Cancer Res, Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas, 3294",{},{"id":28,"text":1937,"url":28,"identifiers":1938},"Tsurushima, 1999, Jpn J Cancer Res, Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes, 536",{},{"id":28,"text":1940,"url":28,"identifiers":1941},"Uhm, 2011, Int J Radiat Oncol Biol Phys, Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo\u002FNorth Central Cancer Treatment Group Study N0074, 347",{},{"id":28,"text":1943,"url":28,"identifiers":1944},"Ulasov, 2008, J Med Virol, Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy, 1595",{},{"id":28,"text":1946,"url":28,"identifiers":1947},"Ulasov, 2007, Hum Gene Ther, Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma, 589",{},{"id":28,"text":1949,"url":28,"identifiers":1950},"Vallera, 2002, J Natl Cancer Inst, Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT, 597",{},{"id":28,"text":1952,"url":28,"identifiers":1953},"van, 2009, J Clin Oncol, Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034, 1268",{},{"id":28,"text":1955,"url":28,"identifiers":1956},"van, 2009, J Clin Oncol, MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: A report from EORTC Brain Tumor Group Study 26951, 5881",{},{"id":28,"text":1958,"url":28,"identifiers":1959},"Van, 2009, Brain Pathol, Dendritic cell therapy of high-grade gliomas, 694",{},{"id":28,"text":1961,"url":28,"identifiers":1962},"Van, 2004, Semin Oncol, Emerging molecular therapies for brain tumors, 38",{},{"id":28,"text":1964,"url":28,"identifiers":1965},"Vauleon E, Avril T, Collet B, Mosser J, Quillien V. Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010;2010.",{"doi":1966},"10.1155\u002F2010\u002F689171",{"id":28,"text":1968,"url":28,"identifiers":1969},"Veeravagu, 2008, Clin Cancer Res, Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme, 7330",{},{"id":28,"text":1971,"url":28,"identifiers":1972},"Verhaak, 2010, Cancer Cell, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, 98",{},{"id":28,"text":1974,"url":28,"identifiers":1975},"Villalva, 2012, Int J Mol Sci, O6-Methylguanine-Methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions, 6983",{},{"id":28,"text":1977,"url":28,"identifiers":1978},"Vredenburgh, 2007, Clin Cancer Res, Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma, 1253",{},{"id":28,"text":1980,"url":28,"identifiers":1981},"Vredenburgh, 2007, J Clin Oncol, Bevacizumab plus irinotecan in recurrent glioblastoma multiforme, 4722",{},{"id":28,"text":1983,"url":28,"identifiers":1984},"Vredenburgh, 2012, Int J Radiat Oncol Biol Phys, Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme, 58",{},{"id":28,"text":1986,"url":28,"identifiers":1987},"Vredenburgh, 2011, Clin Cancer Res, The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma, 4119",{},{"id":28,"text":1989,"url":28,"identifiers":1990},"Wainwright, 2012, Expert Opin Emerg Drugs, Recent developments on immunotherapy for brain cancer, 181",{},{"id":28,"text":1992,"url":28,"identifiers":1993},"Wan, 2007, Oncogene, Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism, 1932",{},{"id":28,"text":1995,"url":28,"identifiers":1996},"Wang, 2010, Stem Cells, Notch promotes radioresistance of glioma stem cells, 17",{},{"id":28,"text":1998,"url":28,"identifiers":1999},"Wang, 2010, Nature, Glioblastoma stem-like cells give rise to tumour endothelium, 829",{},{"id":28,"text":2001,"url":28,"identifiers":2002},"Watanabe, 1996, Brain Pathol, Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas, 217",{},{"id":28,"text":2004,"url":28,"identifiers":2005},"Watanabe, 2009, Am J Pathol, IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas, 1149",{},{"id":28,"text":2007,"url":28,"identifiers":2008},"Wen, 2008, N Engl J Med, Malignant gliomas in adults, 492",{},{"id":28,"text":2010,"url":28,"identifiers":2011},"Wen, 2006, Clin Cancer Res, Phase I\u002FII study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08, 4899",{},{"id":28,"text":2013,"url":28,"identifiers":2014},"Westphal, 2003, Neuro Oncol, A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma, 79",{},{"id":28,"text":2016,"url":28,"identifiers":2017},"Wilcox, 2001, J Natl Cancer Inst, Reovirus as an oncolytic agent against experimental human malignant gliomas, 903",{},{"id":28,"text":2019,"url":28,"identifiers":2020},"Wood, 2000, J Neurooncol, A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III\u002FIV astrocytoma, 113",{},{"id":28,"text":2022,"url":28,"identifiers":2023},"Xu, 2012, Clin Dev Immunol, Cellular-based immunotherapies for patients with glioblastoma multiforme, 764213",{},{"id":28,"text":2025,"url":28,"identifiers":2026},"Yajima, 2005, Clin Cancer Res, Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma, 5900",{},{"id":28,"text":2028,"url":28,"identifiers":2029},"Yamamoto, 1994, Cancer Res, Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo, 3656",{},{"id":28,"text":2031,"url":28,"identifiers":2032},"Yamanaka, 2008, Trends Mol Med, Cell- and peptide-based immunotherapeutic approaches for glioma, 228",{},{"id":28,"text":2034,"url":28,"identifiers":2035},"Yamanaka, 2003, Br J Cancer, Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I\u002FII trial, 1172",{},{"id":28,"text":2037,"url":28,"identifiers":2038},"Yan, 2009, N Engl J Med, IDH1 and IDH2 mutations in gliomas, 765",{},{"id":28,"text":2040,"url":28,"identifiers":2041},"Yu, 2004, Cancer Res, Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma, 4973",{},{"id":28,"text":2043,"url":28,"identifiers":2044},"Yu, 2001, Cancer Res, Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration, 842",{},{"id":28,"text":2046,"url":28,"identifiers":2047},"Zhang, 2012, Curr Mol Pharmacol, Temozolomide: Mechanisms of action, repair and resistance, 102",{},{"id":28,"text":2049,"url":28,"identifiers":2050},"Zhao, 2008, Mol Cancer Res, Neural stem cell tropism to glioma: Critical role of tumor hypoxia, 1819",{},{"id":2052,"createTime":2053,"updateTime":2053,"relativeEntities":2054,"slug":2055,"properties":2056,"entityType":941,"verifyStatus":882,"verifyTime":2053,"verifyNote":2069,"languages":2070,"translateLanguages":28,"viewCount":32,"primaryUrl":2071,"fullTextUrl":28,"authors":2072,"publicationType":963,"publisherRelationship":2114,"citationCount":2150,"citationInfo":2151,"publishDate":2154,"publishYear":2152,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":2155,"openAccess":28,"references":2156,"isForceReanalyzing":1082},"ca1286b6-4df3-48d5-a1d1-08c5020ed9f7","2024-09-25T20:02:20.919+00:00",[],"Whole-brain-radiotherapy-for-brain-metastasis",{"openalex":2057,"mag":2059,"title":2061,"pm":2063,"doi":2065,"pmc":2067},{"VOID":2058},"W1988957846",{"VOID":2060},"1988957846",{"EN":2062},"Whole brain radiotherapy for brain metastasis",{"VOID":2064},"23717795",{"VOID":2066},"10.4103\u002F2152-7806.111301",{"VOID":2068},"3656558","Author affiliation is blank",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fwhole-brain-radiotherapy-for-brain-metastasis\u002F",[2073,2092,2103],{"id":2074,"sortIndex":32,"researcher":28,"roles":2075,"affiliations":2076,"properties":2085,"displayName":2089,"givenName":28,"familyName":28},"9b987db1-32a4-4c0f-af19-8ba5e589748e",[],[2077],{"id":2078,"sortIndex":32,"affiliation":2079,"properties":28},"250cdfce-e6b4-4ae7-b14b-59cd08fb3cc3",{"id":2078,"createTime":28,"updateTime":28,"relativeEntities":2080,"slug":28,"properties":2081,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2084,"statistic":28},[],{"title":2082},{"VI":2083},"Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA",[],{"orcid":2086,"title":2088,"openalex":2090},{"VOID":2087},"https:\u002F\u002Forcid.org\u002F0000-0001-9427-2426",{"EN":2089},"E. McTyre",{"VOID":2091},"A5022886652",{"id":2093,"sortIndex":40,"researcher":28,"roles":2094,"affiliations":2095,"properties":2096,"displayName":2100,"givenName":28,"familyName":28},"92e682be-5356-457d-b0dc-7c44bd26019e",[],[],{"orcid":2097,"title":2099,"openalex":2101},{"VOID":2098},"https:\u002F\u002Forcid.org\u002F0000-0003-2971-7673",{"EN":2100},"Jacob G. Scott",{"VOID":2102},"A5024863178",{"id":2104,"sortIndex":123,"researcher":28,"roles":2105,"affiliations":2106,"properties":2107,"displayName":2111,"givenName":28,"familyName":28},"67be0a9e-c3da-4da7-ba77-1d00048c0fcd",[],[],{"orcid":2108,"title":2110,"openalex":2112},{"VOID":2109},"https:\u002F\u002Forcid.org\u002F0000-0001-9336-1734",{"EN":2111},"Prakash Chinnaiyan",{"VOID":2113},"A5031142519",{"url":28,"publisher":2115,"properties":2144},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2116,"slug":872,"properties":2117,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2121,"manageAffiliations":2130,"indexDatabases":2136,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2118,"title":2119,"country":2120},{"VOID":877},{"EN":879},{"VOID":875},[2122,2126],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":2123,"label":2124,"description":2125,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":2127,"label":2128,"description":2129,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[2131],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":2132,"slug":28,"properties":2133,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2135,"statistic":28},[],{"title":2134},{"EN":902},[],[2137],{"id":906,"indexDatabase":2138,"url":912,"indexYears":913,"academicFieldIds":2143,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2139,"label":2140,"description":2141,"key":781,"publicationTags":2142,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":2145,"pages":2146,"volume":2148},{"VOID":1000},{"VOID":2147},"236",{"VOID":2149},"4",124,{"total":2150,"publishYear":2152,"statisticByYear":2153},2013,{"2014":123,"2015":146,"2016":357,"2017":49,"2018":130,"2019":49,"2020":51,"2021":205,"2022":129,"2023":126,"2024":49},"2013-01-01",[917],[2157,2160,2163,2166,2169,2172,2175,2178,2181,2184,2187,2190,2193,2196,2199,2202,2205,2208,2211,2214,2217,2220,2223,2226,2229,2232,2235,2238,2241,2244,2247,2250,2253,2256,2259,2262,2265,2268,2271,2274,2277,2280,2283,2286,2289,2292,2295,2298,2301,2304,2307,2310,2313,2316,2319,2322,2325,2328,2331,2334,2337,2341,2344,2347,2350,2353,2357,2360,2363,2366,2369,2372,2375,2378,2381,2384,2387,2390,2393,2396,2399,2402,2405,2408,2411,2414,2417,2420,2423,2426,2429],{"id":28,"text":2158,"url":28,"identifiers":2159},"Andrews, 2004, Lancet, Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial, 1665",{},{"id":28,"text":2161,"url":28,"identifiers":2162},"Antonadou, 2002, Int J Radiat Oncol Biol Phys, Whole brain radiotherapy alone or in combination with temozolomide for brain metastases.A phase III study (abstract), 93",{},{"id":28,"text":2164,"url":28,"identifiers":2165},"Aoyama, 2006, JAMA, Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial, 2483",{},{"id":28,"text":2167,"url":28,"identifiers":2168},"Armstrong, 1995, J Clin Oncol, Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: Neuropsychologic outcome and proposed mechanisms, 2263",{},{"id":28,"text":2170,"url":28,"identifiers":2171},"Armstrong, 1994, J Clin Oncol, Postoperative radiation for lung cancer metastatic to the brain, 2340",{},{"id":28,"text":2173,"url":28,"identifiers":2174},"Auperin, 1999, N Engl J Med, Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.Prophylactic Cranial Irradiation Overview Collaborative Group, 476",{},{"id":28,"text":2176,"url":28,"identifiers":2177},"Barnholtz-Sloan, 2004, J Clin Oncol, Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit cancer surveillance system, 2865",{},{"id":28,"text":2179,"url":28,"identifiers":2180},"Bezjak, 2001, Radiother Oncol, Radiotherapy for brain metastases: Defining palliative response, 71",{},{"id":28,"text":2182,"url":28,"identifiers":2183},"Bitzer, 1995, Stroke, Progressive cerebral occlusive disease after radiation therapy, 131",{},{"id":28,"text":2185,"url":28,"identifiers":2186},"Borgelt, 1980, Int J Radiat Oncol Biol Phys, The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group, 1",{},{"id":28,"text":2188,"url":28,"identifiers":2189},"Burger, 1979, Cancer, The morphologic effects of radiation administered therapeutically for intracranial gliomas: A postmortem study of 25 cases, 1256",{},{"id":28,"text":2191,"url":28,"identifiers":2192},"Ch′ien, 1980, Ann Neurol, Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia, 273",{},{"id":28,"text":2194,"url":28,"identifiers":2195},"Chang, 2009, Lancet Oncol, Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial, 1037",{},{"id":28,"text":2197,"url":28,"identifiers":2198},"Chao, 1954, Cancer, Roentgen-ray therapy of cerebral metastases, 682",{},{"id":28,"text":2200,"url":28,"identifiers":2201},"Chua, 2010, Clin Lung Cancer, Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: A randomized, open-label phase II study, 176",{},{"id":28,"text":2203,"url":28,"identifiers":2204},"Cross, 2003, Neurol Clin, Neurologic complications of radiation therapy, 249",{},{"id":28,"text":2206,"url":28,"identifiers":2207},"Davey, 2008, Radiother Oncol, A phase III study of accelerated versus conventional hypofractionated whole brain irradiation in patients of good performance status with brain metastases not suitable for surgical excision, 173",{},{"id":28,"text":2209,"url":28,"identifiers":2210},"de, 2004, Neurology, Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression, 535",{},{"id":28,"text":2212,"url":28,"identifiers":2213},"Desai, 2006, Int J Radiat Oncol Biol Phys, Radiation-induced moyamoya syndrome, 1222",{},{"id":28,"text":2215,"url":28,"identifiers":2216},"Do, 2009, Int J Radiat Oncol Biol Phys, Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases, 486",{},{"id":28,"text":2218,"url":28,"identifiers":2219},"Duffey, 1996, Arch Neurol, Progressive deterioration of intellect and motor function occurring several decades after cranial irradiation.A new facet in the clinical spectrum of radiation encephalopathy, 814",{},{"id":28,"text":2221,"url":28,"identifiers":2222},"Emami, 1991, Int J Radiat Oncol Biol Phys, Tolerance of normal tissue to therapeutic irradiation, 109",{},{"id":28,"text":2224,"url":28,"identifiers":2225},"EORTC-18981. Phase III randomized study of temozolomide with or without WBRT in patients with stage IV melanoma with asymptomatic brain metastases. Ongoing study. Closed.",{},{"id":28,"text":2227,"url":28,"identifiers":2228},"Evans, 1987, Int J Radiat Oncol Biol Phys, Use of steroids to suppress vascular response to radiation, 563",{},{"id":28,"text":2230,"url":28,"identifiers":2231},"Faithfull, 1991, J Adv Nurs, Patients′ experiences following cranial radiotherapy: A study of the somnolence syndrome, 939",{},{"id":28,"text":2233,"url":28,"identifiers":2234},"Fike, 2009, Semin Radiat Oncol, Neural precursor cells and central nervous system radiation sensitivity, 122",{},{"id":28,"text":2236,"url":28,"identifiers":2237},"Filloux, 1987, West J Med, Subacute leukoencephalopathy complicating acute lymphoblastic leukemia, 207",{},{"id":28,"text":2239,"url":28,"identifiers":2240},"Freeman, 1973, Br Med J, Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia, 523",{},{"id":28,"text":2242,"url":28,"identifiers":2243},"Gamboa-Vignolle, 2012, Radiother Oncol, Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: A randomised phase II trial, 187",{},{"id":28,"text":2245,"url":28,"identifiers":2246},"Gaspar, 1997, Int J Radiat Oncol Biol Phys, Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, 745",{},{"id":28,"text":2248,"url":28,"identifiers":2249},"Gavrilovic, 2005, J Neurooncol, Brain metastases: Epidemiology and pathophysiology, 5",{},{"id":28,"text":2251,"url":28,"identifiers":2252},"Ghia, 2007, Int J Radiat Oncol Biol Phys, Distribution of brain metastases in relation to the hippocampus: Implications for neurocognitive functional preservation, 971",{},{"id":28,"text":2254,"url":28,"identifiers":2255},"Goldstein, 2012, Hematol Oncol Clin North Am, Current management of gestational trophoblastic neoplasia, 111",{},{"id":28,"text":2257,"url":28,"identifiers":2258},"Gore, 2005, Clin Adv Hematol Oncol, RTOG 0214: A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer, 625",{},{"id":28,"text":2260,"url":28,"identifiers":2261},"Gremmer, 2008, J Neurooncol, Successful management of brain metastasis from malignant germ cell tumours with standard induction chemotherapy, 335",{},{"id":28,"text":2263,"url":28,"identifiers":2264},"Hagen, 1990, Neurology, The role of radiation therapy following resection of single brain metastasis from melanoma, 158",{},{"id":28,"text":2266,"url":28,"identifiers":2267},"Herrmann, 1987, Radiobiol Radiother (Berl), The RTOG\u002FEORTC classification criteria for early and late radiation reactions, 519",{},{"id":28,"text":2269,"url":28,"identifiers":2270},"Hindo, 1970, Cancer, Large dose increment irradiation in treatment of cerebral metastases, 138",{},{"id":28,"text":2272,"url":28,"identifiers":2273},"Johannesen, 2003, Radiother Oncol, Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy, 169",{},{"id":28,"text":2275,"url":28,"identifiers":2276},"Katz, 1981, Int J Radiat Oncol Biol Phys, The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system, 897",{},{"id":28,"text":2278,"url":28,"identifiers":2279},"Knisely, 2008, Int J Radiat Oncol Biol Phys, A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118), 79",{},{"id":28,"text":2281,"url":28,"identifiers":2282},"Kocher, 2011, J Clin Oncol, Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study, 134",{},{"id":28,"text":2284,"url":28,"identifiers":2285},"Lal, 2011, Expert Rev Pharmacoecon Outcomes Res, Economic impact of stereotactic radiosurgery for malignant intracranial brain tumors, 195",{},{"id":28,"text":2287,"url":28,"identifiers":2288},"Lassman, 2003, Neurol Clin, Brain metastases, 1",{},{"id":28,"text":2290,"url":28,"identifiers":2291},"Li, 2007, J Clin Oncol, Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function, 1260",{},{"id":28,"text":2293,"url":28,"identifiers":2294},"Linos, 2009, J Investig Dermatol, Increasing burden of melanoma in the United States, 1666",{},{"id":28,"text":2296,"url":28,"identifiers":2297},"Lokich, 1975, JAMA, The management of cerebral metastasis, 748",{},{"id":28,"text":2299,"url":28,"identifiers":2300},"Marks, 2010, Int J Radiat Oncol Biol Phys, Use of normal tissue complication probability models in the clinic, S10",{},{"id":28,"text":2302,"url":28,"identifiers":2303},"Marsh, 2010, J Oncol, Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches, 198208",{},{"id":28,"text":2305,"url":28,"identifiers":2306},"Marsh, 2010, J Med Imaging Radiat Oncol, Sparing of the hippocampus and limbic circuit during whole brain radiation therapy: A dosimetric study using helical tomotherapy, 375",{},{"id":28,"text":2308,"url":28,"identifiers":2309},"Marsh, 2010, Int J Radiat Oncol Biol Phys, Sparing of the neural stem cell compartment during whole-brain radiation therapy: A dosimetric study using helical tomotherapy, 946",{},{"id":28,"text":2311,"url":28,"identifiers":2312},"Marsh, 2010, Int J Radiat Oncol Biol Phys, Intracranial metastatic disease spares the limbic circuit: A review of 697 metastatic lesions in 107 patients, 504",{},{"id":28,"text":2314,"url":28,"identifiers":2315},"Mehta, 2009, Int J Radiat Oncol Biol Phys, Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: Results of a phase III trial, 1069",{},{"id":28,"text":2317,"url":28,"identifiers":2318},"Merchant, 2006, Int J Radiat Oncol Biol Phys, Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma, 210",{},{"id":28,"text":2320,"url":28,"identifiers":2321},"Mornex, 2003, Melanoma Res, A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma, 97",{},{"id":28,"text":2323,"url":28,"identifiers":2324},"NCT01372774. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery. Ongoing study.",{},{"id":28,"text":2326,"url":28,"identifiers":2327},"Neuhaus, 2009, Br J Cancer, A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer, 291",{},{"id":28,"text":2329,"url":28,"identifiers":2330},"Nussbaum, 1996, Cancer, Brain metastases.Histology, multiplicity, surgery, and survival, 1781",{},{"id":28,"text":2332,"url":28,"identifiers":2333},"Palmer, 2001, J Clin Oncol, Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis, 2302",{},{"id":28,"text":2335,"url":28,"identifiers":2336},"Patchell, 2003, Cancer Treat Rev, The management of brain metastases, 533",{},{"id":28,"text":2338,"url":28,"identifiers":2339},"Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 1998;280:1485-9.",{"doi":2340},"10.1001\u002Fjama.280.17.1485",{"id":28,"text":2342,"url":28,"identifiers":2343},"Pesce, 2012, Eur J Cancer, Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide.A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70\u002F03), 377",{},{"id":28,"text":2345,"url":28,"identifiers":2346},"Posner, 1977, Semin Oncol, Management of central nervous system metastases, 81",{},{"id":28,"text":2348,"url":28,"identifiers":2349},"Postmus, 2000, J Clin Oncol, Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy: A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group, 3400",{},{"id":28,"text":2351,"url":28,"identifiers":2352},"Prabhu, 2012, Int J Radiat Oncol Biol Phys, Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control, e61",{},{"id":28,"text":2354,"url":28,"identifiers":2355},"Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975;35:306-18.",{"doi":2356},"10.1002\u002F1097-0142(197502)35:2\u003C306::AID-CNCR2820350203>3.0.CO;2-J",{"id":28,"text":2358,"url":28,"identifiers":2359},"Prokic, 2013, Int J Radiat Oncol Biol Phys, Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: A planning study on treatment concepts, 264",{},{"id":28,"text":2361,"url":28,"identifiers":2362},"Rodrigues, 2012, Radiat Oncol, A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases, 42",{},{"id":28,"text":2364,"url":28,"identifiers":2365},"Rodrigues, 2011, Int J Radiat Oncol Biol Phys, Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases, 1128",{},{"id":28,"text":2367,"url":28,"identifiers":2368},"RTOG-0614. A Randomized, phase III, double-blind, placebo-controlled trial of memantine for prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy. Ongoing study.",{},{"id":28,"text":2370,"url":28,"identifiers":2371},"RTOG-0933. A phase II trial of hippocampal avoidance during whole brain radiotherapy for brain metastases. Ongoing study.",{},{"id":28,"text":2373,"url":28,"identifiers":2374},"Ryan, 2000, J Pediatr Oncol Nurs, Radiation somnolence syndrome, 50",{},{"id":28,"text":2376,"url":28,"identifiers":2377},"Schouten, 2002, Cancer, Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma, 2698",{},{"id":28,"text":2379,"url":28,"identifiers":2380},"Sheline, 1980, Int J Radiat Oncol Biol Phys, Therapeutic irradiation and brain injury, 1215",{},{"id":28,"text":2382,"url":28,"identifiers":2383},"Skibber, 1996, Ann Surg Oncol, Cranial irradiation after surgical excision of brain metastases in melanoma patients, 118",{},{"id":28,"text":2385,"url":28,"identifiers":2386},"Slotman, 2007, N Engl J Med, Prophylactic cranial irradiation in extensive small-cell lung cancer, 664",{},{"id":28,"text":2388,"url":28,"identifiers":2389},"Sneed, 1996, Neurosurg Clin N Am, Radiotherapy for cerebral metastases, 505",{},{"id":28,"text":2391,"url":28,"identifiers":2392},"Soffietti, 2002, J Neurol, Management of brain metastases, 1357",{},{"id":28,"text":2394,"url":28,"identifiers":2395},"Suzuki, 1969, Arch Neurol, Cerebrovascular \"moyamoya\" disease.Disease showing abnormal net-like vessels in base of brain, 288",{},{"id":28,"text":2397,"url":28,"identifiers":2398},"Taal, 2008, Cancer, Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide, 405",{},{"id":28,"text":2400,"url":28,"identifiers":2401},"Tallet, 2012, Radiat Oncol, Neurocognitive function impairment after whole brain radiotherapy for brain metastases: Actual assessment, 77",{},{"id":28,"text":2403,"url":28,"identifiers":2404},"Tsao, 2012, Cochrane Database Syst Rev, Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases, CD003869",{},{"id":28,"text":2406,"url":28,"identifiers":2407},"Ullrich, 2007, Neurology, Moyamoya following cranial irradiation for primary brain tumors in children, 932",{},{"id":28,"text":2409,"url":28,"identifiers":2410},"Ushio, 1991, Neurosurgery, Chemotherapy of brain metastases from lung carcinoma: A controlled randomized study, 201",{},{"id":28,"text":2412,"url":28,"identifiers":2413},"Uzal, 1998, Radiother Oncol, Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia, 29",{},{"id":28,"text":2415,"url":28,"identifiers":2416},"Valk, 1991, AJNR Am J Neuroradiol, Radiation injury of the brain, 45",{},{"id":28,"text":2418,"url":28,"identifiers":2419},"van, 2003, Eur J Cancer, The role of chemotherapy in brain metastases, 2114",{},{"id":28,"text":2421,"url":28,"identifiers":2422},"van, 2012, Radiother Oncol, A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer, 225",{},{"id":28,"text":2424,"url":28,"identifiers":2425},"Walker, 1985, Neurology, Epidemiology of brain tumors: The national survey of intracranial neoplasms, 219",{},{"id":28,"text":2427,"url":28,"identifiers":2428},"Weiss, 2010, Lancet Oncol, Neurocognitive function after WBRT plus SRS or SRS alone, 220",{},{"id":28,"text":2430,"url":28,"identifiers":2431},"Young, 1974, Cancer, Rapid-course radiation therapy of cerebral metastases: Results and complications, 1069",{},{"id":2433,"createTime":2434,"updateTime":2434,"relativeEntities":2435,"slug":2436,"properties":2437,"entityType":941,"verifyStatus":26,"verifyTime":2434,"verifyNote":942,"languages":2450,"translateLanguages":28,"viewCount":32,"primaryUrl":2451,"fullTextUrl":28,"authors":2452,"publicationType":963,"publisherRelationship":2565,"citationCount":156,"citationInfo":2601,"publishDate":2604,"publishYear":2602,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":2605,"openAccess":28,"references":2606,"isForceReanalyzing":1082},"5b2c23c2-52be-400e-b9c6-b736764fd328","2024-08-30T16:28:27.409+00:00",[],"A-proposed-grading-system-for-endovascular-treatment-of-cerebral-arteriovenous-malformations-Buffalo-score",{"openalex":2438,"mag":2440,"title":2442,"pm":2444,"doi":2446,"pmc":2448},{"VOID":2439},"W2081680518",{"VOID":2441},"2081680518",{"EN":2443},"A proposed grading system for endovascular treatment of cerebral arteriovenous malformations: Buffalo score",{"VOID":2445},"25657856",{"VOID":2447},"10.4103\u002F2152-7806.148847",{"VOID":2449},"4310056",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fa-proposed-grading-system-for-endovascular-treatment-of-cerebral-arteriovenous-malformations-buffalo-score-2\u002F",[2453,2470,2489,2508,2527,2546],{"id":2454,"sortIndex":32,"researcher":28,"roles":2455,"affiliations":2456,"properties":2465,"displayName":2467,"givenName":28,"familyName":28},"f2a237c6-8b05-4f55-8e91-f2f9dc123975",[],[2457],{"id":2458,"sortIndex":32,"affiliation":2459,"properties":28},"a04dffaf-e56d-4969-bd3e-c7d98e0028b8",{"id":2458,"createTime":28,"updateTime":28,"relativeEntities":2460,"slug":28,"properties":2461,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2464,"statistic":28},[],{"title":2462},{"EN":2463},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, New York, USA ; Division of Neurosurgery, Department of Surgery, The University of Arizona, Tucson, Arizona, USA.",[],{"title":2466,"openalex":2468},{"EN":2467},"Travis M. Dumont",{"VOID":2469},"A5076155407",{"id":2471,"sortIndex":40,"researcher":28,"roles":2472,"affiliations":2473,"properties":2482,"displayName":2486,"givenName":28,"familyName":28},"58ac6965-1e5c-4fae-8104-1068bb1ae79d",[],[2474],{"id":2475,"sortIndex":32,"affiliation":2476,"properties":28},"f2b0b136-792e-4b64-9afb-a53a2ed9f4a6",{"id":2475,"createTime":28,"updateTime":28,"relativeEntities":2477,"slug":28,"properties":2478,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2481,"statistic":28},[],{"title":2479},{"EN":2480},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, New York, USA ; Department of Neurosurgery, University of South Florida, Tampa, Florida, USA.",[],{"orcid":2483,"title":2485,"openalex":2487},{"VOID":2484},"https:\u002F\u002Forcid.org\u002F0000-0001-6649-4128",{"EN":2486},"Peter Kan",{"VOID":2488},"A5051212455",{"id":2490,"sortIndex":123,"researcher":28,"roles":2491,"affiliations":2492,"properties":2501,"displayName":2505,"givenName":28,"familyName":28},"02d10be0-34f6-4522-b73c-dadf031ac895",[],[2493],{"id":2494,"sortIndex":32,"affiliation":2495,"properties":28},"44ef806a-72a1-4337-bd75-887831dbfa36",{"id":2494,"createTime":28,"updateTime":28,"relativeEntities":2496,"slug":28,"properties":2497,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2500,"statistic":28},[],{"title":2498},{"EN":2499},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Neurology, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA ; Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, New York, USA.",[],{"orcid":2502,"title":2504,"openalex":2506},{"VOID":2503},"https:\u002F\u002Forcid.org\u002F0000-0002-0842-9026",{"EN":2505},"Kenneth V. Snyder",{"VOID":2507},"A5045616278",{"id":2509,"sortIndex":42,"researcher":28,"roles":2510,"affiliations":2511,"properties":2520,"displayName":2524,"givenName":28,"familyName":28},"762ffa18-c192-48e6-a909-cdb5e50a9641",[],[2512],{"id":2513,"sortIndex":32,"affiliation":2514,"properties":28},"008a529c-b41d-4bd1-a94c-43459c050ab9",{"id":2513,"createTime":28,"updateTime":28,"relativeEntities":2515,"slug":28,"properties":2516,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2519,"statistic":28},[],{"title":2517},{"EN":2518},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA ; Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, New York, USA ; Jacobs Institute, Buffalo, New York, USA.",[],{"orcid":2521,"title":2523,"openalex":2525},{"VOID":2522},"https:\u002F\u002Forcid.org\u002F0000-0003-0339-3818",{"EN":2524},"L. Nelson Hopkins",{"VOID":2526},"A5048566091",{"id":2528,"sortIndex":45,"researcher":28,"roles":2529,"affiliations":2530,"properties":2539,"displayName":2543,"givenName":28,"familyName":28},"25e01940-bd95-49fe-91b0-deba4145d3a0",[],[2531],{"id":2532,"sortIndex":32,"affiliation":2533,"properties":28},"560cdf27-6d4e-4ecb-bc2e-fd50badfa56f",{"id":2532,"createTime":28,"updateTime":28,"relativeEntities":2534,"slug":28,"properties":2535,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2538,"statistic":28},[],{"title":2536},{"EN":2537},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA ; Jacobs Institute, Buffalo, New York, USA.",[],{"orcid":2540,"title":2542,"openalex":2544},{"VOID":2541},"https:\u002F\u002Forcid.org\u002F0000-0002-9519-0059",{"EN":2543},"Adnan H. Siddiqui",{"VOID":2545},"A5037816826",{"id":2547,"sortIndex":46,"researcher":28,"roles":2548,"affiliations":2549,"properties":2558,"displayName":2562,"givenName":28,"familyName":28},"60bff176-88ce-4e12-ba73-4314021d8d51",[],[2550],{"id":2551,"sortIndex":32,"affiliation":2552,"properties":28},"de2d7715-8981-4a7d-bd68-b7206621945d",{"id":2551,"createTime":28,"updateTime":28,"relativeEntities":2553,"slug":28,"properties":2554,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2557,"statistic":28},[],{"title":2555},{"EN":2556},"Department of Neurosurgery, School of Medicine and Biomedical Sciences, State University of New York, USA ; Department of Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA ; Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, New York, USA.",[],{"orcid":2559,"title":2561,"openalex":2563},{"VOID":2560},"https:\u002F\u002Forcid.org\u002F0000-0002-6208-3724",{"EN":2562},"Elad I. Levy",{"VOID":2564},"A5028101627",{"url":28,"publisher":2566,"properties":2595},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2567,"slug":872,"properties":2568,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2572,"manageAffiliations":2581,"indexDatabases":2587,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2569,"title":2570,"country":2571},{"VOID":877},{"EN":879},{"VOID":875},[2573,2577],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":2574,"label":2575,"description":2576,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":2578,"label":2579,"description":2580,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[2582],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":2583,"slug":28,"properties":2584,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2586,"statistic":28},[],{"title":2585},{"EN":902},[],[2588],{"id":906,"indexDatabase":2589,"url":912,"indexYears":913,"academicFieldIds":2594,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2590,"label":2591,"description":2592,"key":781,"publicationTags":2593,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":2596,"pages":2597,"volume":2599},{"VOID":1187},{"VOID":2598},"3",{"VOID":2600},"6",{"total":156,"publishYear":2602,"statisticByYear":2603},2015,{"2015":42,"2016":42,"2017":47,"2018":49,"2019":45,"2020":48,"2021":126,"2022":205,"2023":49,"2024":48},"2015-01-01",[917],[2607,2610,2613,2616,2619,2622,2625,2628,2631,2634,2637,2640,2643],{"id":28,"text":2608,"url":28,"identifiers":2609},"Feliciano, 2010, P R Health Sci J, A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review, 117",{},{"id":28,"text":2611,"url":28,"identifiers":2612},"Hamilton, 1994, Neurosurgery, The prospective application of a grading system for arteriovenous malformations, 2",{},{"id":28,"text":2614,"url":28,"identifiers":2615},"Hartmann, 2002, Stroke, Risk of endovascular treatment of brain arteriovenous malformations, 1816",{},{"id":28,"text":2617,"url":28,"identifiers":2618},"Haw, 2006, J Neurosurg, Complications of embolization of arteriovenous malformations of the brain, 226",{},{"id":28,"text":2620,"url":28,"identifiers":2621},"Kim, 2006, Neurosurgery, Postembolization neurological deficits in cerebral arteriovenous malformations: Stratification by arteriovenous malformation grade, 53",{},{"id":28,"text":2623,"url":28,"identifiers":2624},"Ledezma, 2006, Neurosurgery, Complications of cerebral arteriovenous malformation embolization: Multivariate analysis of predictive factors, 602",{},{"id":28,"text":2626,"url":28,"identifiers":2627},"Pollock, 2008, Neurosurgery, Modification of the radiosurgery-based arteriovenous malformation grading system, 239",{},{"id":28,"text":2629,"url":28,"identifiers":2630},"Pollock, 2002, J Neurosurg, A proposed radiosurgery-based grading system for arteriovenous malformations, 79",{},{"id":28,"text":2632,"url":28,"identifiers":2633},"Spetzler, 1986, J Neurosurg, A proposed grading system for arteriovenous malformations, 476",{},{"id":28,"text":2635,"url":28,"identifiers":2636},"Strozyk, 2009, Neurosurg Clin N Am, Endovascular treatment of intracranial arteriovenous malformation, 399",{},{"id":28,"text":2638,"url":28,"identifiers":2639},"Tawk, 2011, World Neurosurg, Utility of pharmacologic provocative neurological testing before embolization of occipital lobe arteriovenous malformations, 276",{},{"id":28,"text":2641,"url":28,"identifiers":2642},"van, 2011, JAMA, Treatment of brain arteriovenous malformations: A systematic review and meta-analysis, 2011",{},{"id":28,"text":2644,"url":28,"identifiers":2645},"Yuki, 2010, J Neurosurg, Treatment of brain arteriovenous malformations with high-flow arteriovenous fistulas: Risk and complications associated with endovascular embolization in multimodality treatment.Clinical article, 715",{},{"id":2647,"createTime":2648,"updateTime":2648,"relativeEntities":2649,"slug":2650,"properties":2651,"entityType":941,"verifyStatus":26,"verifyTime":2664,"verifyNote":942,"languages":2665,"translateLanguages":28,"viewCount":32,"primaryUrl":2666,"fullTextUrl":28,"authors":2667,"publicationType":963,"publisherRelationship":2687,"citationCount":139,"citationInfo":2723,"publishDate":1005,"publishYear":1003,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":2725,"openAccess":28,"references":2726,"isForceReanalyzing":1082},"693645a7-7e5f-4425-b0cd-e48151744b80","2024-09-23T02:46:45.065+00:00",[],"Understanding-paroxysmal-sympathetic-hyperactivity-after-traumatic-brain-injury",{"openalex":2652,"mag":2654,"title":2656,"pm":2658,"doi":2660,"pmc":2662},{"VOID":2653},"W1985742746",{"VOID":2655},"1985742746",{"EN":2657},"Understanding paroxysmal sympathetic hyperactivity after traumatic brain injury",{"VOID":2659},"25506508",{"VOID":2661},"10.4103\u002F2152-7806.144632",{"VOID":2663},"4253044","2024-09-23T02:46:45.064+00:00",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Funderstanding-paroxysmal-sympathetic-hyperactivity-after-traumatic-brain-injury\u002F",[2668],{"id":2669,"sortIndex":32,"researcher":28,"roles":2670,"affiliations":2671,"properties":2680,"displayName":2684,"givenName":28,"familyName":28},"cc687e7d-d948-4b8c-9659-50c31a00a1d5",[],[2672],{"id":2673,"sortIndex":32,"affiliation":2674,"properties":28},"d993aba4-62cc-476f-a369-fff116525267",{"id":2673,"createTime":28,"updateTime":28,"relativeEntities":2675,"slug":28,"properties":2676,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2679,"statistic":28},[],{"title":2677},{"EN":2678},"Kentucky One Healthcare, University of Louisville Hospital, 530 S Jackson St, Louisville, KY 40202, USA.",[],{"orcid":2681,"title":2683,"openalex":2685},{"VOID":2682},"https:\u002F\u002Forcid.org\u002F0000-0002-3228-3856",{"EN":2684},"Kimberly Meyer",{"VOID":2686},"A5077615902",{"url":28,"publisher":2688,"properties":2717},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2689,"slug":872,"properties":2690,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2694,"manageAffiliations":2703,"indexDatabases":2709,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2691,"title":2692,"country":2693},{"VOID":877},{"EN":879},{"VOID":875},[2695,2699],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":2696,"label":2697,"description":2698,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":2700,"label":2701,"description":2702,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[2704],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":2705,"slug":28,"properties":2706,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2708,"statistic":28},[],{"title":2707},{"EN":902},[],[2710],{"id":906,"indexDatabase":2711,"url":912,"indexYears":913,"academicFieldIds":2716,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2712,"label":2713,"description":2714,"key":781,"publicationTags":2715,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":2718,"pages":2720,"volume":2722},{"VOID":2719},"14",{"VOID":2721},"490",{"VOID":1000},{"total":139,"publishYear":1003,"statisticByYear":2724},{"2016":42,"2017":145,"2018":45,"2019":205,"2020":45,"2021":123,"2023":42,"2024":40},[917],[2727,2730,2733,2736,2739,2742,2745,2748,2752,2755,2758,2761,2764,2767,2770,2773,2776,2779,2782,2785,2788],{"id":28,"text":2728,"url":28,"identifiers":2729},"Baguley, 1999, Mayo Clin Proc, Nomenclature of \"paroxysmal sympathetic storms\", 105",{},{"id":28,"text":2731,"url":28,"identifiers":2732},"Baguley, 2008, Med Hypotheses, Excitatory: Inhibitory Ratio Model (EIR Model): An integrative explanation of acute automonic overactivity syndromes, 26",{},{"id":28,"text":2734,"url":28,"identifiers":2735},"Baguley, 1999, J Neurol Neurosurg Psychiatry, Dysautonomia after traumatic brain injury: A forgotten syndrome?, 39",{},{"id":28,"text":2737,"url":28,"identifiers":2738},"Baguley, 2007, J Neurol Neurosurg Psychiatry, Gabapentin in the management of dysautonomia following severe traumatic brain injury: A case series, 539",{},{"id":28,"text":2740,"url":28,"identifiers":2741},"Baguley, 2009, Am J Phys Med Rehabil, Dysautonomia after severe traumatic brain injury: Evidence of persisting overresponsiveness to afferent stimuli, 615",{},{"id":28,"text":2743,"url":28,"identifiers":2744},"Baguley, 2004, Brain Inj, Pharmacological management of Dysautonomia following traumatic brain injury, 409",{},{"id":28,"text":2746,"url":28,"identifiers":2747},"Baguley, 2009, Arch Phys Med Rehabil, Diagnosing dysautonomia after acute traumatic brain injury: Evidence for overresponsiveness to afferent stimuli, 580",{},{"id":28,"text":2749,"url":28,"identifiers":2750},"Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabenstein AA, Dolce G, Hendricks HT. Paroxysmal sympathetic hyperactivity after acquired brain injury: Consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma 2104; Epub: Apr 2014. PMID 24731076.",{"doi":2751},"10.1089\u002Fneu.2013.3301",{"id":28,"text":2753,"url":28,"identifiers":2754},"Boeve, 1998, Mayo Clin Proc, Paroxysmal sympathetic storms (\"diencephalic seizures\") after severe diffuse axonal head injury, 148",{},{"id":28,"text":2756,"url":28,"identifiers":2757},"Bullard, 1987, Ann Neurol, Diencephalic seizures: Responsiveness to bromocriptine and morphine, 609",{},{"id":28,"text":2759,"url":28,"identifiers":2760},"Centers for Disease Control and Prevention. Injury Prevention and Control: Traumatic Brain Injury; 2010. Available from: http:\u002F\u002Fwww.cdc.gov\u002FTraumaticBrainInjury\u002Findex.html [Last accessed on 2011 Apr 15]",{},{"id":28,"text":2762,"url":28,"identifiers":2763},"Cuny, 2001, Brain Inj, Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal Baclofen therapy, 917",{},{"id":28,"text":2765,"url":28,"identifiers":2766},"Fernandez-Ortega, 2006, J Trauma, Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury, 1129",{},{"id":28,"text":2768,"url":28,"identifiers":2769},"Hendricks, 2010, Eur J Neurol, Dysautonomia after severe traumatic brain injury, 1172",{},{"id":28,"text":2771,"url":28,"identifiers":2772},"Hinson, 2012, Curr Opin Crit Care, Manifestations of the hyperadrenergic state after acquired brain injury, 139",{},{"id":28,"text":2774,"url":28,"identifiers":2775},"Lemke, 2007, Crit Care Nurse, Sympathetic storming after severe traumatic brain injury, 30",{},{"id":28,"text":2777,"url":28,"identifiers":2778},"Lv, 2011, J Trauma, Risk factors related to dysautonomia after severe traumatic brain injury, 538",{},{"id":28,"text":2780,"url":28,"identifiers":2781},"Payen, 1990, Crit Care Med, Head injury: Clonidine decreases plasma catecholamines, 392",{},{"id":28,"text":2783,"url":28,"identifiers":2784},"Penfield, 1929, Arch NeurPsych, Diencephalic autonomic epilepsy, 354",{},{"id":28,"text":2786,"url":28,"identifiers":2787},"Rossitch, 1988, Br J Neurosurg, The autonomic dysfunction syndrome: Aetiology and treatment, 471",{},{"id":28,"text":2789,"url":28,"identifiers":2790},"Russo, 2000, J Paediatr Child Health, Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury, 283",{},{"id":2792,"createTime":2793,"updateTime":2793,"relativeEntities":2794,"slug":2795,"properties":2796,"entityType":941,"verifyStatus":26,"verifyTime":2793,"verifyNote":942,"languages":2809,"translateLanguages":28,"viewCount":32,"primaryUrl":2810,"fullTextUrl":28,"authors":2811,"publicationType":963,"publisherRelationship":2966,"citationCount":138,"citationInfo":3000,"publishDate":3003,"publishYear":3001,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":3004,"openAccess":28,"references":3005,"isForceReanalyzing":1082},"e9c3cbc1-1acc-4796-ba3d-ad2b77cf4f7d","2024-08-31T12:58:24.289+00:00",[],"Cortical-aneurysms-of-the-middle-cerebral-artery-A-review-of-the-literature",{"openalex":2797,"mag":2799,"title":2801,"pm":2803,"doi":2805,"pmc":2807},{"VOID":2798},"W2738428374",{"VOID":2800},"2738428374",{"EN":2802},"Cortical aneurysms of the middle cerebral artery: A review of the literature",{"VOID":2804},"28680736",{"VOID":2806},"10.4103\u002Fsni.sni_50_17",{"VOID":2808},"5482160",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fcortical-aneurysms-of-the-middle-cerebral-artery-a-review-of-the-literature\u002F",[2812,2837,2860,2881,2900,2915,2932,2949],{"id":2813,"sortIndex":32,"researcher":28,"roles":2814,"affiliations":2815,"properties":2832,"displayName":2834,"givenName":28,"familyName":28},"1107499e-dd07-4a52-920b-0c0be4486c41",[],[2816,2824],{"id":2817,"sortIndex":32,"affiliation":2818,"properties":28},"282e67c2-fed1-4bd9-a1fb-b3174bdcea1d",{"id":2817,"createTime":28,"updateTime":28,"relativeEntities":2819,"slug":28,"properties":2820,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2823,"statistic":28},[],{"title":2821},{"EN":2822},"Department of Neurosurgery, San Salvatore City Hospital, L'Aquila,",[],{"id":2825,"sortIndex":40,"affiliation":2826,"properties":28},"fc98cdeb-1973-4fc8-ac85-f44a152bf9c1",{"id":2825,"createTime":28,"updateTime":28,"relativeEntities":2827,"slug":28,"properties":2828,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2831,"statistic":28},[],{"title":2829},{"VI":2830},"University of California, Los Angeles, CA USA",[],{"title":2833,"openalex":2835},{"EN":2834},"Danilo De Paulis",{"VOID":2836},"A5061211999",{"id":2838,"sortIndex":40,"researcher":28,"roles":2839,"affiliations":2840,"properties":2853,"displayName":2857,"givenName":28,"familyName":28},"239b45fd-8fb9-4343-9927-135f4bb74e6c",[],[2841,2847],{"id":2817,"sortIndex":32,"affiliation":2842,"properties":28},{"id":2817,"createTime":28,"updateTime":28,"relativeEntities":2843,"slug":28,"properties":2844,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2846,"statistic":28},[],{"title":2845},{"EN":2822},[],{"id":2825,"sortIndex":40,"affiliation":2848,"properties":28},{"id":2825,"createTime":28,"updateTime":28,"relativeEntities":2849,"slug":28,"properties":2850,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2852,"statistic":28},[],{"title":2851},{"VI":2830},[],{"orcid":2854,"title":2856,"openalex":2858},{"VOID":2855},"https:\u002F\u002Forcid.org\u002F0000-0003-2018-2940",{"EN":2857},"Alessandro Ricci",{"VOID":2859},"A5080233707",{"id":2861,"sortIndex":123,"researcher":28,"roles":2862,"affiliations":2863,"properties":2876,"displayName":2878,"givenName":28,"familyName":28},"fc3be1a4-c4cb-48d5-a435-470a997fb1e6",[],[2864,2870],{"id":2817,"sortIndex":32,"affiliation":2865,"properties":28},{"id":2817,"createTime":28,"updateTime":28,"relativeEntities":2866,"slug":28,"properties":2867,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2869,"statistic":28},[],{"title":2868},{"EN":2822},[],{"id":2825,"sortIndex":40,"affiliation":2871,"properties":28},{"id":2825,"createTime":28,"updateTime":28,"relativeEntities":2872,"slug":28,"properties":2873,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2875,"statistic":28},[],{"title":2874},{"VI":2830},[],{"title":2877,"openalex":2879},{"EN":2878},"Hambra Di Vitantonio",{"VOID":2880},"A5053293063",{"id":2882,"sortIndex":42,"researcher":28,"roles":2883,"affiliations":2884,"properties":2893,"displayName":2897,"givenName":28,"familyName":28},"fd20283d-1b90-48d5-a830-2c128d7f0b82",[],[2885],{"id":2886,"sortIndex":32,"affiliation":2887,"properties":28},"9fd52d24-99c1-48e2-9acc-7a3897d10996",{"id":2886,"createTime":28,"updateTime":28,"relativeEntities":2888,"slug":28,"properties":2889,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2892,"statistic":28},[],{"title":2890},{"EN":2891},"Department of Life, Health and Environmental Sciences (MESVA), University of L'Aquila, Italy",[],{"orcid":2894,"title":2896,"openalex":2898},{"VOID":2895},"https:\u002F\u002Forcid.org\u002F0000-0002-0521-6519",{"EN":2897},"Mattia Del Maestro",{"VOID":2899},"A5033676295",{"id":2901,"sortIndex":45,"researcher":28,"roles":2902,"affiliations":2903,"properties":2910,"displayName":2912,"givenName":28,"familyName":28},"beb2097a-a9f4-4452-a317-5e5121199188",[],[2904],{"id":2886,"sortIndex":32,"affiliation":2905,"properties":28},{"id":2886,"createTime":28,"updateTime":28,"relativeEntities":2906,"slug":28,"properties":2907,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2909,"statistic":28},[],{"title":2908},{"EN":2891},[],{"title":2911,"openalex":2913},{"EN":2912},"Soheila Dehcordi Raysi",{"VOID":2914},"A5058836922",{"id":2916,"sortIndex":46,"researcher":28,"roles":2917,"affiliations":2918,"properties":2925,"displayName":2929,"givenName":28,"familyName":28},"ed8ad5dc-3b47-4c75-9d87-9908a7fd0e62",[],[2919],{"id":2886,"sortIndex":32,"affiliation":2920,"properties":28},{"id":2886,"createTime":28,"updateTime":28,"relativeEntities":2921,"slug":28,"properties":2922,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2924,"statistic":28},[],{"title":2923},{"EN":2891},[],{"orcid":2926,"title":2928,"openalex":2930},{"VOID":2927},"https:\u002F\u002Forcid.org\u002F0000-0003-1004-910X",{"EN":2929},"Domenico Murrone",{"VOID":2931},"A5025046395",{"id":2933,"sortIndex":48,"researcher":28,"roles":2934,"affiliations":2935,"properties":2942,"displayName":2946,"givenName":28,"familyName":28},"f3986f38-7fa7-44c4-936a-4eac6f1d9959",[],[2936],{"id":2886,"sortIndex":32,"affiliation":2937,"properties":28},{"id":2886,"createTime":28,"updateTime":28,"relativeEntities":2938,"slug":28,"properties":2939,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2941,"statistic":28},[],{"title":2940},{"EN":2891},[],{"orcid":2943,"title":2945,"openalex":2947},{"VOID":2944},"https:\u002F\u002Forcid.org\u002F0000-0002-1381-8528",{"EN":2946},"Sabino Luzzi",{"VOID":2948},"A5014860951",{"id":2950,"sortIndex":49,"researcher":28,"roles":2951,"affiliations":2952,"properties":2959,"displayName":2963,"givenName":28,"familyName":28},"cf02e068-6b5e-42d6-8c74-901efb82c394",[],[2953],{"id":2886,"sortIndex":32,"affiliation":2954,"properties":28},{"id":2886,"createTime":28,"updateTime":28,"relativeEntities":2955,"slug":28,"properties":2956,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2958,"statistic":28},[],{"title":2957},{"EN":2891},[],{"orcid":2960,"title":2962,"openalex":2964},{"VOID":2961},"https:\u002F\u002Forcid.org\u002F0000-0003-1933-1355",{"EN":2963},"Renato Galzio",{"VOID":2965},"A5028186049",{"url":28,"publisher":2967,"properties":2996},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":2968,"slug":872,"properties":2969,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":2973,"manageAffiliations":2982,"indexDatabases":2988,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":2970,"title":2971,"country":2972},{"VOID":877},{"EN":879},{"VOID":875},[2974,2978],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":2975,"label":2976,"description":2977,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":2979,"label":2980,"description":2981,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[2983],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":2984,"slug":28,"properties":2985,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":2987,"statistic":28},[],{"title":2986},{"EN":902},[],[2989],{"id":906,"indexDatabase":2990,"url":912,"indexYears":913,"academicFieldIds":2995,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":2991,"label":2992,"description":2993,"key":781,"publicationTags":2994,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":2997,"pages":2998,"volume":2999},{"VOID":1187},{"VOID":5},{"VOID":996},{"total":138,"publishYear":3001,"statisticByYear":3002},2017,{"2019":45,"2020":205,"2021":199,"2022":42,"2023":40,"2024":40},"2017-01-01",[917],[3006,3009,3012,3015,3018,3021,3024,3027,3030,3033,3036,3039,3042,3045],{"id":28,"text":3007,"url":28,"identifiers":3008},"Ahn, 2005, Acta Neurochir, Aneurysm in the penetrating artery of the distal middle cerebral artery presenting as intracerebral haemorrhage, 1287",{},{"id":28,"text":3010,"url":28,"identifiers":3011},"Ausman, 1990, Surg Neurol, A new microsurgical approach to cerebrovascular lesions of the sylvian point: Report of two cases, 48",{},{"id":28,"text":3013,"url":28,"identifiers":3014},"Della, 2017, World Neurosurg, The “ICG Entrapment Sign” in Cerebral Aneurysm Surgery Assisted by Indocyanine Green Videoangiography, 287",{},{"id":28,"text":3016,"url":28,"identifiers":3017},"Elsharkawy, 2013, Neurosurgery, A new, more accurate classification of middle cerebral artery aneurysms: Computed tomography angiographic study of 1,009 consecutive cases with 1,309 middle cerebral artery aneurysms, 94",{},{"id":28,"text":3019,"url":28,"identifiers":3020},"Farsad, 2009, Open Neurol J, Computed tomographic angiography as an adjunct to digital subtraction angiography for the pre-operative assessment of cerebral aneurysms, 1",{},{"id":28,"text":3022,"url":28,"identifiers":3023},"Gibo, 1981, J Neurosurg, Microsurgical anatomy of the middle cerebral artery, 151",{},{"id":28,"text":3025,"url":28,"identifiers":3026},"Horiuchi, 2004, J Neurosurg, Ruptured distal middle cerebral artery aneurysm, 384",{},{"id":28,"text":3028,"url":28,"identifiers":3029},"Lee, 2013, J Cerebrovasc Endovasc Neurosurg, Ruptured mycotic aneurysm of the distal middle cerebral artery manifesting as subacute subduralhematoma, 235",{},{"id":28,"text":3031,"url":28,"identifiers":3032},"Lv, 2016, Interv Neuroradiol, Endovascular treatment of distal middle cerebral artery aneurysms: Report of eight cases and literature review, 12",{},{"id":28,"text":3034,"url":28,"identifiers":3035},"Della, 2017, World Neurosurg, The “ICG Entrapment Sign” in Cerebral Aneurysm Surgery Assisted by Indocyanine GreenVideoangiography, 287",{},{"id":28,"text":3037,"url":28,"identifiers":3038},"Raabe, 2003, Neurosurgery, Near-infrared indocyanine green video angiography: A new method for intraoperative assessment of vascular flow, 132",{},{"id":28,"text":3040,"url":28,"identifiers":3041},"Raabe, 2005, Zentralbl Neurochir, Technique and image quality of intraoperative indocyanine green angiography during aneurysm surgery using surgical microscope integrated near-infrared video technology, 1",{},{"id":28,"text":3043,"url":28,"identifiers":3044},"Raza, 2012, Neurosurgery, Intra-arterial intraoperative computed tomography angiography guided navigation: A new technique for localization of vascular pathology, 240",{},{"id":28,"text":3046,"url":28,"identifiers":3047},"Zhao, 2016, World Neurosurg, A Multicenter Analysis of Computed Tomography Angiography Alone Versus Digital Subtraction Angiography for the Surgical Treatment of Poor-Grade Aneurysmal Subarachnoid Hemorrhage, 106",{},{"id":3049,"createTime":3050,"updateTime":3050,"relativeEntities":3051,"slug":3052,"properties":3053,"entityType":941,"verifyStatus":26,"verifyTime":3050,"verifyNote":942,"languages":3068,"translateLanguages":28,"viewCount":32,"primaryUrl":3069,"fullTextUrl":28,"authors":3070,"publicationType":963,"publisherRelationship":3186,"citationCount":147,"citationInfo":3221,"publishDate":28,"publishYear":28,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":3223,"openAccess":28,"references":3224,"isForceReanalyzing":1082},"9aba7344-3050-4438-b8e7-75e68316b2bd","2024-08-31T12:58:31.124+00:00",[],"Transnasal-endoscopic-removal-of-a-retrochiasmatic-cavernoma-A-case-report-and-review-of-literature",{"mag":3054,"pmc":3056,"openalex":3058,"abstract":3060,"title":3062,"pm":3064,"doi":3066},{"VOID":3055},"2969233308",{"VOID":3057},"6744740",{"VOID":3059},"W2969233308",{"EN":3061},"\u003Cjats:sec id=\"st1\">\n\u003Cjats:title>Background:\u003C\u002Fjats:title>\n\u003Cjats:p>Cavernomas arising in the region of the optic apparatus are extremely rare, accounting for <1% of all the central nervous system cavernomas. Most patients are affected by acute visual disturbances related to hemorrhagic events. A prompt resection of the lesion together with a decompression of the optic apparatus may lead to a functional improvement. Almost all patients reported in literature were treated by means of a craniotomy, whereas only few papers described the use of a transnasal approach.\u003C\u002Fjats:p>\n\u003C\u002Fjats:sec>\n\u003Cjats:sec id=\"st2\">\n\u003Cjats:title>Case Description:\u003C\u002Fjats:title>\n\u003Cjats:p>We report the case of a 53-year-old woman with a hemorrhagic, cavernous malformation of the optic chiasm region and we discuss the technical nuances of the endoscopic transnasal approach we employed. We also review literature for patients with cavernomas treated with a transsphenoidal approach. In our case, the patient underwent the gross-total resection of the lesion through a fully endoscopic transnasal route and the visual disturbances improved immediately after the operation. The ventral access allowed an adequate exposure of the chiasm\u002Fanterior circulation complex, thus avoiding an excessive dissection and retraction of neurovascular structures. Moreover, with the aid of angled scopes, we were able to identify the frail vascular supply of the chiasm by employing the suprachiasmatic corridor as well as the infrachiasmatic one. We stress the need for a careful reconstruction of the skull base to avoid a postoperative cerebrospinal fluid leak.\u003C\u002Fjats:p>\n\u003C\u002Fjats:sec>\n\u003Cjats:sec id=\"st3\">\n\u003Cjats:title>Conclusions:\u003C\u002Fjats:title>\n\u003Cjats:p>With the evolution and spreading of the neuroendoscopic techniques, in selected cases, we advocate the use of the transnasal route for the removal of cavernomas arising in the region of the anterior optic pathways.\u003C\u002Fjats:p>\n\u003C\u002Fjats:sec>",{"EN":3063},"Transnasal endoscopic removal of a retrochiasmatic cavernoma: A case report and review of literature",{"VOID":3065},"31528414",{"VOID":3067},"10.25259\u002Fsni-132-2019",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Ftransnasal-endoscopic-removal-of-a-retrochiasmatic-cavernoma-a-case-report-and-review-of-literature\u002F",[3071,3090,3115,3132,3152,3166],{"id":3072,"sortIndex":32,"researcher":28,"roles":3073,"affiliations":3074,"properties":3083,"displayName":3087,"givenName":28,"familyName":28},"221a72fb-d846-447b-87bf-517157c2a63d",[],[3075],{"id":3076,"sortIndex":32,"affiliation":3077,"properties":28},"19419a0d-ca2d-4756-b6d5-e7edb1567a27",{"id":3076,"createTime":28,"updateTime":28,"relativeEntities":3078,"slug":28,"properties":3079,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3082,"statistic":28},[],{"title":3080},{"VI":3081},"Neurosurgery Unit, Department of Surgical Sciences, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",[],{"orcid":3084,"title":3086,"openalex":3088},{"VOID":3085},"https:\u002F\u002Forcid.org\u002F0000-0001-7304-6120",{"EN":3087},"Cesare Zoia",{"VOID":3089},"A5034793795",{"id":3091,"sortIndex":40,"researcher":28,"roles":3092,"affiliations":3093,"properties":3108,"displayName":3112,"givenName":28,"familyName":28},"2a1938cb-2dc8-461f-9995-01161689a564",[],[3094,3102],{"id":3095,"sortIndex":32,"affiliation":3096,"properties":28},"8837f911-b033-4c36-acda-eddfe495ba14",{"id":3095,"createTime":28,"updateTime":28,"relativeEntities":3097,"slug":28,"properties":3098,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3101,"statistic":28},[],{"title":3099},{"EN":3100},"Neurosurgery Unit, Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, viale Golgi 19, Pavia, Italy.",[],{"id":3076,"sortIndex":40,"affiliation":3103,"properties":28},{"id":3076,"createTime":28,"updateTime":28,"relativeEntities":3104,"slug":28,"properties":3105,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3107,"statistic":28},[],{"title":3106},{"VI":3081},[],{"orcid":3109,"title":3111,"openalex":3113},{"VOID":3110},"https:\u002F\u002Forcid.org\u002F0000-0003-3620-2600",{"EN":3112},"Daniele Bongetta",{"VOID":3114},"A5016667776",{"id":3116,"sortIndex":123,"researcher":28,"roles":3117,"affiliations":3118,"properties":3125,"displayName":3129,"givenName":28,"familyName":28},"946b7ce1-3497-49fb-9405-72bf2ba00c4d",[],[3119],{"id":3095,"sortIndex":32,"affiliation":3120,"properties":28},{"id":3095,"createTime":28,"updateTime":28,"relativeEntities":3121,"slug":28,"properties":3122,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3124,"statistic":28},[],{"title":3123},{"EN":3100},[],{"orcid":3126,"title":3128,"openalex":3130},{"VOID":3127},"https:\u002F\u002Forcid.org\u002F0000-0002-9004-7587",{"EN":3129},"Gianluigi Dorelli",{"VOID":3131},"A5069620453",{"id":3133,"sortIndex":42,"researcher":28,"roles":3134,"affiliations":3135,"properties":3148,"displayName":2946,"givenName":28,"familyName":28},"3095004a-7735-4422-a940-441e6cb2248c",[],[3136,3142],{"id":3095,"sortIndex":32,"affiliation":3137,"properties":28},{"id":3095,"createTime":28,"updateTime":28,"relativeEntities":3138,"slug":28,"properties":3139,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3141,"statistic":28},[],{"title":3140},{"EN":3100},[],{"id":3076,"sortIndex":40,"affiliation":3143,"properties":28},{"id":3076,"createTime":28,"updateTime":28,"relativeEntities":3144,"slug":28,"properties":3145,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3147,"statistic":28},[],{"title":3146},{"VI":3081},[],{"orcid":3149,"title":3150,"openalex":3151},{"VOID":2944},{"EN":2946},{"VOID":2948},{"id":3153,"sortIndex":45,"researcher":28,"roles":3154,"affiliations":3155,"properties":3162,"displayName":2897,"givenName":28,"familyName":28},"4c93d6e2-c7d1-435a-8be5-9df40bf4ff0c",[],[3156],{"id":3076,"sortIndex":32,"affiliation":3157,"properties":28},{"id":3076,"createTime":28,"updateTime":28,"relativeEntities":3158,"slug":28,"properties":3159,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3161,"statistic":28},[],{"title":3160},{"VI":3081},[],{"orcid":3163,"title":3164,"openalex":3165},{"VOID":2895},{"EN":2897},{"VOID":2899},{"id":3167,"sortIndex":46,"researcher":28,"roles":3168,"affiliations":3169,"properties":3182,"displayName":2963,"givenName":28,"familyName":28},"560610f3-961d-4cc9-a7f8-5df7e4bf82dc",[],[3170,3176],{"id":3095,"sortIndex":32,"affiliation":3171,"properties":28},{"id":3095,"createTime":28,"updateTime":28,"relativeEntities":3172,"slug":28,"properties":3173,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3175,"statistic":28},[],{"title":3174},{"EN":3100},[],{"id":3076,"sortIndex":40,"affiliation":3177,"properties":28},{"id":3076,"createTime":28,"updateTime":28,"relativeEntities":3178,"slug":28,"properties":3179,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3181,"statistic":28},[],{"title":3180},{"VI":3081},[],{"orcid":3183,"title":3184,"openalex":3185},{"VOID":2961},{"EN":2963},{"VOID":2965},{"url":28,"publisher":3187,"properties":3216},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":3188,"slug":872,"properties":3189,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":3193,"manageAffiliations":3202,"indexDatabases":3208,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":3190,"title":3191,"country":3192},{"VOID":877},{"EN":879},{"VOID":875},[3194,3198],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":3195,"label":3196,"description":3197,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":3199,"label":3200,"description":3201,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[3203],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":3204,"slug":28,"properties":3205,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3207,"statistic":28},[],{"title":3206},{"EN":902},[],[3209],{"id":906,"indexDatabase":3210,"url":912,"indexYears":913,"academicFieldIds":3215,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":3211,"label":3212,"description":3213,"key":781,"publicationTags":3214,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"pages":3217,"volume":3219},{"VOID":3218},"76",{"VOID":3220},"10",{"total":147,"publishYear":28,"statisticByYear":3222},{"2019":42,"2020":357,"2021":205,"2022":48,"2023":123,"2024":40},[],[3225,3229,3233,3237,3241,3245,3249,3253,3257,3261,3265,3269,3273,3277,3281,3285,3289],{"id":28,"text":3226,"url":28,"identifiers":3227},"Aiba, 1995, Natural history of intracranial cavernous malformations, J Neurosurg, 83, 56, 10.3171\u002Fjns.1995.83.1.0056",{"doi":3228},"10.3171\u002Fjns.1995.83.1.0056",{"id":28,"text":3230,"url":28,"identifiers":3231},"Al-Sharydah, 2018, Endoscopic management of atypical sellar cavernous hemangioma:A case report and review of the literature, Int J Surg Case Rep, 42, 161, 10.1016\u002Fj.ijscr.2017.12.006",{"doi":3232},"10.1016\u002Fj.ijscr.2017.12.006",{"id":28,"text":3234,"url":28,"identifiers":3235},"Curling, 1991, An analysis of the natural history of cavernous angiomas, J Neurosurg, 75, 702, 10.3171\u002Fjns.1991.75.5.0702",{"doi":3236},"10.3171\u002Fjns.1991.75.5.0702",{"id":28,"text":3238,"url":28,"identifiers":3239},"Deshmukh, 2003, Surgical management of cavernous malformations involving the cranial nerves, Neurosurgery, 53, 352, 10.1227\u002F01.NEU.0000073531.84342.C2",{"doi":3240},"10.1227\u002F01.NEU.0000073531.84342.C2",{"id":28,"text":3242,"url":28,"identifiers":3243},"Divitiis, 2007, Extended endoscopic endonasal transsphenoidale approach for the removal of suprasellar tumors, Neurosurgery, 60, 46, 10.1227\u002F01.NEU.0000249211.89096.25",{"doi":3244},"10.1227\u002F01.NEU.0000249211.89096.25",{"id":28,"text":3246,"url":28,"identifiers":3247},"Goldstein, 2017, Epidemiology of cavernous malformations, Handb Clin Neurol, 143, 241, 10.1016\u002FB978-0-444-63640-9.00023-0",{"doi":3248},"10.1016\u002FB978-0-444-63640-9.00023-0",{"id":28,"text":3250,"url":28,"identifiers":3251},"Hempelmann, 2007, Complete resection of a cavernous haemangioma of the optic nerve, the chiasm, and the optic tract, Acta Neurochir, 149, 699, 10.1007\u002Fs00701-007-1163-8",{"doi":3252},"10.1007\u002Fs00701-007-1163-8",{"id":28,"text":3254,"url":28,"identifiers":3255},"Kim, 1997, An analysis of the natural history of cavernous malformations, Surg Neurol, 48, 9, 10.1016\u002FS0090-3019(96)00425-9",{"doi":3256},"10.1016\u002FS0090-3019(96)00425-9",{"id":28,"text":3258,"url":28,"identifiers":3259},"Lehner, 2006, Cavernous haemangiomas of the anterior visual pathways. Short review on occasion of an exceptional case, Acta Neurochir, 148, 571, 10.1007\u002Fs00701-006-0751-3",{"doi":3260},"10.1007\u002Fs00701-006-0751-3",{"id":28,"text":3262,"url":28,"identifiers":3263},"Liu, 2010, Cavernous malformations of the optic pathway and hypothalamus:Analysis of 65 cases in the literature, Neurosurg Focus, 29, E17, 10.3171\u002F2010.5.FOCUS10129",{"doi":3264},"10.3171\u002F2010.5.FOCUS10129",{"id":28,"text":3266,"url":28,"identifiers":3267},"Meng, 2017, Endoscopic endonasal transsphenoidal approach for the removal of optochiasmatic cavernoma:Case report and literature review, World Neurosurg, 106, 1053.e11, 10.1016\u002Fj.wneu.2017.07.026",{"doi":3268},"10.1016\u002Fj.wneu.2017.07.026",{"id":28,"text":3270,"url":28,"identifiers":3271},"Muta, 2006, Cavernous malformation of the optic chiasm:Case report, Br J Neurosurg, 20, 312, 10.1080\u002F02688690601000238",{"doi":3272},"10.1080\u002F02688690601000238",{"id":28,"text":3274,"url":28,"identifiers":3275},"Ozer, 2007, Optochiasmatic cavernous angioma:Unexpected diagnosis. Case report, Neurol Med Chir, 47, 128, 10.2176\u002Fnmc.47.128",{"doi":3276},"10.2176\u002Fnmc.47.128",{"id":28,"text":3278,"url":28,"identifiers":3279},"Robinson, 1991, Natural history of the cavernous angioma, J Neurosurg, 75, 709, 10.3171\u002Fjns.1991.75.5.0709",{"doi":3280},"10.3171\u002Fjns.1991.75.5.0709",{"id":28,"text":3282,"url":28,"identifiers":3283},"Son, 2008, Cavernous malformation of the optic chiasm:Case report, J Korean Neurosurg Soc, 44, 88, 10.3340\u002Fjkns.2008.44.2.88",{"doi":3284},"10.3340\u002Fjkns.2008.44.2.88",{"id":28,"text":3286,"url":28,"identifiers":3287},"Sorenson, 2018, Surgical resection of cavernous malformation of the optic nerve, Oper Neurosurg (Hagerstown), 14, 314, 10.1093\u002Fons\u002Fopx125",{"doi":3288},"10.1093\u002Fons\u002Fopx125",{"id":28,"text":3290,"url":28,"identifiers":3291},"Venkataramana, 2016, Cavernous malformation of the optic chiasm:Neuro-endoscopic removal, Asian J Neurosurg, 11, 71, 10.4103\u002F1793-5482.145114",{"doi":3292},"10.4103\u002F1793-5482.145114",{"id":3294,"createTime":3295,"updateTime":3295,"relativeEntities":3296,"slug":3297,"properties":3298,"entityType":941,"verifyStatus":882,"verifyTime":3295,"verifyNote":2069,"languages":3311,"translateLanguages":28,"viewCount":32,"primaryUrl":3312,"fullTextUrl":28,"authors":3313,"publicationType":963,"publisherRelationship":3459,"citationCount":132,"citationInfo":3495,"publishDate":3498,"publishYear":3496,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":3499,"openAccess":28,"references":3500,"isForceReanalyzing":1082},"db1b6fe2-6ff4-4497-b806-baf34004b057","2024-08-31T12:58:22.421+00:00",[],"Engraftment-neuroglial-transdifferentiation-and-behavioral-recovery-after-complete-spinal-cord-transection-in-rats",{"openalex":3299,"mag":3301,"title":3303,"pm":3305,"doi":3307,"pmc":3309},{"VOID":3300},"W2792115750",{"VOID":3302},"2792115750",{"EN":3304},"Engraftment, neuroglial transdifferentiation and behavioral recovery after complete spinal cord transection in rats",{"VOID":3306},"29497572",{"VOID":3308},"10.4103\u002Fsni.sni_369_17",{"VOID":3310},"5806420",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fengraftment-neuroglial-transdifferentiation-and-behavioral-recovery-after-complete-spinal-cord-transection-in-rats\u002F",[3314,3336,3355,3370,3385,3400,3419,3436,3444],{"id":3315,"sortIndex":32,"researcher":28,"roles":3316,"affiliations":3317,"properties":3332,"displayName":2946,"givenName":28,"familyName":28},"4c995abb-be10-4130-9acc-31bc0cbcb92a",[],[3318,3326],{"id":3319,"sortIndex":32,"affiliation":3320,"properties":28},"25a7d431-e383-4cef-9480-2b746373c078",{"id":3319,"createTime":28,"updateTime":28,"relativeEntities":3321,"slug":28,"properties":3322,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3325,"statistic":28},[],{"title":3323},{"EN":3324},"Department of Emergency and Organ Transplantation, University of Bari \"Aldo Moro\", Bari,",[],{"id":2817,"sortIndex":40,"affiliation":3327,"properties":28},{"id":2817,"createTime":28,"updateTime":28,"relativeEntities":3328,"slug":28,"properties":3329,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3331,"statistic":28},[],{"title":3330},{"EN":2822},[],{"orcid":3333,"title":3334,"openalex":3335},{"VOID":2944},{"EN":2946},{"VOID":2948},{"id":3337,"sortIndex":40,"researcher":28,"roles":3338,"affiliations":3339,"properties":3348,"displayName":3352,"givenName":28,"familyName":28},"cb152d42-7c09-4c64-af34-ec544fa42a1b",[],[3340],{"id":3341,"sortIndex":32,"affiliation":3342,"properties":28},"7c0e2490-9c7d-45e5-9815-200ce9617e5d",{"id":3341,"createTime":28,"updateTime":28,"relativeEntities":3343,"slug":28,"properties":3344,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3347,"statistic":28},[],{"title":3345},{"EN":3346},"Department of Veterinary Medicine, University of Perugia, Perugia,",[],{"orcid":3349,"title":3351,"openalex":3353},{"VOID":3350},"https:\u002F\u002Forcid.org\u002F0000-0002-5908-6641",{"EN":3352},"Alberto Maria Crovace",{"VOID":3354},"A5102819744",{"id":3356,"sortIndex":123,"researcher":28,"roles":3357,"affiliations":3358,"properties":3365,"displayName":3367,"givenName":28,"familyName":28},"df7e6331-6a1a-4cc2-9fd8-e89d0c96b97a",[],[3359],{"id":3319,"sortIndex":32,"affiliation":3360,"properties":28},{"id":3319,"createTime":28,"updateTime":28,"relativeEntities":3361,"slug":28,"properties":3362,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3364,"statistic":28},[],{"title":3363},{"EN":3324},[],{"title":3366,"openalex":3368},{"EN":3367},"Lacitignola Luca",{"VOID":3369},"A5077891630",{"id":3371,"sortIndex":42,"researcher":28,"roles":3372,"affiliations":3373,"properties":3380,"displayName":3382,"givenName":28,"familyName":28},"0a4a91c6-12bb-44e1-8a23-4c8949e8e732",[],[3374],{"id":3319,"sortIndex":32,"affiliation":3375,"properties":28},{"id":3319,"createTime":28,"updateTime":28,"relativeEntities":3376,"slug":28,"properties":3377,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3379,"statistic":28},[],{"title":3378},{"EN":3324},[],{"title":3381,"openalex":3383},{"EN":3382},"Vincenzo Nicola Valerio",{"VOID":3384},"A5085508977",{"id":3386,"sortIndex":45,"researcher":28,"roles":3387,"affiliations":3388,"properties":3395,"displayName":3397,"givenName":28,"familyName":28},"4e5f3449-858f-48bf-bab3-9a21b44237b7",[],[3389],{"id":3319,"sortIndex":32,"affiliation":3390,"properties":28},{"id":3319,"createTime":28,"updateTime":28,"relativeEntities":3391,"slug":28,"properties":3392,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3394,"statistic":28},[],{"title":3393},{"EN":3324},[],{"title":3396,"openalex":3398},{"EN":3397},"Francioso Edda",{"VOID":3399},"A5088480997",{"id":3401,"sortIndex":46,"researcher":28,"roles":3402,"affiliations":3403,"properties":3412,"displayName":3416,"givenName":28,"familyName":28},"53804860-b318-4bba-b572-f254bc45907d",[],[3404],{"id":3405,"sortIndex":32,"affiliation":3406,"properties":28},"f5a0d55c-70a3-426d-8c49-922502e9fea1",{"id":3405,"createTime":28,"updateTime":28,"relativeEntities":3407,"slug":28,"properties":3408,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3411,"statistic":28},[],{"title":3409},{"EN":3410},"Animal Pathology Section, School of Biosciences and Veterinary Medicine, University of Camerino, Matelica,",[],{"orcid":3413,"title":3415,"openalex":3417},{"VOID":3414},"https:\u002F\u002Forcid.org\u002F0000-0001-8617-5984",{"EN":3416},"Giacomo Rossi",{"VOID":3418},"A5050832568",{"id":3420,"sortIndex":48,"researcher":28,"roles":3421,"affiliations":3422,"properties":3431,"displayName":3433,"givenName":28,"familyName":28},"a19c934f-1f1a-49fa-abdd-8994ce001a16",[],[3423],{"id":3424,"sortIndex":32,"affiliation":3425,"properties":28},"59e46616-2a86-49f4-840a-99eab30964c2",{"id":3424,"createTime":28,"updateTime":28,"relativeEntities":3426,"slug":28,"properties":3427,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3430,"statistic":28},[],{"title":3428},{"EN":3429},"Department of Neurology, Public Health and Disability, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan,",[],{"title":3432,"openalex":3434},{"EN":3433},"Invernici Gloria",{"VOID":3435},"A5094641643",{"id":3437,"sortIndex":49,"researcher":28,"roles":3438,"affiliations":3439,"properties":3440,"displayName":2963,"givenName":28,"familyName":28},"cba74ed5-fd28-4154-8337-397e0d81aa52",[],[],{"orcid":3441,"title":3442,"openalex":3443},{"VOID":2961},{"EN":2963},{"VOID":2965},{"id":3445,"sortIndex":357,"researcher":28,"roles":3446,"affiliations":3447,"properties":3454,"displayName":3456,"givenName":28,"familyName":28},"56b0e3eb-9bfe-4ba8-b82d-b0b5679fe560",[],[3448],{"id":3319,"sortIndex":32,"affiliation":3449,"properties":28},{"id":3319,"createTime":28,"updateTime":28,"relativeEntities":3450,"slug":28,"properties":3451,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3453,"statistic":28},[],{"title":3452},{"EN":3324},[],{"title":3455,"openalex":3457},{"EN":3456},"Crovace Antonio",{"VOID":3458},"A5100553257",{"url":28,"publisher":3460,"properties":3489},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":3461,"slug":872,"properties":3462,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":3466,"manageAffiliations":3475,"indexDatabases":3481,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":3463,"title":3464,"country":3465},{"VOID":877},{"EN":879},{"VOID":875},[3467,3471],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":3468,"label":3469,"description":3470,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":3472,"label":3473,"description":3474,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[3476],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":3477,"slug":28,"properties":3478,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3480,"statistic":28},[],{"title":3479},{"EN":902},[],[3482],{"id":906,"indexDatabase":3483,"url":912,"indexYears":913,"academicFieldIds":3488,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":3484,"label":3485,"description":3486,"key":781,"publicationTags":3487,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":3490,"pages":3491,"volume":3493},{"VOID":1187},{"VOID":3492},"19",{"VOID":3494},"9",{"total":132,"publishYear":3496,"statisticByYear":3497},2018,{"2017":40,"2018":40,"2019":48,"2020":49,"2021":123,"2022":49,"2024":45},"2018-01-01",[917],[3501,3504,3507,3510,3513,3516,3519,3522,3525,3528,3531,3534,3537,3540,3543,3546,3549,3552,3555,3558,3561,3564,3567,3570,3573,3576,3579,3583,3586,3589,3592,3595,3598,3601,3604,3607,3610,3614,3617,3620,3623,3626,3629,3632,3635,3638,3641,3644,3647,3650,3653,3656,3659,3662,3665,3668,3671,3675,3678,3681,3684,3687,3690,3693,3696,3699,3702,3705,3708],{"id":28,"text":3502,"url":28,"identifiers":3503},"Assunção-Silva, 2015, Stem Cells Int, Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration, 948040",{},{"id":28,"text":3505,"url":28,"identifiers":3506},"Baptiste, 2007, Prog Brain Res, Update on the treatment of spinal cord injury, 217",{},{"id":28,"text":3508,"url":28,"identifiers":3509},"Basso, 1995, J Neurotrauma, A sensitive and reliable locomotor rating scale for open field testing in rats, 1",{},{"id":28,"text":3511,"url":28,"identifiers":3512},"Benson, 2005, Proc Natl Acad Sci U S A, Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth, 10694",{},{"id":28,"text":3514,"url":28,"identifiers":3515},"Canavero, 2016, CNS Neurosci Ther, The Spark of Life: Engaging the Cortico-Truncoreticulo-Propriospinal Pathway by Electrical Stimulation, 260",{},{"id":28,"text":3517,"url":28,"identifiers":3518},"Canavero, 2016, Surg Neurol Int, Houston, GEMINI has landed: Spinal cord fusion achieved, S626",{},{"id":28,"text":3520,"url":28,"identifiers":3521},"Canavero, 2016, Surgery, Neurologic foundations of spinal cord fusion (GEMINI), 11",{},{"id":28,"text":3523,"url":28,"identifiers":3524},"Cao, 2009, Chin Med J (Engl), Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury, 225",{},{"id":28,"text":3526,"url":28,"identifiers":3527},"Caplan, 2007, J Cell Physiol, Adult mesenchymal stem cells for tissue engineering versus regenerative medicine, 341",{},{"id":28,"text":3529,"url":28,"identifiers":3530},"Chen, 2000, Nature, Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1, 434",{},{"id":28,"text":3532,"url":28,"identifiers":3533},"Coleman, 2000, J Spinal Disord, A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury, 185",{},{"id":28,"text":3535,"url":28,"identifiers":3536},"Czernik, 2013, J Cell Biochem, Differentiation potential and GFP labeling of sheep bone marrow-derived mesenchymal stem cells, 134",{},{"id":28,"text":3538,"url":28,"identifiers":3539},"Das, 2011, Curr Stem Cell Res Ther, Current status and prospective application of stem cell-based therapies for spinal cord injury, 93",{},{"id":28,"text":3541,"url":28,"identifiers":3542},"Desantis, 2015, Ann Anat, Ultrastructural study of cultured ovine bone marrow-derived mesenchymal stromal cells, 43",{},{"id":28,"text":3544,"url":28,"identifiers":3545},"Dezawa, 2004, J Clin Invest, Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation, 1701",{},{"id":28,"text":3547,"url":28,"identifiers":3548},"Dominici, 2006, Cytotherapy, Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement, 315",{},{"id":28,"text":3550,"url":28,"identifiers":3551},"Eftekharpour, 2008, Neurosurg Focus, Current status of experimental cell replacement approaches to spinal cord injury, E19",{},{"id":28,"text":3553,"url":28,"identifiers":3554},"Faden, 1982, Neurology, Comparison of early and late naloxone treatment in experimental spinal injury, 677",{},{"id":28,"text":3556,"url":28,"identifiers":3557},"Friedenstein, 1970, Cell Tissue Kinet, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, 393",{},{"id":28,"text":3559,"url":28,"identifiers":3560},"Goldschlager, 2013, Curr Stem Cell Res Ther, Current and future applications for stem cell therapies in spine surgery, 381",{},{"id":28,"text":3562,"url":28,"identifiers":3563},"Hall, 1995, J Neurotrauma, Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord, 245",{},{"id":28,"text":3565,"url":28,"identifiers":3566},"Hall, 2004, NeuroRx, Neuroprotection and acute spinal cord injury: A reappraisal, 80",{},{"id":28,"text":3568,"url":28,"identifiers":3569},"Harrop, 2012, J Neurosurg Spine, Evaluation of clinical experience using cell-based therapies in patients with spinal cord injury: A systematic review, 230",{},{"id":28,"text":3571,"url":28,"identifiers":3572},"Hata, 2006, J Cell Biol, RGMa inhibition promotes axonal growth and recovery after spinal cord injury, 47",{},{"id":28,"text":3574,"url":28,"identifiers":3575},"Holden, 2002, Science, Stem cells.Plasticity: Time for a reappraisal?, 2126",{},{"id":28,"text":3577,"url":28,"identifiers":3578},"Hurlbert, 2000, J Neurosurg, Methylprednisolone for acute spinal cord injury: An inappropriate standard of care, 1",{},{"id":28,"text":3580,"url":28,"identifiers":3581},"Ito Y, Sugimoto Y, Tomioka M, Kai N, Tanaka M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: A prospective study about neurological recovery and early complications. Spine (Phila. Pa. 1976) 2009;34:2121-4.",{"doi":3582},"10.1097\u002FBRS.0b013e3181b613c7",{"id":28,"text":3584,"url":28,"identifiers":3585},"Jiang, 2002, Nature, Pluripotency of mesenchymal stem cells derived from adult marrow, 41",{},{"id":28,"text":3587,"url":28,"identifiers":3588},"Joyce, 2010, Regen Med, Mesenchymal stem cells for the treatment of neurodegenerative disease, 933",{},{"id":28,"text":3590,"url":28,"identifiers":3591},"Karimi-Abdolrezaee, 2012, Adv Exp Med Biol, Stem cells and spinal cord injury repair, 53",{},{"id":28,"text":3593,"url":28,"identifiers":3594},"Koda, 2005, Neuroreport, Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice, 1763",{},{"id":28,"text":3596,"url":28,"identifiers":3597},"Koshizuka, 2004, J Neuropathol Exp Neurol, Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice, 64",{},{"id":28,"text":3599,"url":28,"identifiers":3600},"Louro, 2008, Neurol Res, Stem and progenitor cell therapies: Recent progress for spinal cord injury repair, 5",{},{"id":28,"text":3602,"url":28,"identifiers":3603},"Löw, 2008, J Neurosci, Netrin-1 is a novel myelin-associated inhibitor to axon growth, 1099",{},{"id":28,"text":3605,"url":28,"identifiers":3606},"Lyahyai, 2012, BMC Vet Res, Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood, 169",{},{"id":28,"text":3608,"url":28,"identifiers":3609},"Makino, 1999, J Clin Invest, Cardiomyocytes can be generated from marrow stromal cells in vitro, 697",{},{"id":28,"text":3611,"url":28,"identifiers":3612},"Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila. Pa. 1976) 2001;26:426-30.",{"doi":3613},"10.1097\u002F00007632-200102150-00020",{"id":28,"text":3615,"url":28,"identifiers":3616},"McCreedy, 2012, Neurosci Lett, Combination therapies in the CNS: Engineering the environment, 115",{},{"id":28,"text":3618,"url":28,"identifiers":3619},"McKerracher, 1994, Neuron, Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth, 805",{},{"id":28,"text":3621,"url":28,"identifiers":3622},"Meirelles, 2009, Front Biosci, Methodology, biology and clinical applications of mesenchymal stem cells, 4281",{},{"id":28,"text":3624,"url":28,"identifiers":3625},"Miller, 2012, Neurosci Lett, Translating stem cell therapies to the clinic, 87",{},{"id":28,"text":3627,"url":28,"identifiers":3628},"Moreau-Fauvarque, 2003, J Neurosci, The transmembrane semaphorin Sema4D\u002FCD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion, 9229",{},{"id":28,"text":3630,"url":28,"identifiers":3631},"Mukhopadhyay, 1994, Neuron, A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration, 757",{},{"id":28,"text":3633,"url":28,"identifiers":3634},"Nandoe, 2009, J Spinal Cord Med, Stem cell-based therapies for spinal cord injury, 105",{},{"id":28,"text":3636,"url":28,"identifiers":3637},"Noble, 2011, Curr Opin Neurol, Cell therapies for the central nervous system: How do we identify the best candidates?, 570",{},{"id":28,"text":3639,"url":28,"identifiers":3640},"Obermair, 2008, Physiology (Bethesda), Endogenous neural progenitor cells as therapeutic target after spinal cord injury, 296",{},{"id":28,"text":3642,"url":28,"identifiers":3643},"Phinney, 2007, Stem Cells, Concise review: Mesenchymal stem\u002Fmultipotent stromal cells: The state of transdifferentiation and modes of tissue repair--current views, 2896",{},{"id":28,"text":3645,"url":28,"identifiers":3646},"Prockop, 1997, Science, Marrow stromal cells as stem cells for nonhematopoietic tissues, 71",{},{"id":28,"text":3648,"url":28,"identifiers":3649},"Reynolds, 1992, Science, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, 1707",{},{"id":28,"text":3651,"url":28,"identifiers":3652},"Richardson, 1980, Nature, Axons from CNS neurons regenerate into PNS grafts, 264",{},{"id":28,"text":3654,"url":28,"identifiers":3655},"Rowland, 2008, Neurosurg Focus, Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon, E2",{},{"id":28,"text":3657,"url":28,"identifiers":3658},"Ruff, 2012, Exp Neurol, Cell-based transplantation strategies to promote plasticity following spinal cord injury, 78",{},{"id":28,"text":3660,"url":28,"identifiers":3661},"Ryan, 2007, Clin Exp Immunol, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, 353",{},{"id":28,"text":3663,"url":28,"identifiers":3664},"Sakaguchi, 2005, Arthritis Rheum, Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source, 2521",{},{"id":28,"text":3666,"url":28,"identifiers":3667},"Sakiyama-Elbert, 2001, FASEB J, Development of growth factor fusion proteins for cell-triggered drug delivery, 1300",{},{"id":28,"text":3669,"url":28,"identifiers":3670},"Sanchez-Ramos, 2000, Exp Neurol, Adult bone marrow stromal cells differentiate into neural cells in vitro, 247",{},{"id":28,"text":3672,"url":28,"identifiers":3673},"Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila. Pa. 1976) 2001;26:S2-12.",{"doi":3674},"10.1097\u002F00007632-200112151-00002",{"id":28,"text":3676,"url":28,"identifiers":3677},"Short, 2000, Spinal Cord, High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective, 273",{},{"id":28,"text":3679,"url":28,"identifiers":3680},"Silva, 2014, Prog Neurobiol, From basics to clinical: A comprehensive review on spinal cord injury, 25",{},{"id":28,"text":3682,"url":28,"identifiers":3683},"Silver, 2004, Nat Rev Neurosci, Regeneration beyond the glial scar, 146",{},{"id":28,"text":3685,"url":28,"identifiers":3686},"Simard, 2004, FASEB J, Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia, 998",{},{"id":28,"text":3688,"url":28,"identifiers":3689},"Stenderup, 2003, Bone, Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells, 919",{},{"id":28,"text":3691,"url":28,"identifiers":3692},"Stocum, 2002, J Musculoskelet Neuronal Interact, Regenerative biology and medicine, 270",{},{"id":28,"text":3694,"url":28,"identifiers":3695},"Takayama, 2009, Anat Rec (Hoboken), Characteristic morphology and distribution of bone marrow derived cells in the cornea, 756",{},{"id":28,"text":3697,"url":28,"identifiers":3698},"Vawda, 2013, Curr Stem Cell Res Ther, Mesenchymal cells in the treatment of spinal cord injury: Current and future perspectives, 25",{},{"id":28,"text":3700,"url":28,"identifiers":3701},"Wang, 2002, Nature, Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth, 941",{},{"id":28,"text":3703,"url":28,"identifiers":3704},"Weiss, 1996, J Neurosci, Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis, 7599",{},{"id":28,"text":3706,"url":28,"identifiers":3707},"Wyatt, 2012, Prog Brain Res, Stem cell-based treatments for spinal cord injury, 233",{},{"id":28,"text":3709,"url":28,"identifiers":3710},"Zuk, 2002, Mol Biol Cell, Human adipose tissue is a source of multipotent stem cells, 4279",{},{"id":3712,"createTime":3713,"updateTime":3713,"relativeEntities":3714,"slug":3715,"properties":3716,"entityType":941,"verifyStatus":26,"verifyTime":3713,"verifyNote":942,"languages":3729,"translateLanguages":28,"viewCount":32,"primaryUrl":3730,"fullTextUrl":28,"authors":3731,"publicationType":963,"publisherRelationship":3800,"citationCount":131,"citationInfo":3836,"publishDate":2604,"publishYear":2602,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":3838,"openAccess":28,"references":3839,"isForceReanalyzing":1082},"ff3d7e7d-4f1d-49fe-9110-a1b7ce242801","2024-09-11T15:17:27.030+00:00",[],"Management-of-hydrocephalus-in-children-with-posterior-fossa-tumors",{"openalex":3717,"mag":3719,"title":3721,"pm":3723,"doi":3725,"pmc":3727},{"VOID":3718},"W2417900663",{"VOID":3720},"2417900663",{"EN":3722},"Management of hydrocephalus in children with posterior fossa tumors",{"VOID":3724},"26236555",{"VOID":3726},"10.4103\u002F2152-7806.161413",{"VOID":3728},"4521311",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Fmanagement-of-hydrocephalus-in-children-with-posterior-fossa-tumors\u002F",[3732,3751,3768,3785],{"id":3733,"sortIndex":32,"researcher":28,"roles":3734,"affiliations":3735,"properties":3744,"displayName":3748,"givenName":28,"familyName":28},"2abc804b-d82e-4f59-b9e8-372803778ce9",[],[3736],{"id":3737,"sortIndex":32,"affiliation":3738,"properties":28},"2e33bf45-ddb9-48a4-9dc4-22c4b6fba12b",{"id":3737,"createTime":28,"updateTime":28,"relativeEntities":3739,"slug":28,"properties":3740,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3743,"statistic":28},[],{"title":3741},{"VI":3742},"Department of Neurosurgery, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 77030, USA",[],{"orcid":3745,"title":3747,"openalex":3749},{"VOID":3746},"https:\u002F\u002Forcid.org\u002F0000-0003-3294-6637",{"EN":3748},"Sandi Lam",{"VOID":3750},"A5047569992",{"id":3752,"sortIndex":40,"researcher":28,"roles":3753,"affiliations":3754,"properties":3761,"displayName":3765,"givenName":28,"familyName":28},"bc893601-d682-486f-998d-5925a2116aeb",[],[3755],{"id":3737,"sortIndex":32,"affiliation":3756,"properties":28},{"id":3737,"createTime":28,"updateTime":28,"relativeEntities":3757,"slug":28,"properties":3758,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3760,"statistic":28},[],{"title":3759},{"VI":3742},[],{"orcid":3762,"title":3764,"openalex":3766},{"VOID":3763},"https:\u002F\u002Forcid.org\u002F0000-0002-7485-1794",{"EN":3765},"Gaddum Duemani Reddy",{"VOID":3767},"A5103154470",{"id":3769,"sortIndex":123,"researcher":28,"roles":3770,"affiliations":3771,"properties":3778,"displayName":3782,"givenName":28,"familyName":28},"ee62205e-492f-418c-8f0d-0ef8103ca921",[],[3772],{"id":3737,"sortIndex":32,"affiliation":3773,"properties":28},{"id":3737,"createTime":28,"updateTime":28,"relativeEntities":3774,"slug":28,"properties":3775,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3777,"statistic":28},[],{"title":3776},{"VI":3742},[],{"orcid":3779,"title":3781,"openalex":3783},{"VOID":3780},"https:\u002F\u002Forcid.org\u002F0009-0006-8775-1510",{"EN":3782},"Yimo Lin",{"VOID":3784},"A5101890933",{"id":3786,"sortIndex":42,"researcher":28,"roles":3787,"affiliations":3788,"properties":3795,"displayName":3797,"givenName":28,"familyName":28},"0c634707-d59d-45b8-b09e-b3f367d85833",[],[3789],{"id":3737,"sortIndex":32,"affiliation":3790,"properties":28},{"id":3737,"createTime":28,"updateTime":28,"relativeEntities":3791,"slug":28,"properties":3792,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3794,"statistic":28},[],{"title":3793},{"VI":3742},[],{"title":3796,"openalex":3798},{"EN":3797},"Andrew Jea",{"VOID":3799},"A5013433741",{"url":28,"publisher":3801,"properties":3830},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":3802,"slug":872,"properties":3803,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":3807,"manageAffiliations":3816,"indexDatabases":3822,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":3804,"title":3805,"country":3806},{"VOID":877},{"EN":879},{"VOID":875},[3808,3812],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":3809,"label":3810,"description":3811,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":3813,"label":3814,"description":3815,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[3817],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":3818,"slug":28,"properties":3819,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3821,"statistic":28},[],{"title":3820},{"EN":902},[],[3823],{"id":906,"indexDatabase":3824,"url":912,"indexYears":913,"academicFieldIds":3829,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":3825,"label":3826,"description":3827,"key":781,"publicationTags":3828,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":3831,"pages":3833,"volume":3835},{"VOID":3832},"12",{"VOID":3834},"346",{"VOID":2600},{"total":131,"publishYear":2602,"statisticByYear":3837},{"2016":40,"2017":40,"2018":42,"2019":42,"2020":48,"2021":45,"2022":40,"2023":45,"2024":123},[917],[3840,3843,3846,3850,3853,3856,3859,3862,3865,3868,3871,3874,3877],{"id":28,"text":3841,"url":28,"identifiers":3842},"Bognár, 2003, Childs Nerv Syst, Analysis of CSF shunting procedure requirement in children with posterior fossa tumors, 332",{},{"id":28,"text":3844,"url":28,"identifiers":3845},"Culley, 1994, Neurosurgery, An analysis of factors determining the need for ventriculoperitoneal shunts after posterior fossa tumor surgery in children, 402",{},{"id":28,"text":3847,"url":28,"identifiers":3848},"Di Rocco F, Jucá CE, Zerah M, Sainte-Rose C. Endoscopic third ventriculostomy and posterior fossa tumors. World Neurosurg 2013;79:S18.e15-9.",{"doi":3849},"10.1016\u002Fj.wneu.2012.02.018",{"id":28,"text":3851,"url":28,"identifiers":3852},"Due-Tønnessen, 2007, Pediatr Neurosurg, Management of hydrocephalus in children with posterior fossa tumors: Role of tumor surgery, 92",{},{"id":28,"text":3854,"url":28,"identifiers":3855},"Foreman, 2013, J Neurosurg Pediatr, Validation and modification of a predictive model of postresection hydrocephalus in pediatric patients with posterior fossa tumors, 220",{},{"id":28,"text":3857,"url":28,"identifiers":3858},"Fritsch, 2005, J Neurosurg, Hydrocephalus in children with posterior fossa tumors: Role of endoscopic third ventriculostomy, 40",{},{"id":28,"text":3860,"url":28,"identifiers":3861},"Johnson, 2014, Cancer Epidemiol Biomarkers Prev, Childhood brain tumor epidemiology: A brain tumor epidemiology consortium review, 2716",{},{"id":28,"text":3863,"url":28,"identifiers":3864},"Kumar, 1996, Br J Neurosurg, Ventriculo-peritoneal shunt requirement in children with posterior fossa tumours: An 11-year audit, 467",{},{"id":28,"text":3866,"url":28,"identifiers":3867},"Morelli, 2005, J Neurosurg, Persistent hydrocephalus after early surgical management of posterior fossa tumors in children: Is routine preoperative endoscopic third ventriculostomy justified?, 247",{},{"id":28,"text":3869,"url":28,"identifiers":3870},"Riva-Cambrin, 2009, J Neurosurg Pediatr, Predicting postresection hydrocephalus in pediatric patients with posterior fossa tumors, 378",{},{"id":28,"text":3872,"url":28,"identifiers":3873},"Sainte-Rose, 2001, J Neurosurg, Management of hydrocephalus in pediatric patients with posterior fossa tumors: The role of endoscopic third ventriculostomy, 791",{},{"id":28,"text":3875,"url":28,"identifiers":3876},"Santos, 2008, Childs Nerv Syst, Hydrocephalus in posterior fossa tumors in children.Are there factors that determine a need for permanent cerebrospinal fluid diversion?, 1397",{},{"id":28,"text":3878,"url":28,"identifiers":3879},"Schijman, 2004, Childs Nerv Syst, Management of hydrocephalus in posterior fossa tumors: How, what, when?, 192",{},{"id":3881,"createTime":3882,"updateTime":3882,"relativeEntities":3883,"slug":3884,"properties":3885,"entityType":941,"verifyStatus":26,"verifyTime":3898,"verifyNote":942,"languages":3899,"translateLanguages":28,"viewCount":32,"primaryUrl":3900,"fullTextUrl":28,"authors":3901,"publicationType":963,"publisherRelationship":4042,"citationCount":134,"citationInfo":4078,"publishDate":2604,"publishYear":2602,"citationAnalyzeStatus":882,"lastCitationAnalyze":28,"indexDatabases":4080,"openAccess":28,"references":4081,"isForceReanalyzing":1082},"b076204b-4744-401c-8c93-740b10b26158","2024-08-31T02:48:21.688+00:00",[],"Treatment-of-low-back-pain-in-patients-with-vertebral-compression-fractures-and-superior-cluneal-nerve-entrapment-neuropathies",{"openalex":3886,"mag":3888,"title":3890,"pm":3892,"doi":3894,"pmc":3896},{"VOID":3887},"W2341583462",{"VOID":3889},"2341583462",{"EN":3891},"Treatment of low back pain in patients with vertebral compression fractures and superior cluneal nerve entrapment neuropathies",{"VOID":3893},"26693392",{"VOID":3895},"10.4103\u002F2152-7806.170455",{"VOID":3897},"4671138","2024-08-31T02:48:21.687+00:00",[31],"http:\u002F\u002Fsurgicalneurologyint.com\u002Fsurgicalint-articles\u002Ftreatment-of-low-back-pain-in-patients-with-vertebral-compression-fractures-and-superior-cluneal-nerve-entrapment-neuropathies\u002F",[3902,3921,3940,3957,3972,3989,4006,4023],{"id":3903,"sortIndex":32,"researcher":28,"roles":3904,"affiliations":3905,"properties":3914,"displayName":3918,"givenName":28,"familyName":28},"efd32d71-bcbc-48e6-baf0-d0a543ed8fd5",[],[3906],{"id":3907,"sortIndex":32,"affiliation":3908,"properties":28},"7b032523-050f-4b37-b32a-662878536bdc",{"id":3907,"createTime":28,"updateTime":28,"relativeEntities":3909,"slug":28,"properties":3910,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3913,"statistic":28},[],{"title":3911},{"VI":3912},"Department of Neurosurgery, Chiba Hokuso Hospital, Nippon Medical School, Inzai, Chiba, Japan",[],{"orcid":3915,"title":3917,"openalex":3919},{"VOID":3916},"https:\u002F\u002Forcid.org\u002F0000-0003-2545-4060",{"EN":3918},"Kyongsong Kim",{"VOID":3920},"A5034581292",{"id":3922,"sortIndex":40,"researcher":28,"roles":3923,"affiliations":3924,"properties":3933,"displayName":3937,"givenName":28,"familyName":28},"33b0e900-e5cf-410c-a894-044e331a147c",[],[3925],{"id":3926,"sortIndex":32,"affiliation":3927,"properties":28},"a0e7cf97-e609-490b-8672-48ac0c20871e",{"id":3926,"createTime":28,"updateTime":28,"relativeEntities":3928,"slug":28,"properties":3929,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3932,"statistic":28},[],{"title":3930},{"EN":3931},"Department of Neurosurgery, Kushiro Rosai Hospital, Kushiro, Hokkaido, Japan.",[],{"orcid":3934,"title":3936,"openalex":3938},{"VOID":3935},"https:\u002F\u002Forcid.org\u002F0000-0001-5298-1806",{"EN":3937},"Toyohiko Isu",{"VOID":3939},"A5030440879",{"id":3941,"sortIndex":123,"researcher":28,"roles":3942,"affiliations":3943,"properties":3950,"displayName":3954,"givenName":28,"familyName":28},"a1f76ab3-7ccc-49c8-8e81-6c3dde5ca497",[],[3944],{"id":3926,"sortIndex":32,"affiliation":3945,"properties":28},{"id":3926,"createTime":28,"updateTime":28,"relativeEntities":3946,"slug":28,"properties":3947,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3949,"statistic":28},[],{"title":3948},{"EN":3931},[],{"orcid":3951,"title":3953,"openalex":3955},{"VOID":3952},"https:\u002F\u002Forcid.org\u002F0000-0002-7329-2775",{"EN":3954},"Yasuhiro Chiba",{"VOID":3956},"A5083806931",{"id":3958,"sortIndex":42,"researcher":28,"roles":3959,"affiliations":3960,"properties":3967,"displayName":3969,"givenName":28,"familyName":28},"6ded8706-cd5b-4d5c-be4c-7a411c98bb1b",[],[3961],{"id":3926,"sortIndex":32,"affiliation":3962,"properties":28},{"id":3926,"createTime":28,"updateTime":28,"relativeEntities":3963,"slug":28,"properties":3964,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3966,"statistic":28},[],{"title":3965},{"EN":3931},[],{"title":3968,"openalex":3970},{"EN":3969},"Naotaka Iwamoto",{"VOID":3971},"A5014817023",{"id":3973,"sortIndex":45,"researcher":28,"roles":3974,"affiliations":3975,"properties":3982,"displayName":3986,"givenName":28,"familyName":28},"e9706bce-4358-4e63-b8b2-4caf58fdc19d",[],[3976],{"id":3926,"sortIndex":32,"affiliation":3977,"properties":28},{"id":3926,"createTime":28,"updateTime":28,"relativeEntities":3978,"slug":28,"properties":3979,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":3981,"statistic":28},[],{"title":3980},{"EN":3931},[],{"orcid":3983,"title":3985,"openalex":3987},{"VOID":3984},"https:\u002F\u002Forcid.org\u002F0000-0002-0061-4868",{"EN":3986},"Kazuyoshi Yamazaki",{"VOID":3988},"A5041609129",{"id":3990,"sortIndex":46,"researcher":28,"roles":3991,"affiliations":3992,"properties":4001,"displayName":4003,"givenName":28,"familyName":28},"8645b6a2-23d1-4546-9d33-75137fa4d061",[],[3993],{"id":3994,"sortIndex":32,"affiliation":3995,"properties":28},"b2cd68c6-b80c-4f13-924f-e1c24ee28586",{"id":3994,"createTime":28,"updateTime":28,"relativeEntities":3996,"slug":28,"properties":3997,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":4000,"statistic":28},[],{"title":3998},{"VI":3999},"Department of Neurosurgery, Nippon Medical School, Tokyo, Japan",[],{"title":4002,"openalex":4004},{"EN":4003},"Daijiro Morimoto",{"VOID":4005},"A5032990646",{"id":4007,"sortIndex":48,"researcher":28,"roles":4008,"affiliations":4009,"properties":4016,"displayName":4020,"givenName":28,"familyName":28},"23a397c8-dea6-4a81-9848-1b7f32601281",[],[4010],{"id":3926,"sortIndex":32,"affiliation":4011,"properties":28},{"id":3926,"createTime":28,"updateTime":28,"relativeEntities":4012,"slug":28,"properties":4013,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":4015,"statistic":28},[],{"title":4014},{"EN":3931},[],{"orcid":4017,"title":4019,"openalex":4021},{"VOID":4018},"https:\u002F\u002Forcid.org\u002F0000-0002-5899-9932",{"EN":4020},"Masanori Isobe",{"VOID":4022},"A5063589194",{"id":4024,"sortIndex":49,"researcher":28,"roles":4025,"affiliations":4026,"properties":4035,"displayName":4039,"givenName":28,"familyName":28},"ffd49bd4-4079-4f41-ac58-5a5829210665",[],[4027],{"id":4028,"sortIndex":32,"affiliation":4029,"properties":28},"e37e2fe5-2ae7-45f2-90dd-a7c3e752768d",{"id":4028,"createTime":28,"updateTime":28,"relativeEntities":4030,"slug":28,"properties":4031,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":4034,"statistic":28},[],{"title":4032},{"EN":4033},"Department of Neurology, Sapporo Yamanoue Hospital, Spporo, Hokkaido, Japan.",[],{"orcid":4036,"title":4038,"openalex":4040},{"VOID":4037},"https:\u002F\u002Forcid.org\u002F0009-0004-0760-5341",{"EN":4039},"Kiyoharu Inoue",{"VOID":4041},"A5007949315",{"url":28,"publisher":4043,"properties":4072},{"id":868,"createTime":869,"updateTime":870,"relativeEntities":4044,"slug":872,"properties":4045,"entityType":25,"verifyStatus":882,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":32,"subjectFields":4049,"manageAffiliations":4058,"indexDatabases":4064,"url":918,"thumbnailPath":28,"statistic":28,"gsStatistic":28,"type":28,"analyzePriority":28},[],{"issn":4046,"title":4047,"country":4048},{"VOID":877},{"EN":879},{"VOID":875},[4050,4054],{"id":885,"createTime":28,"updateTime":28,"relativeEntities":4051,"label":4052,"description":4053,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":888},{},{"id":891,"createTime":28,"updateTime":28,"relativeEntities":4055,"label":4056,"description":4057,"parentId":28,"standard":28,"scholarHubFieldId":28},[],{"EN":894},{},[4059],{"id":898,"createTime":28,"updateTime":28,"relativeEntities":4060,"slug":28,"properties":4061,"entityType":28,"verifyStatus":28,"verifyTime":28,"verifyNote":28,"languages":28,"translateLanguages":28,"viewCount":28,"url":28,"parentIds":4063,"statistic":28},[],{"title":4062},{"EN":902},[],[4065],{"id":906,"indexDatabase":4066,"url":912,"indexYears":913,"academicFieldIds":4071,"indexDatabaseRanking":917},{"id":775,"createTime":28,"updateTime":28,"relativeEntities":4067,"label":4068,"description":4069,"key":781,"publicationTags":4070,"standard":28},[],{"EN":778,"VI":778},{"EN":778,"VI":780},[783],[915,916],{"issue":4073,"pages":4075,"volume":4077},{"VOID":4074},"25",{"VOID":4076},"619",{"VOID":2600},{"total":134,"publishYear":2602,"statisticByYear":4079},{"2016":40,"2017":48,"2018":45,"2019":123,"2020":123,"2021":46,"2024":40},[917],[4082,4085,4088,4091,4094],{"id":28,"text":4083,"url":28,"identifiers":4084},"Chiba Y, Isu T, Kim K, Iwamoto N, Morimoto D, Yamazaki K, et al. Intermittent low back pain attributable to superior cluneal nerve entrapment neuropathy. J Neurosurg Spine.  [In Press].",{},{"id":28,"text":4086,"url":28,"identifiers":4087},"Kim, 2013, J Neurosurg Spine, The usefulness of ICG video angiography in the surgical treatment of superior cluneal nerve entrapment neuropathy: Technical note, 624",{},{"id":28,"text":4089,"url":28,"identifiers":4090},"Kuniya, 2013, J Neurosurg Spine, Anatomical study of superior cluneal nerve entrapment, 76",{},{"id":28,"text":4092,"url":28,"identifiers":4093},"Maigne, 1976, Spine (Phila Pa, Entrapment neuropathy of the medial superior cluneal nerve.Nineteen cases surgically treated, with a minimum of 2 years′ follow-up, 1156",{},{"id":28,"text":4095,"url":28,"identifiers":4096},"Morimoto, 2013, J Neurosurg Spine, Surgical treatment of superior cluneal nerve entrapment neuropathy, 71",{}]